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ABSTRACT
Objectives: To document the incidence, mortality and morbidity from childhood invasive 
Haemophilus influenzae type b (Hib) disease and the risk factors for developing Hib 
disease in the Sydney Statistical Division (SSD). To evaluate the costs and benefits of 
Hib immunisation in non-Aboriginal Australian children, generalised from the SSD. To 
evaluate the impact of the introduction of Hib immunisation on Hib disease in the SSD, 
based on pre-immunisation data.
Design: The studies included a number of research designs. These were measures of 
disease incidence in a defined geographic area, follow-up studies, disease costing, 
decision analysis, economic evaluation using cost-effectiveness and cost-utility methods, 
and a prospective population-based case-control study.
Measures: Measurement of age-specific disease incidence was by retrospective and 
prospective disease surveillance, established through a network of notifying laboratories 
and hospitals within the SSD. Measurement of long-term disease outcome and the 
impact of Hib disease on families, collection of data on case and control characteristics 
and ascertainment of receipt of Hib immunisation was by questionnaire and telephone 
interview.
in
Results: The incidence of all invasive Hib disease in Sydney children 0-4 years was
40-50 per 100,000 per year prior to the introduction of Hib immunisation. Meningitis 
was responsible for approximately 50% of cases and predominated under the age of two 
years, while epiglottitis accounted for approximately 30% of cases and predominated 
over this age. There was significant short-term morbidity from all forms of Hib disease. 
Meningitis was associated with serious sequelae (death, severe neurologic disability , 
profound hearing loss) in approximately 10% of children, with another 10% suffering 
lesser long-term disabilities. The model of immunisation against Hib disease predicted 
that public-sector immunisation would be cost-saving for children under the age of two 
years with conservative assumptions of benefit and costs. Children from English- 
speaking backgrounds were at increased risk of Hib disease if they were cared for with 
other children outside the home. Large families and crowding were associated with 
disease risk in younger children, particularly those from non English-speaking 
backgrounds. Older children who developed Hib disease were more likely to be from 
more advantaged and smaller families, correlating with the later disease onset observed 
in children from geographic areas with relatively fewer young children. Following the 
introduction of Hib immunisation in the SSD, a sharp fall in disease incidence was 
observed in all age-groups eligible for immunisation once vaccine uptake approached 
50%.
Conclusions: This thesis documents the pattern and burden of Hib disease before 
immunisation, risk factors for Hib disease, and its reduction and likely disappearance 
following immunisation in a well-defined population.
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CHAPTER ONE
WORLDWIDE EPIDEMIOLOGY OF  
INVASIVE Haemophilus influenzae DISEASE
1.1 DESCRIPTIVE EPIDEMIOLOGY
Haemophilus influenzae type b (Hib) is an important childhood pathogen in 
virtually all areas of the world where it has been adequately studied.1 There is 
evidence that the incidence of Hib meningitis and its importance relative to 
other pathogens, particularly Neisseria meningiditis, has been increasing in a 
number of countries.2'5 In general, the importance of invasive Hib disease 
depends on its age-specific incidence, mortality and morbidity in the context of 
other preventable health problems in any geographic area.
The nature and quality of the epidemiologic data available can be considered 
in three main categories : industrialised countries; indigenous populations 
within industrialised countries; and unindustrialised countries. Even taking this 
variability in data quality into account, there are very marked differences in the 
incidence, age distribution and disease spectrum of invasive Hib disease within 
and among these three population groups. The available data on both the
2descriptive epidemiology of Hib disease and the bactériologie, host and 
environmental factors which have been suggested to explain differences in the 
patterns of invasive Hib disease between populations will be addressed in this 
chapter.
Population-based studies documenting the epidemiology of invasive Hib disease 
are now available from many areas in Europe, North America and Australasia. 
Studies from other parts of the world are more sparse, often deal with 
meningitis only and are usually not population-based. These studies differ in 
methods of case ascertainment, incidence and age distribution of various foci as 
well as the seasonal pattern of Hib disease and levels of mortality and 
morbidity.
1.11 Case ascertainment 
1.111 Meningitis
Case ascertainment in virtually all studies assumes that almost all cases are 
identified in hospitals and depends on access to medical care, the level of non­
prescription antibiotic use and the availability of appropriate laboratory 
facilities for isolation and serotyping.6 Ascertainment of meningitis is the most 
complete, although in less developed countries pre-hospital deaths may not be 
identified as meningitis and culture-negative meningitis is much more common 
than in industrialised countries.7 Detection of Hib polysaccharide in 
cerebrospinal fluid or urine by latex agglutination has the potential to
3substantially reduce the rate of culture-negative meningitis in developing 
countries8 but is often not available. Indigenous populations within developed 
countries, such as Alaskan Eskimos9 and Australian Aborigines,10 have 
relatively good access to medical care and diagnostic facilities despite 
remoteness; ascertainment is probably much more complete among them than 
developing countries.
1.112 Epiglottitis
Epiglottitis is also unlikely to go unrecognised but case definitions vary, with 
some studies only accepting bacteraemic cases, while others have judged a 
clinical case definition to be more appropriate, as epiglottitis in children is 
almost always due to Hib.11
1.113 Other bacteraemic Hib disease
Ascertainment of other disease entities is totally dependent on culture, as the 
clinical features are not specific for Hib. Intensified active surveillance for Hib 
in Finland resulted in an increase in non-meningitis, non-epiglottitis (NMNE) 
cases of only 6%12 but in Geneva changes in diagnostic practice were deemed 
responsible for an apparent significant increase in the incidence of NMNE 
cases.13
Bacteraemic Hib pneumonia is uncommon in industrialised countries and, in the 
absence of bacteraemia, positive results from urinary antigen testing are likely
4to be false positives.14 By contrast, acute lower respiratory tract infection 
(ALRI) is common and pneumonia a common manifestation of invasive Hib 
disease in indigenous9,10 and less developed15 communities. In this setting, 
ALRI is commonly due to Streptococcus pneumoniae or Haemophilus 
influenzae16 and urinary antigen testing is likely to be much more specific for 
Hib infection.17 The degree of under-ascertainment of Hib as a cause of ALRI 
and death from pneumonia is uncertain in developing countries; other serotypes 
of Haemophilus influenzae are also important.15
1.12 Incidence of invasive Hib disease
1.121 Meningitis
Table 1.1 shows published population-based studies of the incidence of Hib 
meningitis in industrialised countries, with their 95% confidence intervals. In 
the US, Afro-Americans, but not other racial groups, have a significantly higher 
incidence of Hib meningitis than whites.18,20 The incidence of meningitis in US 
whites is in turn approximately double that of predominantly Caucasian 
populations in Europe or Australasia.
5Table 1. 1 POPULATION-BASED STUDIES OF INVASIVE Hib DISEASE
IN INDUSTRIALISED COUNTRIES
STUDY MENINGITIS EPIGLOTTITIS TOTAL
Incidence* Incidence Incidence
United States
(95% Cl)+ (95% Cl) (95% Cl )
Fresno18 60 (50-80) 6.5 (2.1-15.1) 90 (70-110)
New York19 40 (28-55) - 64 (49-83)
Atlanta20 57 (45-71) - 82 (67-97)
Dallas21 58 (49-67) 2.7 (1.2-5.2) 98 (88-110)
Minnesota22 42 (37-47) 4.0 (2.6-5.8) 64 (59-71)
Europe
Finland12 26 (22-30) 12.8 (10.4-16.2) 52 (47-58)
Sweden22 31 (28-34) 24.6 (22.1-27.2) >56 (>50)
Denmark24 27 (23-31) 8.0 (5.7-10.8) 40 (35-45)
Oxford25 24 (20-28) 3.8 (2.4-5.7) 33 (29-38)
Wales26 22 (18-26) 5.3 (4.6-6.1) 35 (30-40)
Israel (Jews)27 22 - 2.0 (0 - 4.7) 51 (41-61)
Geneva13 25 (20-31) 19.0 (14-25) 56 (48-65)
Australasia
Victoria28 25 (22-29) 22.7 (19.6-25.8) 59 (54-64)
Sydney29 20 (16-23) 11.9 (9.5-14.8) 39 (34 -43)
Western Australia30 27 (23-32) 13.5 (10.9-16.2) >40 (>34)
Auckland31 27 (22-32) 3.8 (3.1-4.4) 41 (35-47)
+
Per 100,000 children 0-4 years 
95% confidence interval
6In the latter countries, the incidence of meningitis is strikingly uniform in the 
range 20 - 30 per 100,000, with a similar range of 95% CIs. Data are sparse for 
other industrialised countries. In Japan,37 Hib caused 28/89 (31%) of culture- 
positive purulent meningitis in childhood and was the single most common 
organism in children over three months of age; in Singapore,38 Hib caused 3/12 
(25%) of childhood bacterial meningitis beyond the neonatal age group.
In most indigenous populations, the pattern is strikingly different, with point 
estimates of incidence five to ten fold higher than industrialised 
countries.(Table 1.2) As many of these studies are based on comparatively 
small numbers of cases, the 95% CIs are wide; however the lower 95% CIs 
remain significantly higher than those for industrialised countries. A number of 
studies have compared the incidence of Hib disease in indigenous and non- 
indigenous populations in the same geographic area.9’10,26 In Alaska9 and the 
Northern Territory of Australia10 disease incidence was significantly lower in 
non-natives, while in the Negev region of Israel, Jews and Bedouins had a 
similar total incidence of Hib disease27 but the incidence of Hib meningitis in 
Bedouins was twice that of Jews.39 The incidence of disease may also vary 
among indigenous groups in the same area. In the Northern Territory, 
Aborigines in the arid Central region had a significantly higher incidence of 
meningitis than those in the wetter North10 and in Alaska, the incidence in 
Eskimo populations was higher than Indians.9
The reported incidence of meningitis in unindustrialised countries is 
significantly lower than indigenous populations, and comparable to some
7industrialised countries, particularly when incidence 0-4 years is considered 
(Table 1.2). These figures are minimum estimates; under-ascertainment was 
suggested elsewhere in Chile by the significantly higher incidence found in one 
area of Santiago with superior hospital services.35 Other data from non- 
industrialised countries consist of hospital-based studies which report the 
relative proportion of childhood meningitis caused by Haemophilus influenzae, 
Neisseria meningitidis and Streptococcus pneumoniae but do not estimate 
incidence.39'44 Haemophilus influenzae is the most prevalent cause of 
childhood bacterial meningitis in some areas41 while in others Streptococcus 
pneumoniae is more common, especially in infancy.39,42,43 In regions where 
epidemic meningococcal disease occurs, the importance Haemophilus 
influenzae as the most common cause of childhood endemic meningitis is 
obscured during epidemic periods.40,44
The age distribution of Hib meningitis is closely related to incidence, with high 
incidence populations showing a shift in the age distribution to the left. The 
percentage of meningitis occurring under 12 months of age increases from 30% 
in Finland12 to 95% in Alaskan Eskimos32 as the incidence of meningitis 
increases. The skewed age distribution of disease observed in some non- 
industrialised countries despite relatively low total incidence7,34,35 may be a 
marker of under-ascertainment. It is interesting that the percentage of 
meningitis cases occurring before three months of age did not differ 
significantly between native and non-native populations in Alaska9 or 
Australia.10 This is probably due to relatively high levels of Hib capsular 
antibody at birth in high incidence populations, as demonstrated in Alaska,9
8
which have fallen to low levels by three months.9
Table 1.2 POPULATION-BASED STUDIES OF INVASIVE Hib DISEASE 
IN NON-INDUSTRIALISED COUNTRIES
STUDY MENINGITIS MENINGITIS TOTAL
0-1 Years 0-4 Years 0-4 years
lncidence*(95%CI) Incidence (95%CI) Incidence (95%CI)
INDIGENOUS
POPULATIONS
Alaskan natives9 871 (630-1175 282 (216-364) 601 (495-707)
Eskimos32 2323 (1473-3485) 474 (310-694) -
Apaches33 1169 254 -
Aborigines10 716 (503-986) 150 (107-204) 529 (420-659)
Bedouins27 181 - 58 -
OTHER
Gambia7 297 (230-379) 60 (32-75) -
Senegal34 132 36 -
Chile (all Santiago)35 47 (40-55) 15 (13-17) 22 (19-24)
Chile (Area Norte)35 85 (59-119) 25 (19-33) 43 (34-53)
Qatar36 47 (21-93) 16 (8-27) 26 (16-39)
+
Per 100,000 children 0-1 or 0-4 years 
95% confidence interval in these communities.
91.122 Epiglottitis
In general, as the incidence of meningitis increases, the median age of disease 
onset falls and epiglottitis becomes relatively less. Epiglottitis is virtually 
unknown except in industrialised populations.7,9,10,27,32'36 There are also 
considerable differences in the incidence of epiglottitis among industrialised 
countries with very similar disease incidence and age distribution and even 
within Australia (Table 1.1). Epiglottitis is uncommon under 12 months,12,23,28 
with the peak incidence generally occurring after 24 months of age. However 
as cases do occur under 12 and rarely under six months of age, the age at 
disease onset alone does not explain the absence of the condition in high 
incidence populations. Epiglottitis is associated with higher levels of 
anticapsular antibody46 and lower levels of bacteraemia.47 In Minnesota48 but 
not in Finland49 a significant increase in epiglottitis was observed in cases who 
had received unconjugated PRP vaccine.
1.123 Other infections
Acute lower respiratory tract infection (ALRI) due to Hib is of particular 
interest in a worldwide context. In industrialised countries, bacteraemic Hib 
pneumonia is well described, but accounts for less than 10% of invasive Hib 
disease in most series. The age incidence has a bimodal peak in some studies, 
occurring in infants, often with other foci of Hib disease and also in children at 
the upper end of the age range.12,13,28,29 In indigenous populations, pneumonia is 
the next most common site of invasive Haemophilus influenzae disease after
10
meningitis and follows the age distribution of the latter;9,10 other capsular types 
and non-typable strains are seen as well as type b.10
In non-industrialised countries, ALRI is often the most common cause of death 
in children 0-4 years.15,50 Intensive community and hospital surveillance in the 
Gambia estimated that although Hib was only responsible for 5-10% of 
pneumonia, the high incidence of Hib pneumonia made it responsible for twice 
as many deaths as Hib meningitis.15 In the highlands of Papua New Guinea, the 
incidence of culture-proven Hib ALRI was estimated as 2860 per 100,000 0-4 
years and thought to be the principal endpoint for assessing the efficacy of 
immunisation against Hib. There are few data on the importance of invasive 
Hib disease other than ALRI and meningitis in non-industrialised countries. Hib 
caused less than 3% of community-acquired bacteraemia in Rwanda, Africa 
where Salmonella spp accounted for some 80% of isolates.51
1.13 Seasonality
A variety of seasonal patterns have been described in industrialised countries. 
In the northern US52 and Finland,12 there was a bimodal spring and autumn 
peak in disease incidence, in contrast to the winter peak in pneumococcal and 
meningococcal disease.52 In Australia, a definite winter peak was noted.28,29 
while Sweden reported no significant seasonal differences.22,23 By contrast, 
Australian Aborigines10 had a summer peak in disease incidence as did 
Bedouin Arabs,27 corresponding to peak diarrhoeal disease incidence. Jews in
11
the same geographic area as the Bedouins had a distinct winter disease peak, 
corresponding to high levels of respiratory morbidity.27 These seasonal patterns 
are of interest because of their possible relationship to epidemic patterns of 
other infective agents, particularly respiratory viruses12,53 although non- 
respiratory infections may also be important.27
1.14 Mortality and morbidity
The diseases caused by Hib are life threatening. In developed countries, the 
mortality from Hib meningitis has fallen from some 20% in the 1950s4 to 5% 
or iess12-21>25 262830 with improvements in treatment but there has been little 
further reduction in mortality since the 1970s. Epiglottitis and pneumonia are 
also potentially fatal, with a mortality rate of 2-5%.23,28 Almost all deaths in 
developed countries with good access to medical services are now due to 
fulminant disease and occur before hospital admission.29 Improved intensive 
care or antibiotic treatment is unlikely to be of benefit. In indigenous 
communities, mortality may be slightly higher than the non-native population 
due to remoteness and transportation difficulties30 but is of a similar order.9,39 
By contrast, mortality from Hib meningitis is 20 - 50% in less developed 
countries, with substantial underestimation of pre-hospital deaths likely.7 This 
mortality rate represents a much higher numerical burden because of the young 
age of most of the population.52 ALRI is probably also an important cause of 
mortality from Hib disease in developing countries and may be more important 
than meningitis.15
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The short-term morbidity of Hib disease in developed countries is high 
resulting in hospital admission, often intensive care, with high attendant costs.53 
Severe long-term morbidity is almost all from meningitis, although epiglottitis 
occasionally results in hypoxic brain injury and septic arthritis can result in 
deformity. Severe handicap occurs in 3-5% of survivors of Hib meningitis22,30,53 
and hearing loss severe enough to require hearing aids in another 3-5%.22,30,53 
The frequency of less severe handicaps is more difficult to measure and is 
controversial, with some studies reporting high rates of intellectual and motor 
problems which controlled studies have found to be due to confounding by 
socio-economic factors.54 In less developed countries, severe handicap from 
meningitis is likely to result in early mortality.7'52 Nevertheless it is clear that in 
all parts of the world, Hib disease causes a high morbidity and mortality in 
proportion to its incidence.
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1.2 CAUSAL EPIDEMIOLOGY
A number of factors have been advanced to explain the observed differences in 
the epidemiology throughout the world. They may be broadly grouped into 
bacterial factors influencing virulence, factors increasing host susceptibility to 
Hib and environmental factors resulting in increased exposure to Hib.
1.21 Bacterial factors
Hib can be subtyped by methods which differentiate outer membrane 
components of Hib (outer membrane proteins and liposaccharide) or bacterial 
enzymes (biotyping and electrophoretic typing). These methods have substantial 
overlap, and strains of the most common types are often difficult to distinguish. 
There are interesting differences in the electrophoretic types (ETs) prevalent in 
different pans of the world, corresponding to some extent to migration patterns 
and suggesting that Hib consists of a relatively small number of clones 
worldwide.55 There is little evidence to relate these genetic markers to 
virulence.1 The only study to demonstrate a correlation between organism type 
(OMP type lc/ ET 21.8) and disease type (meningitis vs epiglottitis) was from 
Finland;56 this association has not been confirmed elsewhere.55
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1.22 Host factors
Age is the first and most important factor in susceptibility to invasive Hib 
disease in all populations and is related to the level of protective antibody to 
the capsular polysaccharide of Hib (PRP), which does not rise appreciably until 
two years of age. It is intriguing that in high incidence populations, although 
the mean level of PRP antibody remains low throughout the second year of life, 
almost all disease occurs in the first year of life, despite continuing high levels 
of exposure to respiratory pathogens and Hib.9 Recurrent disease is common in 
Alaskan Eskimo populations (8%) compared with <1% of children in Texas.57 
Together these factors suggest that host factors are important - the high level of 
exposure selects out all the susceptibles in the population early in life, who 
may have recurrent disease because of continuing high exposure; those who 
have not developed disease by 12 months of age remain free of it.
There has been much work examining factors associated with impaired 
antibody response to Hib, in particular the possible effect of different alleles of 
immunoglobulin genes1 and factors related to PRP vaccine failure.58 Although 
some significant differences in allotypes and other genetic markers have been 
described, associated with both increased and decreased risk of Hib disease,1 
these factors are not present in a large proportion of the populations studied 
and do not explain population differences. Very few studies of allotype or 
antibody response have adequately controlled for confounding variables related 
to exposure59 or been free from selection bias.48
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The interpretation of racial differences in susceptibility to Hib disease is 
controversial.6 Numerous studies from the US have found a higher disease 
incidence in blacks.6,18,21 The two studies which controlled for socioeconomic 
variables have found that race did not20 and did6 remain a significant predictor 
of disease risk. Information on other racial groups is scanty. It has been 
suggested that at least some Asian children may be less susceptible to Hib 
disease55 and in an Australian study, children whose mothers were bom 
overseas were less likely to have epiglottitis.60
1.23 Environmental factors
Factors related to disease exposure such as crowding and exposure to young 
children have been consistently found to be important predictors of Hib disease 
risk.6 Studies of the role of socioeconomic factors in Hib disease in developed 
countries have been recently reviewed.61 The prevalence of daycare outside the 
home and breast feeding in the community may be an important determinant of 
the age distribution of disease. In Scandinavian countries, exposure to daycare 
is delayed, breastfeeding is prolonged and later disease onset seen.61
Daycare outside the home is probably a more significant risk factor for children 
who do not have any young siblings.61
Although a number of studies have found children from lower socioeconomic 
status families over-represented among cases,6 socioeconomic status appears to 
be an intervening variable for other factors, such as crowding, rather than a
16
predictor of disease risk.61 Other infections, particularly respiratory infections, 
predispose to Hib disease61 and may account in part for the very high disease 
incidence seen in less developed countries, where respiratory infection is also 
prevalent.15
The only study of environmental factors in other than an industrialised 
country62 found that the presence of more than one family in the household was 
a significant risk factor in Eskimo children, perhaps the equivalent of daycare 
exposure. It is likely that bacterial, host and environmental factors are 
important in different settings. For instance, where environmental exposure is 
high, such as in some indigenous populations, this may be the predominant 
factor, but in other populations where host susceptibility is less, high 
environmental exposure may not be sufficient to increase disease susceptibility.
In summary, there are now data on the epidemiology of invasive Hib disease 
from most parts of the industrialised world although data are more sparse from 
other areas. The apparent geographic differences remain incompletely 
explained. There is good evidence that under-ascertainment and environmental 
factors are important and lesser evidence for the importance of genetic 
differences among hosts and strains of the organism. Nevertheless, it is 
apparent that Hib is an important childhood pathogen throughout many 
geographic areas and populations and that prevention of Hib disease is an 
important objective in many settings.
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CHAPTER TWO
DESCRIPTIVE EPIDEMIOLOGY OF INVASIVE 
Haemophilus influenzae type b disease 
IN THE SYDNEY STATISTICAL DIVISION
2.1 HISTORICAL DATA
Since the 1940s, Haemophilus influenzae type b (Hib) has been increasingly 
recognised as the commonest bacterial cause of serious childhood infections in 
industrialised countries. Population-based data extending over 25 to 40 years 
from Sweden,2 Minnesota63 and Pittsburgh,64 provide convincing evidence of a 
significant increase in the incidence of Hib meningitis unexplained by secular 
changes in the base populations. Although no longitudinal population-based 
data are available from Australia, hospital-based data from Sydney,65 Adelaide66 
and Melbourne67 suggest that Haemophilus influenzae replaced Neisseria 
meningitidis as the most frequent cause of childhood bacterial meningitis in the 
1950s. Epiglottitis has been recognised in Australia for at least 25 years and, in 
children, is almost always caused by Hib.11 Hospital-based data from Victoria 
suggest that epiglottitis has increased in incidence and as a proportion of Hib 
disease relative to meningitis.67 69 Other hospital-based studies from Sydney,70 
Brisbane71 and Melbourne72 have documented a variety of clinical presentations
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of invasive Hib disease including cellulitis, arthritis, pneumonia and 
bacteraemia. Hib caused two thirds of bacteraemia71 and 70% of meningitis.67,71 
72 The case mortality rate of Hib meningitis in Australian paediatric centres has 
fallen from 17% in the 1950s65,66 to approximately five percent in the 1970s.28,72 
Since the 1970s, further reductions in mortality or morbidity have not been 
achieved, despite new antimicrobial agents with greatly enhanced in vitro 
activity.73 As many deaths due to Hib meningitis74 and epiglottitis28,75occur 
before admission to hospital, prevention by immunisation is the only means to 
further reduce morbidity and mortality from Hib disease.
This chapter documents the epidemiology of invasive Haemophilus influenzae 
disease among children in the Sydney Statistical Division before immunisation.
2.2 METHODS 
2.21 Case definition
A culture positive case of Hib disease was defined as a child aged 0-14 years 
in whom Haemophilus influenzae was isolated from blood, cerebrospinal fluid 
or any normally sterile site. A culture-negative case was defined as a child 
with endoscopically-proven epiglottitis or with Hib antigen identified in 
cerebrospinal fluid, urine or joint fluid in the presence of features of pyogenic 
meningitis or a syndrome commonly caused by Hib, such as facial cellulitis or
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septic arthritis. Detection of Hib antigen only was considered insufficient proof 
of Hib aetiology for pneumonia14.
Laboratory procedures for the identification of Haemophilus influenzae were 
not audited although all laboratories surveyed participate in the Quality 
Assurance Program of the Royal College of Pathologists of Australia in 
Microbiology. All laboratories used standardised disc methods for testing 
antimicrobial susceptibility. Most used the Calibrated Dichototmous Sensitivity 
(CDS) method, the remainder using the method recommended by the National 
Committee for Clinical Laboratory Standards (NCCLS). Routine serotyping of 
Haemophilus isolates from blood or cerebrospinal fluid was performed in the 
six largest laboratories, although some determined only whether the isolate was 
type b. All serotyping of Haemophilus isolates was by latex agglutination. Most 
of the laboratories which did not routinely serotype performed latex 
agglutination tests for Hib antigen in cerebrospinal fluid in cases of meningitis. 
Isolates processed by laboratories which did not serotype routinely were 
assumed to be type b unless the patient had an underlying predisposition to non 
type b infection (neonate, immunosuppressed or cerebrospinal fluid leak), as 
serotypes other than type b rarely cause bacteraemia in childhood11,77.
2.22 Case Ascertainment
The study population was the Sydney Statistical Division (SSD) excluding the 
northern-most area of Gosford and Wyong. The SSD has natural geographic 
boundaries. NSW Health Department data indicate that less than five per cent
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of children from the SSD going to hospital do so outside the SSD. Such 
children were excluded as were cases if they had resided in the SSD for less 
than 14 days, if the hospital records were lost, or if the culture was taken 
outside the study period.
Case ascertainment was hospital-based and retrospective. All 21 hospitals in 
the SSD which admit patients in the age range 0-5 years were surveyed. At 
17 hospitals, which account for 86% of paediatric admissions, laboratory 
records of blood and cerebrospinal fluid isolates during the study period were 
the primary data source. At the three largest hospitals (Royal Alexandra 
Hospital for Children, Prince of Wales Children’s Hospital and Westmead 
Hospital; 48% of admissions and virtually all the paediatric intensive care 
services in the SSD), full enumeration of discharge diagnoses was available. 
Records for meningitis bacterial (ICD code 320), meningitis unspecified (ICD 
code 322) and epiglottitis (ICD code 464.3) for the years 1985-87 were cross­
checked against laboratory isolates. An additional five cases were identified by 
medical record review (2.5%). Intensive care unit records, log sheets of 
infection control services and the personal records of attending paediatricians 
were scrutinised. All sources were cross-referenced for full ascertainment 
without duplication.
The hospital records of all cases identified were reviewed after obtaining 
consent from hospital research and ethics committees or, in their absence, the 
medical administration of the hospital concerned. Laboratory, clinical and 
demographic data were recorded on a standard form and entered into a Clinical
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Report System data base.
Deaths outside hospital were identified from a listing of certificates where the 
cause of death was recorded as due to meningitis, sepsis or epiglottitis during 
the years 1985-87, obtained from the NSW Department of Health Statistical 
Services Branch. As well, bacteriology records from coroner’s post mortems in 
the SSD were surveyed. As no separate register of paediatric autopsies was 
available these could not be reviewed directly. Hib disease occurring in 
children who neither died nor were admitted to hospital was thought to be 
infrequent and of little public health importance.
The Statistical Package for Interactive Data Analysis (SPIDA) was used for all 
regression analysis. Unless otherwise stated, incidence refers to the cumulative 
incidence 1985-1987, expressed as a rate per 100,000 children per year. Age- 
specific incidence is calculated according to the age categories 0-1 years or 0- 
12 months and 0-4 years or 0-59 months.
2.3 RESULTS
In the study period, 1985-7, 297 patients 0-14 years with invasive Haemophilus 
disease who resided in the SSD were identified. Only one case came from a 
non-hospital source. More than half the Haemophilus isolates were processed 
by laboratories which serotyped routinely. Only three of the 176 Haemophilus
isolates (1.7%), all from cerebrospinal fluid, processed by these six laboratories
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were other than type b (one each type a, type f and "non b"). A further two 
patients with Haemophilus bacteraemia whose records were lost were excluded, 
leaving 292 cases who fulfilled the case definition.
In 275 cases, Haemophilus influenzae was isolated from blood or cerebrospinal 
fluid (272) or another normally sterile site (3). One patient with pyogenic 
meningitis and three patients with epiglottitis had Hib antigen detected in 
cerebrospinal fluid (1) or urine (3), but had negative cultures. Sixteen patients 
(17.6%) with typical endoscopic appearances of epiglottitis had negative blood 
cultures, and three were recorded as having received oral antibiotics prior to 
blood culture. Fifteen cases of epiglottitis were identified from laboratory 
records at hospitals without paediatric intensive care units; culture-negative 
cases at these hospitals could not be ascertained from available records. Four 
cases of culture-negative pyogenic meningitis possibly due to Hib were found 
by discharge diagnosis; aged 9, 12, 41 and 66 months. They represented, at 
most, an additional 4.5% of cases at the three hospitals where these data were 
available.
2.31 Age and focus of infection
The age and focus of infection of culture-positive and culture-negative cases in 
previously well children are shown in Table 2.1. All were community-acquired. 
The cumulative percentages of cases for the four major sites of infection by age 
are showm in Figure 2.1. Meningitis, cellulitis and arthritis had a similar age 
distribution, as did epiglottitis, pneumonia and bacteraemia which were
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predominantly seen in older children. In Figure 2.2, the former three foci are 
shown, with annual incidence expressed as a rate per 100,000 children 0-4 
years. Disease incidence peaked in the second six months of life, as did the 
incidence of meningitis and cellulitis/arthritis. Epiglottitis incidence rose from 
18 months until 48 months of age.
Table 2.1 AGE DISTRIBUTION BY FOCUS OF INFECTION IN 283 PREVIOUSLY WELL CHILDREN 
IN THE SYDNEY STATISTICAL DIVISION 1985-87
Age in months
Focus 0-6 7-12 13-18 19-24 25-60 61 & Over Total
N %
Meningitis 21 33 27(26)* 17 37 8 143 (142) 51
Epiglottitis 0 4(3) 6(5) 14(10) 58(49) 9(8) 91 (75) 32
Cellulitis 2 8 4 2 2 0 18 (18) 6
Arthritis 1 3 4 1 4 0 13 (13) 5
Pneumonia 1 0 2 3 6 0 12 (12) 4
Other 1 1 0 0 2 2 6(6) 2.4
Total 26 49(48) 43(41) 37(33) 109(98) 20(18) 283 (266)
% 9.2 17.3 15.2 13.1 38.5 6.7 100
Figures in brackets are culture positive cases
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2.32 Underlying illness
Community-acquired cases with underlying illnesses included three with 
leukaemia, two with Down’s syndrome, one with primary
hypogammaglobulinaemia, one having had a splenectomy and one receiving 
post renal transplant steroid therapy. Seven of these eight community-acquired 
cases (87.5%) had foci of infection other than meningitis or epiglottitis 
(pneumonia 5, bacteraemia 2, cellulitis 1) compared with 49/283 (17.3%) of 
previously well children (p= 0.00005 Fisher’s exact test). The one child with 
meningitis was a 9 year old who had had a splenectomy. There were no cases 
of epiglottitis. One case was nosocomial - pneumonia in a 41 month old boy 
who had required positive pressure ventilation following severe bums. All these 
nine isolates were processed by laboratories which serotype routinely and were 
type b.
Cases with underlying disease were significantly older than cases without 
underlying disease, with 6/9 (66.7%) of the former 49 months or older 
compared with 38/283 (13.4%) of previously well children (p=0.0005 Fisher’s 
exact test) and 18/192 (9.4%) of previously well children with foci other than 
epiglottitis (P=0.0001 Fisher’s exact test).
2.33 Sex
Males accounted for 52.0% of all cases, varying from 50% of meningitis to 
54.9% of epiglottitis which corresponds to the census data distribution of
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males. There was no significant difference in the proportion of males with 
epiglottitis (50/91) compared with other foci (102/201) (odds ratio 1.26; 95% 
confidence interval 0.7-2.1).
2.34 Seasonality
There was a winter (June to August) peak evident in all three years, (Figure 
2.3) for meningitis, epiglottitis and other infections. The mean annual number 
of cases during the winter months was 11.6, which remained significantly 
greater than any other season ( summer 6.9, autumn 6.6 and spring 7.1), after 
controlling for year to year variation in a linear regression model (P = 0.0001). 
The apparent December peak is unexplained but may be an artefact as the 
number of cases in December varied widely among the three years.
2.36 Geographic distribution of cases
Cases would be predicted to occur at an older age in populations where there 
are fewer susceptible children (those aged less than five years), and also less 
opportunity for exposure, as nasopharyngeal carriage of Hib is most prevalent 
between six months and five years. To test this hypothesis, the proportion of 
the total population of each Local Government Area (LGA) in the SSD which 
was less than five years of age was used as a proxy measure of exposure. 
These proportions, which ranged from 3.5% (North Sydney) to 12.2% 
(Campbelltown),92 were used to group LGAs into four equal strata, from low to 
high proportions of children, shown in Figure 2.4.
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Figure 2.4 LGA Groups within the Sydney Statistical Division
1986 CENSUS
30
The counts of cases in each of the four strata were analysed, using the 
denominator populations 0-12 months and 13-59 months from the 1986 census 
as weights, in a regression model using the Poisson distribution. In the full 
model, there was no variation in the age effect across the last three strata (LGA 
groups two, three and four), but this common effect was significantly different 
from LGA stratum one, which had the lowest proportion of children (P=0.032). 
Incidence was thus analysed separately for the two age categories and for LGA 
group one against the other three LGA groups. These results are shown in 
Table 2.2.
The point estimate of incidence in children 0-12 months in the LGA stratum 
with least children (stratum one), was one third that of the other three LGA 
groups combined (incidence 19.9 per 100,000 vs 60.0 per 100,000) and differed 
significantly from them (P=0.03). In contrast, the incidence in children 13-59 
months of age in stratum one (46.8), was 1.4 times that in the other three strata 
combined, a difference which was almost significant at the P=0.05 level 
(P=0.056). This variation in incidence with age between LGA group one and 
the other LGAs was highlighted when the incidence rate ratio for the two age 
categories was calculated for LGA group one and LGA groups two, three and 
four (Table 2.2). The incidence rate ratio for LGA group one was 0.43, 
significantly different from the incidence rate ratio for LGA groups two, three 
and four combined of 1.84, in that the 95% confidence intervals of the two 
ratios did not overlap (Table 2.2). Despite this, the overall incidence of Hib 
disease among all children less than five years in LGA group one (40.9) did 
not differ from that in the other three LGA groups (38.1).
Calculated from
 the Poisson distribution
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TABLE 2.2 
Incidence* of invasive Hib disease 1985-1987 in previously well children in the Sydney Statistical Division by Local
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2.37 Antibiotic sensitivity of Haemophilus isolates
Of 272 isolates, 44 (16%) were resistant to ampicillin. Ampicillin resistance 
was as frequent in meningitis (17%) as in epiglottitis (16%) and other foci 
(14%) (X2^  = 0.27 P=0.88). Two isolates from patients with meningitis were 
resistant to chloramphenicol in vitro, one of which was also ampicillin resistant. 
The antimicrobial sensitivities of these two isolates were both confirmed by 
reference laboratories. The child with the ampicillin sensitive isolate was 
treated with ampicillin and the other patient with cefotaxime. No 
chloramphenicol resistance was found in the other isolates.
2.38 Mortality
There were six deaths in the study period, all children with meningitis. There 
was a trend towards older ages among cases who died (13, 22, 28, 39, 55 and 
70 months). Two of 98 patients under 24 months of age died (2%), compared 
with four of 46 (8.7%) over this age (P= 0.08 Fisher’s exact test). Two children 
died before arrival at hospital. Four had evolving evidence of brain death 
during a brief period of cardio-respiratory support in hospital. One child had a 
widespread purpuric rash and was initially thought to be suffering from 
meningococcaemia.
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2.4 DISCUSSION
The epidemiology of Hib disease differs markedly among populations in 
different geographic areas. The three most important differences are the total 
disease incidence, the age distribution and the proportion of epiglottitis, which 
are inter-related and have important implications for preventive programs. Each 
of these will be discussed in turn in relation to the present study.
The precision of the estimate of annual incidence of Hib disease in Sydney of 
approximately 40 per 100,000 children under five years of age depends on the 
validity of the assumption that invasive Haemophilus influenzae disease is due 
to type b and the completeness of case ascertainment. The validity of assuming 
b serotype is adequately confirmed by the small proportion of non-b isolates 
found, which is in keeping with other studies from industrialised 
countries.28'77,76,12 A falsely low estimate could result from incomplete 
ascertainment, particularly of culture-negative disease, diagnostic
misclassification of sudden deaths 28,74-75 or hospital discharges, and failure to 
obtain appropriate cultures where the focus of infection is not meningitis or 
epiglottitis.12 Any underestimation is likely to be modest. First, the proportion 
of culture-negative meningitis found in Sydney (5%) is comparable to Sweden 
(7%)78; second, the case fatality rate is comparable to studies where centralised 
autopsy data are available25,78; and third, the increase in case ascertainment 
achieved by prospective, active surveillance is small - the proportion of non­
meningitis, non-epiglottitis cases increased from 17% to 25% in Finland12.
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As complete records were not available at all hospitals and taking into account 
the above factors, underestimation of cases is unlikely to be more than 20% in 
the present study. If so, this would increase the annual incidence of Hib disease 
to a maximum of 46 per 100,000 children under five years. Underascertainment 
of the order of 50% would be necessary to increase the observed incidence in 
Sydney to that reported in Victoria,28 although the annual incidence in both 
centres is appreciably higher than the estimate of 30 per 100,000 from South 
Australia.79
The highest reported incidence of Hib disease in the world is that in Central 
Australian aborigines10, which as in other populations with a high disease 
incidence such as Eskimos9 and American Indians32, is associated with a 
preponderance of cases in younger children. A previously unreported finding 
of this study is that in areas where the proportion of the population under five 
years of age is low, the age-specific incidence of Hib disease differs, with the 
age distribution shifted to the right. In areas with the lowest proportion of the 
total population less than five years, a significantly lower incidence of invasive 
Hib disease was observed in infants less than 12 months. The incidence of Hib 
disease from 13 to 59 months of age was increased in these areas, such that 
overall disease incidence under five years did not differ significantly from areas 
with a higher proportion of young children. This sugggests that later exposure 
and development of protective immunity to Hib occurs among children in areas 
where the proportion of young children is low. These areas also tend to be of 
higher socio-economic status and a number of factors may account for this 
observation, for which the proportion of the population under five years serves
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as a proxy.
Epiglottitis accounted for approximately one third of Hib disease in Sydney, 
similar to Victoria28and Scandinavian countries.12,23,80 The frequency of 
epiglottitis is low in areas with a very high incidence of Hib disease. However, 
disease incidence alone does not appear to explain all the variation in 
epiglottitis seen among geographic areas where Hib disease is less common. In 
Auckland31and Oxford,^despite similar incidences of Hib disease to Sydney, 
epiglottitis was less than half as common. In Victoria^and Goteborg^despite 
total disease incidences similar to Minnesota, the proportion of epiglottitis was 
more than five-fold greater. These differences may be due in part to case 
ascertainment, as the three centres with the largest proportion of epiglottitis all 
included culture-negative cases. Against this, almost all culture-negative cases 
of epiglottitis in children are probably due to Hib11 and even if only culture­
positive cases are included, significant differences remain.
Takala et al have argued that these differences largely disappear when 
epiglottitis is measured as a proportion of disease in children older than two 
years.12 However the studies with sufficient data to calculate this proportion 
show persisting differences: Victoria 64%;28 Sydney 52% and Finland 48%;12 
compared with 31% in Oxford25. Some of the variation in the frequency of 
epiglottitis thus remains unexplained; differences in virulence among strains of 
Hib, as suggested by outer membrane protein subtypes81or genetic markers,82as 
well as host differences may be important.
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The sex distribution of Hib disease in this study was identical to that of the 
population 0 - 1 4  years in Sydney. This is at variance with other studies of 
meningitis from Scandinavia12,22 and the US83, and of epiglottitis from 
Sweden23,80, Finland12 and Melbourne69, where males predominated, although 
no sex difference was found in Dallas, Minnesota76, or Atlanta.20 In Finland, a 
significant difference in sex distribution was found between meningitis and 
epiglottitis (male preponderance) and other types of Hib infection (female 
preponderance).12 No such trend was found in Sydney despite a similar number 
of cases to the Finnish study.
A winter peak in Hib disease was apparent in Sydney, particularly for 
meningitis. In Victoria, with lower mean temperatures, a uniform autumn and 
winter increase was noted.28,69^  Finland12 and the northern US,83 Hib meningitis 
had a bimodal peak while in other areas of the US83 and Sweden,22,23 no 
seasonal pattern was observed, in contrast to the winter peak observed for 
pneumococcal and meningococcal meningitis83. These differing patterns in 
different climatic zones may be related to variations in peak respiratory virus 
activity.12 A variety of respiratory viruses, including Influenza A and 
Respiratory Syncitial Virus, have been shown to potentiate invasive Hib disease 
in an infant rat model84.
Hib resistant to ampicillin was first reported in Australia in 197685 and now 
constitutes 10-20% of isolates in most Australian states.86 Chloramphenicol- 
resistant isolates of Hib from invasive infections were first reported in Australia 
in 1985s7, and have since been reported sporadically from most major centres.67
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The difficulties of dosage adjustment with chloramphenicol and its interaction 
with other drugs, together with recent suggestive evidence of improved 
outcome in Hib meningitis with third generation cephalosporins,88 will further 
advance these agents as the preferred initial therapy for meningitis when Hib is 
a possible cause.
The incidence of invasive Hib disease documented in Sydney was midway 
between the previous estimates for white, urban Australians of 3028 and 606 per 
100,000 children under five years. The age distribution of Hib disease in 
Sydney suggests that a similar proportion of disease could be prevented by 
immunisation at 18 months of age with a protein conjugate vaccine as was 
achieved in Finland19, if comparable levels of compliance with immunisation
were achieved.
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CHAPTER THREE
THE OUTCOME OF Haemophilus influenzae MENINGITIS 
IN THE SYDNEY STATISTICAL DIVISION
3.1 INTRODUCTION
Meningitis is responsible for most of the mortality and almost all severe, long­
term morbidity from invasive Hib disease. Hib is the most common cause of 
childhood bacterial meningitis in industrialised countries.30,90 The incidence, 
mortality and long-term morbidity of invasive Hib disease determine the value 
of immunisation against Hib in a population. The relation of mortality and 
morbidity of meningitis to age is also important, as the available vaccines 
against Hib differ substantially in their efficacy according to age.90
Most hospital-based and population-based studies of Hib meningitis have 
limitations for estimating morbidity. Hospital-based studies frequently have a 
poorly defined study population which is biased to severity by referral patterns,
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small sample sizes or substantial loss to follow-up.54 Many hospital-based 
studies describe detailed neuropsychologic measurements of morbidity, but the 
significance of minor deficits is difficult to determine without appropriate 
control data.54 Population-based studies of Hib meningitis give good estimates 
of incidence and mortality but usually either no data12,28 29,31 or only data at 
hospital discharge13,24,25,91 on outcome. This chapter gives the results of a 
follow-up study conducted to obtain age-stratified estimates of major short and 
long term morbidity from Hib meningitis in a well-defined population, the 
Sydney Statistical Division. These data add to those in Chapter Two on the 
incidence and age distribution of invasive Haemophilus influenzae disease.
3.2 METHODS 
3.21 Case definition
A case of meningitis was defined as isolation of Haemophilus influenzae from 
cerebrospinal fluid (csf) or isolation from blood culture with csf pleocytosis 
(>100 leucocytes) or demonstration of antigen to Hib in csf or urine with csf 
pleocytosis and appropriate clinical findings. Laboratory procedures for the 
isolation and identification of Haemophilus influenzae and antimicrobial 
susceptibility testing have been described previously.29
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3.22 Case ascertainment
The study population was the Sydney Statistical Division (SSD) which 
contained 3364858 persons and 229165 children under 5 years of age in 1986.92 
The methods of case ascertainment for 1985-1987 have been described.29 
During 1989-1990, cases were recruited prospectively by regular telephone 
contact with a designated scientist at all laboratories serving hospitals in the 
SSD. Parents of children identified as having invasive Hib disease who were 
resident in the SSD and fulfilling the case definition29 were approached through 
their attending physician to participate in a case-control study of risk factors for 
Hib disease. Ethical approval for the study was obtained from all hospitals in 
the SSD. Other sources of case ascertainment were not used as very few 
additional cases had been identified previously.29
3.23 Outcome measures
Outcome was ascertained from hospital records and from the records of the 
child’s paediatrician or general practitioner. Cases occurring between 1985- 
1987 for whom no audiological data were available were cross-checked against 
the files of the National Acoustic Laboratory, which maintains records on all 
children requiring hearing aids or continuing audiological follow-up. The 
parents of cases occurring in 1989-1990 who had agreed to participate in the 
study were surveyed at least three months after discharge regarding their child’s 
general progress and ongoing follow-up.
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As the study did not include recall for neurologic or psychological testing, 
measurement bias and error was a potential problem. This was minimised by 
restricting outcome measures to specific, readily ascertained endpoints which 
were likely to be recorded in the hospital record and/or readily available from 
medical attendants for all children in the study. No attempt was made to verify 
or validate the reported endpoints, as they were judged sufficiently specific not 
to be misciassified. Data on discharge status were obtained from the case 
record by the author (PM) or a research nurse (RJ or MH), using a structured 
questionnaire.
The endpoints used were:
1. Abnormality at hospital discharge
Defined as recorded abnormality on neurological examination (visual deficit, 
hemiparesis, ataxia or abnormal gait, loss of previously attained milestones or 
profound hearing loss) or prescription of anticonvulsant medication at 
discharge.
2. Deficit at follow-up
This was defined in four categories:
(i) Severe neurologic deficit was defined as multiple deficits with significant 
functional impairment. Categories of deficit included visual loss, hemi or
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quadraparesis, hydrocephalus requiring a ventricular shunt and seizures and 
included all cases with marked intellectual impairment or developmental delay.
(ii) Mild to moderate neurological deficit was defined as any unequivocal 
neurological abnormality persisting beyond six months after discharge which 
impaired function but was not associated with significant intellectual or 
developmental impairment. These included seizures and well defined gross or 
fine motor problems such as balance or eye-hand coordination but not children 
who had only minor or "soft" neurological signs on special testing or learning 
or behavioural problems, as the significance of these findings is difficult to 
assess without appropriate controls10 and a standardised examination procedure 
was not used. Children classified as having any grade of neurologic deficit 
might have sensorineural hearing loss as well.
(iii) Deficits of uncertain significance were defined as a reported deficit whose 
significance was difficult to assess, such as fits occurring with fever below five 
years of age in a child with a past history of meningitis.
(iv) Isolated sensorineural loss was defined as mild to moderate (measurable 
unilateral or bilateral loss of less than 60 dB with no functional impairment), 
severe unilateral loss (no functional hearing on one side but not requiring 
hearing aids) and severe bilateral loss (requiring hearing aids or cochlear 
implant), in the absence of any other significant neurologic deficit.
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3.24 Hypothesised outcome predictors
Two measures of illness severity and hospital complications, admission to 
intensive care and positive pressure ventilation, were recorded in both time 
periods. Other complications were recorded only in 1989-90 in four categories: 
fever for more than seven days, fits within 48 hours of admission, fits more 
than 48 hours after admission and focal neurological signs.
3.25 Statistical methods
The prior hypotheses were that the severity and nature of deficits varied with 
age and that requirement for intensive care and status at discharge would be 
predictive of outcome. These hypotheses were tested by comparison of 
proportions using an exact method which derived odds ratios by maximum 
likelihood estimation (MLE) and calculated confidence intervals using an 
algorithm and an iterative procedure (EPIXACT Statistics and Epidemiology 
Research Corporation Seattle USA). In some instances, particularly for very 
large or small values, the odds ratio derived from MLE may differ slightly 
from the odds ratio calculated by the usual formula.
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3.3 RESULTS 
3.31 Study population
In the combined study period, 229 cases who fulfilled the case definition were 
identified, 144 in the period 1985-1987 and 85 in the period 1989 to August 
1990. There were six deaths before discharge and one shortly after discharge 
(in a child with significant underlying illness), a mortality of three percent. A 
further five children had prior neurological deficits, leaving a total of 217 
children who were able to be assessed for outcome after meningitis. (Figure 
3.1)
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Outcome of Hib meningitis by discharge status
Age 0-14 years; Sydney 1985-87 and 1989-90
Total series 
229
O utcom e
assessed
217
7 deaths (3%)
5 prior defic it (2%)
Norm al 
at d ischarge 
172 (79%)
Abnormal 
at discharge 
45 (21%) '
-  Persistent 
defic it 
12 (7%)
-  Persistent 
deficit 
29 (64%)
-  U ncerta in 
deficit 
7 (4%)
-  Deficit 
resolved 
16 (36%)
-  Unknown 
7 (4%)
-  No 
deficit 
146 (85%)
Figure 3.1
46
3.32 Completeness of follow-up
3.321 Age at follow-up
Of the 217 patients eligible for assessment, some follow-up information was 
available for 211, 169 (80%) for six months or more and 121 (57%) for 12 
months or more post discharge. More than 95% of children were more than 12 
months old and 77% more than 24 months old at the time of the last available 
follow-up.
3.322 Hearing tests
Audiologic testing which was reported as normal had been done when the child 
was more than 12 months old in 96% and more than 24 months old in 62% of 
cases; sensorineural hearing loss had been documented when the child was 
more than two years of age in 18 (86%) of cases.
3.323 Status at discharge
Children who had no neurologic deficits at follow-up had been last seen more 
than six months after discharge in 79% and more than 12 months after 
discharge in 55% of cases. Children who had neurologic deficits other than 
isolated hearing loss had been assessed more than 12 months after discharge in 
19 (83%) of cases.
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One or more abnormalities were detected at discharge in 45 patients (21%). 
These were ataxia in 19, multiple deficits (primarily hemiparesis and seizures) 
in 10, seizures requiring anticonvulsant therapy in 6, isolated hemiparesis and 
isolated hearing loss each in three patients, loss of previously attained 
milestones in two patients, and an isolated sixth nerve palsy and hydrocephalus 
each in one patient. Of these 45 children, 29 (64%) had persistent deficits at 
more than 12 months after discharge. (Figure 3.1)
Of the 172 patients who had no recorded abnormality at discharge, information 
on their progress was available in 165 (96%); in 126 (76%) at 12 months or 
more post discharge and in 141 (85%) at six months or more post discharge. 
Persistent deficits were recorded in 12 (7%) of these 165 children, 6 of which 
were isolated sensorineural hearing loss. Another seven children had deficits of 
uncertain significance.
Overall, 24 children (12% of the total) had persistent neurologic deficits, which 
were severe in nine cases (4%). Another 17 children (8%) had sensorineural 
loss without other neurologic deficits; seven (3%) required a hearing aid (4) or 
cochlear implant. (Figure 3.2)
Figure 3.2
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Long-term outcome of Hib meningitis
Age 0-14 years; Sydney 1985-87 and 1989-90
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3.325 Outcome according to discharge status 
Hemiparesis
Ten children (5%) had hemi or quadparesis at discharge. In three cases, there 
were no other neurological problems; all these children were normal at follow­
up. Of the remaining seven children, three had seizures requiring anticonvulsant 
therapy at discharge as their only additional problem; two were normal at 
follow-up and one developed communicating hydrocephalus requiring a 
ventriculospinal shunt six months after discharge. Four patients had hemiparesis 
as part of a picture of multiple handicap and global developmental delay at 
discharge, all had persistent severe deficits at follow-up.
Seizures
Among the 80 children 1989-1990, 12 (15%) had one or more seizures after 
admission to hospital. In seven cases, fits were the only complication of 
meningitis; six (50%) occurred only in the first 48 hours after hospital 
admission. Only the child who had fits more than 48 hours after admission had 
fits after discharge and required continuing anticonvulsants. Five patients (42%) 
had fits together with other focal neurological signs; three were normal at 
follow-up and two had a persistent severe neurological deficit.
Overall, a persistent seizure disorder in the absence of any other neurological 
deficit was recorded in 4 children (2%); 2/16 (13%) of those discharged on 
anticonvulsants ( OR 13.8, 95% Cl 0.94 to 203) and 1% of other patients.
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Ataxia
Ataxia was present at discharge in 18 patients and developed after discharge in 
another patient. Seven children (37%) were normal at follow-up, three had 
persistent motor problems, and seven (37%) had sensorineural hearing loss 
which was severe and bilateral in four cases (21%). Only one patient (6%), 
who had other neurologic deficits, had been discharged on anticonvulsants 
which is similar to the proportion of patients in the series discharged on 
anticonvulsants (7%). The risk of hearing loss requiring hearing aids at least 
doubled among children who developed ataxia (4/20; OR 26, 95% Cl 2 to 
1425, P=0.01).
Hearing
Records of formal audiological testing were available for 176 (81%) of the 
series, with a further 32 (15%) being assessed as having normal hearing 
clinically. Two thirds of the hearing tests were performed within three months 
of discharge, but all 13 patients with a severe uni or bilateral sensorineural loss 
had this confirmed more than six months after discharge.
Overall, a sensorineural hearing loss was found in 21 (12%) of the children 
tested; four (19%) had other neurologic deficits in addition to hearing loss, one 
of which was severe. Among the 13 patients (7%) with severe uni or bilateral 
loss, three (23%) had other deficits. In two thirds of the 21 cases, hearing loss 
had not been noted at discharge, although it was suspected in all but one of the 
seven patients with severe bilateral loss. Ataxia was associated with hearing
loss in most of the children with severe losses - four of seven had ataxia before
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discharge, and in one other ataxia developed later.
3.33 Possible predictors of outcome
3.331 Age
The age
deficit is shown in Table 3.1.
Table 3.1 PATIENTS WITH SENSORINEURAL HEARING LOSS AND OTHER NEUROLOGIC DEFICITSAMONG 210 CHILDREN LESS THAN FIVE YEARS OF AGE FOLLOWING
HAEMOPHILUS INFLUENZAE TYPE B MENINGITIS IN SYDNEY 1985-87 AND 1989-90
NATURE OF DEFICIT AGE IN THREE CATEGORIES
0-12 MTHS 
(N=90)
Number(%) ORI
13-24 MONTHS 
(N=69)
Number(%) OR
(95% CI)§
25-60 MONTHS 
(N-51)
Number(%) OR 
(95% Cl)
ALL STRATA 
Test
for trend
Severe deficit# 7 (7.8) 1 -O 2 (3.0) 0.4
(0.03-2.0)
0 (0) 0 Negat ive P=0.03
Any deficit# 15 (16.7) 1.0 5 (7.2) 0.4(0.1-1.3)
3 (5.9) 0.3
(0.06-1.3)
Negative P“0 .06
Hearing aid 1 (1.1) 1.0 2 (2.9) 2.6(0.1-158)
4 (7.8) 7.5
0.7-377) Positive P-0.052
Severe uni or . _
bilateral loss 2 (2.2) 1 .U 3 (4.3) 2.0(0.2-24)
8 (15.7) 8.0
(1.5-81)
Positive P»0.003
Isolated
severe uni or . _ . . .
bilateral loss 1 (1.1) 1.0 3 (4.3) 4.0(0.3-214)
8 (15.7) 16.3
(2.1-742)
Pos it ive PC0.001
Any hearing loss 5 (5.6) 1.0 4 (5.8) 1. 1(0.2-5.1)
11 (21.6) 4.6
(1.4-18)
Positive P=0.005
Ataxia at discharge 2 (2.4) 1 .0 5 (7.3) 3.4(0.5-35)
12 (23.5) 13.3
(2.8-128)
Pos it ive PcO.001
1 Odds rat io § 95% confidence interval* Not including hearing loss
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Neurologic deficits, excluding hearing loss, were significantly more common 
among younger children and showed a significant trend, with a lower 
proportion of cases affected with increasing age. This was true both for severe 
and all deficits, with the proportion of children less than 12 months of age at 
admission with neurologic deficits at follow-up more than twice that of older 
children. The proportion of infants one to six months old with severe 
neurologic deficits (3/35,8.6%) was similar to those seven to twelve months old 
(4/55,7.2%).
The reverse was true for ataxia at discharge and sensorineural loss, which were 
more than five-fold as common among children more than 24 months of age at 
admission than children 12 months of age or less, a difference which was 
highly significant (Table 3.1). This trend was consistent for all grades of 
sensorineural hearing loss.
3.332 Sex
There was no sex difference in the proportion with meningitis; of the 229 cases 
in the series, 113 (49.3%) were male. There was a consistent trend for males to 
be over-represented among children with adverse outcomes, but this was not 
great enough to achieve statistical significance for any outcome category. The 
proportion of male patients who required hearing aids (4/7,57%), had any 
documented sensorineural hearing loss (11/21,52%) or had ataxia at discharge 
(12/18,67%, odds ratio 2.1, 95% Cl 0.8-3.3) did not approach statistical
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significance (P>0.2). Similarly, the odds of male sex were increased if a
neurological abnormality was present (odds ratio 1.6, 95% Cl 0.8-3.3) or
anticonvulsant therapy was prescribed (odds ratio 2.0, 95% Cl 0.6-8.1) at
hospital discharge, but also did not approach statistical significance (P>0.2).
The proportion of children who were male and had a persistent severe deficit 
(5/9,56%) or any deficit (15/23,65%, odds ratio 2.0, 95% Cl 0.8-5.7) was 
increased but did not differ significantly from females (P=0.19).
3.333 Illness severity
The proportion of patients admitted to an intensive care unit was 46/217 (18%), 
of whom 12 (26%) received positive pressure ventilation. The proportion of 
patients who received intensive care was significantly higher among children 
less than six months of age (14/35 (40%) OR 2.7, 95% Cl 1.1 to 6.5) than 
children seven to 12 months of age (13%) or older children (20%). Children 
less than six months of age also required positive pressure ventilation more 
frequently (11%) compared with those seven to 12 months of age (2%) or older 
children (6%), but this was not statistically significant (OR 2.2, 95% Cl 0.4 to 
9). Persistent neurologic deficits occurred more frequently in children who 
received intensive care, particularly if ventilation was required. These data are 
shown in Table 3.2. By contrast, the proportion of children with hearing loss 
was not related to severity of illness as indicated by intensive care ( Table 3.2).
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Table 3.2 PERSISTENT NEUROLOGIC DEFICITS AND ADMISSION TO AN INTENSIVE CARE UNITFOLLOWING HAEMOPHILUS INFLUENZAE TYPE B MENINGITIS AMONG 210 CHILDREN 
LESS THAN FIVE YEARS OF AGE IN SYDNEY 1985-87 AND 1989-90
A r t i f i c i a l In ten s iv e No In ten s iv e T o t a l
V e n t i la t i o n Care only Care
N - 12 N = 32 N = 166 N - 210
N (%) ORI N (%) OR N (%) OR N (%) Test f o r
<CI)§ (C l) trend
Severe
Neurologic 4 33) 26 2 (6) 3 .6 3 (2) 1.0 9 (4) P o s i t i v e
Deficit
(4-206) ( .3-33)
PC0.001
Any
Neurologic 5 (42) 9 5 (15) 2.4 13 (7) 1.0 23 (11) P o s i t i v e
Deficit (2-39) ( .6-8)
P<0.001
Severe
Hearing 1 (8) 2.4 0 (0) 0 6 (4) 1.0 7 (3) P o s i t i v e
Loss (.05-23 )
P-1.0
Any
Hearing 2 (17) 1.7 1 (3) 0.3 17 (10) 1 . 0 20 (10) N ega t ive
Loss ( .2 -9 ) ( .01-2)
P-1.0
Isolated
Hearing 1 (8) 0.9 0 (0) 0 16 (10) 1 . 0 17 (8) N ega t ive
Loss ( .02 -7 )
P-0.3
Legend
! Odds r a t i o
§ 95% Confidence i n t e r v a l
3.34 Use o f dexamethasone
Dexamethasone therapy was not given to any patients 1985-1987 and to only 
five patients (6%) 1989-1990. In one case, dexamethasone was apparently given 
because o f severe illness (hemiparesis and seizures). There were no adverse 
features in the other cases. Ail five children were neurologically normal at 
follow-up with normal hearing.
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3.4 DISCUSSION
Estimates of the proportion of children with handicap following Hib meningitis 
have varied widely, from 8 to 40%.13,24,54,78,91,93'95 This variability may be due to 
a variety of factors including biased samples, varying periods and methods of 
follow-up and lack of attention to potential confounding variables.54 The aim of 
this study was to obtain population-based estimates of long-term handicap in 
order to reduce identification bias. These are minimum estimates as the 
completeness of documentation is likely to have varied among the large number 
of hospitals and physicians surveyed and the period of follow-up varied. No 
attempt was made to recall patients or perform special tests to estimate the 
prevalence of more subtle problems such as learning, language or behavioural 
disorder. Early studies suggested that such problems were pervasive96,97 but 
more recent studies have suggested that many of these findings can be 
attributed to environmental factors,54 especially if there were no acute 
meningitis complications.54,98 Estimates of handicap following Hib meningitis 
from this study are comparable to other population-based studies are shown in
Table 3.3.
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T a b l e  3.3 P O P U L A T I O N - B A S E D  S T U D I E S O F  O U T C O M E F R O M H i b M E N I N G I T I
Authors 
Centre(s)
Total Follow-up 
Cases
Severe
deficits
Hearing
Loss
Death
Years N <%> N <%) N (%) N <%>
Claesson et al11
Goteborg
1971-80
147 145 (99) 
Years'!
3 (2.0) 4 (2.8) 2 (1.4)
Tudor-Williams*
Oxford
1985-88
142 35 (25)
12 months'!
1 (2.9) 3 (8.6) 8 (5.6)
Kristensen et al12
Denmark
1985-86
156 152 
at
discharge!
3 (2.0) 2 (1.3) 4 (2.6)
Bol et al13
Netherlands
1975-1983
443 410 (93) 
at
discharge!
43 (8.5) 19 (3.7) 10 (2.0)
Hanna and Wild* 146 (E)§ Handicapped 5 (3.4) 6 (4.1) 6 (4.1)
Western Australia 
1984-88
40 (A)# cases from 
a separate 
register
1 (2.5) 1 (2.5) 4 (10)
Gervaix and Suter14
Switzerland
1976-89
76 At discharge 3 (3.9) 7 (9.2) 0 (0)
Legend
1 Period of follow up 
§ Non aboriginal children 
# Aboriginal children
These data suggest that at least 10% of children will have serious adverse 
outcomes from Haemophilus influenzae type b meningitis (death (3-5%), 
severe, permanent handicap (2-4%) severe, permanent hearing loss (1-4%)). 
Less severe but readily defined neurologic (5%) or hearing (5%) deficits were 
detected in another 10% of patients.
In common with other studies54,98 abnormalities detected at discharge had 
frequently resolved at follow-up. Isolated deficits, such as hemiparesis or fits, 
were particularly likely to resolve, whereas children with multiple deficits had a
much less favourable prognosis.
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The burden of morbidity fell disproportionately on the youngest children, who 
were significantly more likely to receive intensive care (those less than six 
months of age) or have persistent neurologic deficits (those less than 12 months 
of age). Higher morbidity, especially severe morbidity, in the very young is 
important in evaluating possible Hib vaccine strategies. Young age at onset of 
meningitis has been associated with an adverse outcome previously,91'99 
although not in all studies.54
In contrast, hearing loss, both severe and less severe, was uncommon in the 
youngest group with otherwise high morbidity, occurring most frequently in 
children more than two years of age who had not had any significant 
complications during hospitalisation. While some authors have argued that 
hearing loss only occurs together with other deficits,100 our and other data101'102 
indicate that hearing loss is frequently not detected clinically, particularly if 
unilateral, and cannot be ruled out by the absence of other neurologic problems.
Satisfactory testing of hearing is difficult in young children,103 and under­
ascertainment in this group may have been partially responsible for the 
decreased prevalence of hearing loss documented. Against this is that severe 
hearing loss, which should not have been under-ascertained, was also more 
prevalent in older children. Other information on the age distribution of hearing 
deficits, particularly isolated hearing loss, after meningitis is sparse. Studies 
which give some data on the age distribution of cases with isolated hearing loss
are shown in Table 3.4.
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Table 3.4 HEARING LOSS IN HAEMOPHILUS INFLUENZAE type b MENINGITIS
Author Number Hearing Hearing Age Distribution
Centre of cases assessment Loss
Year
Severe Total
Nadol2,<
Boston
1962-75
84 At discharge 
Audiometry
3 (3.6%) Below 2.5 yrs 1/65 (1.5%) 
Above 2.5 yrs 3/19 (14%)
Keane25
Philadelphia
1970-76
67 At discharge 4 (6.0%) 4m,18m,5yr,lOyr
Baldwin et al22 
Alabama
38 Audiometry in 
18/38 (47%)
4 (11%) 8 (21%) Hearing loss median age 14 m 
No hearing loss median age 45m 
(for all organisms)
Vienny et al2‘
Switzerland
1979-82
17 Audiometry
BAER
Prospective
2 (12%) 5 (29%) 17m,18m,50m,76m,15yr
Raivo & 
Koskiniemi2’ 
Finland 
1960-74
131 Audiometry 
At discharge
3 (2.3%) 14 (10.7%) Severe hearing loss 
22m,4 5m,61m
Dodge et al21 
St Louis 
1973-77
118 Audiometry
BAER
4 (3.4%) 7 (5.9%) 8m, 8m, 12m,16m,40m,4lm,56m
Ferry et alu
Tennessee
1975-1977
50 Audiometry 
At discharge
2 (4%) 8 (16%) Not stated
Most studies show a trend towards a higher proportion of hearing loss in older 
children;100,102 one small study showed no association.104 Differences in age 
distribution may be obscured if severe hearing loss is included in a general 
category o f severe handicap,97 if children with other severe deficits, who may 
have hearing loss due to a central lesion98 are not reported separately from 
children with isolated hearing loss96 or if the age distribution of Hib meningitis 
is such that only a small number of cases occur in older age groups.89
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The prevalence of ataxia was higher than in other reports105108 and was usually 
not investigated to determine whether it was of vestibular origin.108 Ataxia was 
documented more commonly in older children. This may have been due to 
under-ascertainment in non-ambulatory children, but ataxia had a similar age 
distribution to severe hearing loss, which should not have been under 
ascertained and has a biologically plausible relationship to ataxia. One third of 
patients with ataxia had associated hearing loss, severe in 17%, confirming the 
importance of ataxia as a risk factor for hearing loss.106 Ataxia, like hearing 
loss, was not associated with other adverse outcomes.
Unprovoked seizures were uncommon in the absence of other neurological 
abnormalities.98 A higher proportion of patients receiving anticonvulsant therapy 
at discharge had subsequent unprovoked seizures. These results are similar to 
those of another population-based study, which found later unprovoked seizures 
were significantly more frequent after meningitis only if fits had complicated 
the acute episode.109
Dexamethasone therapy has been advocated to reduce the incidence of 
neurologic handicap from childhood meningitis, particularly Hib meningitis, but 
is controversial.105,110 There were too few patients so treated in this period of 
the study to draw any conclusions about the value of dexamethasone but these 
data provide a useful reference for any subsequent comparison.
These data give minimum estimates of serious adverse outcomes from Hib 
meningitis in an Australian urban population with good access to medical
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services. The incidence of disability following meningitis are likely to be higher 
than this with more extensive evaluation or less access to services. The 
significantly increased morbidity in children developing meningitis under the 
age of 12 months has important implications for immunisation strategies, which 
are explored in Chapter Four. Children who are normal at discharge are 
unlikely to have significant handicap identified subsequently, with the 
occasional exception of severe hearing loss in young children. Severe hearing 
loss was more common than suggested by some other Australian data.97 
Assessment of the impact of more widespread use of dexamethasone therapy 
would require an even larger number of patients.
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CHAPTER FOUR
AN ECONOMIC ANALYSIS OF IMMUNISATION 
AGAINST Hib DISEASE IN AUSTRALIAN CHILDREN
4.1 INTRODUCTION
Conjugate Hib vaccines are relatively expensive compared to other vaccines111 
and multiple doses are required if immunisation commences before 18 months 
of age.90 Differences in the age distribution of Hib disease are important 
because the efficacy of vaccines against Hib disease is age-dependent.90 In 
Australia, a significant proportion of invasive Hib disease occurs in children 
over the age of 18 months, similar to the pattern seen in Scandinavia. In 
Australia, it was estimated that inclusion of Hib vaccines in the infant 
immunisation schedule would cost at least as much as all other vaccines 
currently given before 18 months of age.53 Evaluation of the benefits and costs 
of immunisation against Hib, in the context of the local disease epidemiology
and health-care costs, was needed.
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A number of economic analyses of immunisation against invasive Hib disease 
in developed countries have been published.111'116 Three studies from the US111' 
113 evaluated immunisation at 18 to 24 months of age with the PRP111'112 Gr 
conjugate vaccines113 and one study from The Netherlands114 evaluated a 
program beginning under six months of age. These four studies used cost- 
benefit112113 and cost-effectiveness111,114 assessments. A further two studies have 
considered Australian data. The first was a cost comparison using data from a 
number of Western countries including Australia,115 while the second evaluated 
one vaccine (PRP-OMP, PedvaxHib, Merck, Sharp and Dohme) given at either 
2, 4 and 12 months or 18 months in a cost-utility analysis.116 The documented 
high incidence of early-onset invasive Hib disease in at least some Aboriginal 
populations117 makes the value of vaccination for them relatively 
uncontroversial. Dramatic potential savings are demonstrable from early Hib 
immunisation in Aboriginal children.117 In non-Aboriginal Australian children, 
the epidemiology of invasive Hib disease is markedly different to both rural 
Aboriginal children and children in other Western countries,1,28,53meriting 
separate consideration.
In this analysis, cost-utility and cost-effectiveness methods were used to 
compare several potential immunisation strategies against Hib disease in non- 
Aboriginal Australian children using a range of Australian epidemiologic data 
and costs. The impact of methodological differences between this and previous 
studies is highlighted.
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4.2 METHODS 
4.21 Analytic model
The hypothetical experience of an Australian birth cohort of 250,000 until five 
years of age was analysed. A decision tree was constructed using the Simultree 
program (Figure 1) to evaluate four alternative Hib immunisation strategies and 
"catch-up" immunisation of older children.
1. no vaccine program (NOVAC)
2. publicly-funded vaccination coinciding with doses of diphtheria, tetanus 
and pertussis (DTP) vaccine before six months of age in a three dose 
schedule completed by 18 months (6MVAC)
3. publicly-funded vaccination beginning with measles, mumps and rubella 
(MMR) vaccine at 12 months of age in a two-dose schedule completed 
at 18 months (12MVAC)
4. publicly-funded vaccination with one dose of vaccine at the time of the 
DTP booster at 18 months of age (18MVAC)
"Catch-up" immunisation of children not included in an immunisation 
program was modelled using hypothetical cohorts immunised in one of 
six possible age bands (six to 12 months, 12-18 months, 18 months to 
two years and two to three, three to four and four to five years) for 
comparison with the immunisation programs above (6,12 and 18
months).
Figure 4.1 Decision tree for Hib immunisat ion 64
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4.22 Model Parameters 
Disease incidence
Hib disease was considered in three categories - meningitis, epiglottitis, and 
other bacteraemic disease. Estimates of the incidence of Hib disease and the 
relative proportions due to epiglottitis and meningitis which occur by various 
ages differ53. Published data on the age-specific incidence of Hib disease from 
the two largest Australian studies (Sydney28 and Victoria29) were used, as they 
were carried out over an identical time period (1985-1987), used similar 
methods of case ascertainment and case definitions and represent high and low 
ends of the spectrum of disease incidence and age distribution in non- 
Aboriginal Australian children. Estimates of total disease incidence, the 
proportion of meningitis and epiglottitis occurring by each age and mortality 
rates for each type of Hib disease were calculated from the total numbers of 
cases and relevant population (for incidence estimates) or case (for age 
distribution) denominators in each disease category. The 95% confidence 
intervals (95% Cl) for these proportions were calculated using an exact method 
for numbers of cases less than 100 and the normal approximation to the 
binomial distribution for larger numbers.118The estimated probabilities of Hib 
disease for the five year birth cohort and their 95% CIs are shown in Table 4.1.
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Table 4.1
ESTIMATED AGE DISTRIBUTION AND INCIDENCE OF Hib DISEASE
Variable Best estimate 95% Cl
Hib disease 0-4 years 0.0025 0.0023 to 0.0027
Proportion of meningitis 0.42 0.42 to 0.49
Proportion of epiglottitis 0.36 0.343 to 0.39
Hib disease by 6 months 0.04 0.02 to 0.06
Hib disease by 12 months 0.24 0.21 to 0.27
Hib disease by 18 months 0.40 0.37 to 0.43
Hib disease by 24 months 0.57 0.54 to 0.60
Hib disease by 36 months 0.75 0.72 to 0.78
Hib disease by 48 months 0.92 0.89 to 0.95
Meningitis by 6 months 0.77 0.59 to 0.95
Meningitis by 12 months 0.70 0.63 to 0.77
Meningitis by 18 months 0.65 0.60 to 0.70
Meningitis by 24 months 0.64 0.60 to 0.68
Meningitis by 36 months 0.57 0.54 to 0.61
Meningitis by 48 months 0.52 0.48 to 0.56
Epiglottitis by 6 months 0 . 0 0 . 0 to 0 .05
Epiglottitis by 12 months 0.07 0.04 to 0.12
Epiglottitis by 18 months 0.10 0.06 to 0.14
Epiglottitis by 24 months 0.14 0.11 to 0.17
Epiglottitis by 36 months 0.23 0.20 to 0.26
Epiglottitis by 48 months 0.29 0.26 to 0.32
Meningitis mortality 0.037 0.02 to 0.063
Epiglottitis mortality 0.016 0.005 to 0.038
Other Hib disease mortality 0.006 0 . 0 to 0 .036
67
Long-term outcome of Hib disease
Long-term handicap following Hib disease was considered in four categories - 
severe handicap, less severe handicap, hearing loss requiring hearing aids and 
less severe sensorineural hearing loss where hearing is impaired but hearing 
aids are not required. Data on the prevalence of severe handicap and hearing 
aids following meningitis are available from Sydney119 and Western Australia.30 
Data on less severe permanent hearing loss and handicap were available only 
from Sydney.119 The prevalence of serious handicap following epiglottitis was 
derived from 346 cases treated in Melbourne.120 The other categories of 
handicap were not relevant for epiglottitis. The incidence of long-term handicap 
following categories of Hib disease other than meningitis and epiglottitis was 
not considered, as these cases are a small proportion of total Hib disease, long­
term handicap is likely to be rare and reliable data are not available.
Whether the incidence of handicap varies with age is an important 
consideration in evaluating Hib immunisation strategies, particularly for severe 
handicap. Data from elsewhere (US96 and the Netherlands91) suggest that the 
rate of permanent handicap is increased in children who are under 12 months of 
age at the time of meningitis, but previous studies have not taken this into 
account.111'116 For this study, the odds ratios and 95% CIs of severe handicap in 
unimmunised relative to immunised children (eg less than 6 months vs greater 
than 6 months) were calculated from the combined Sydney119 and WA30 data, 
using the EPIXACT component of EGRET, with the odds ratio of handicap in 
the unimmunised age group set at one. The odds of handicap were found to be
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significantly lower for children who were more than 12 or 18 months at the 
onset of meningitis compared to younger children, consistent with the above 
studies.91,96 (Table 4.2 and Appendix 1)
Table 4.2 HANDICAP FOLLOWING Hib DISEASE -
PREVALENCE AND AGE DISTRIBUTION
Variable Best estimate 95% Cl
Severe handicap after 0.015
meningitis
Severe handicap after 0.003
epiglottitis
Less severe handicap after 0.08
meningitis
Hearing aid after meningitis 0.037
Less severe hearing loss 0.037
meningitis
Odds of severe handicap 0.44
(>6 vs <6 months)
Odds of severe handicap 0.21
(>12 vs <12 months)
Odds of severe handicap 0.13
0.003 to 0.042
0.0 to 0.016
0.05 to 0.10
0.02 to 0.064 
0.02 to 0.064
0.12 to 2.0
0.04 to 0.84
0.0 to 0.91
(>18 vs <18 months)
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4.23 Utility measurement and discount rate
Children classified in each of the four levels of handicap described above were 
scored using the multi-attribute utility model of Torrance121,122 (Appendix 2). 
This requires the classification of the health state by four dimensions or 
attributes. Utility weights between 0 and 1 can be assigned to each possible 
health state where 0 represents death and 1 good health. The disabilities of each 
of the nine children with severe handicaps were classified by a paediatric 
rehabilitation specialist, using data provided on the functional status of the 
children by their medical attendants or parents. To keep the estimate 
conservative, any items which were not able to be scored because of the child’s 
age or inadequate data were assigned to the best health state. Utility values 
were derived separately using the formula given by Torrance;121 the results and 
method of calculation were not known by the specialist.
The health states of three children had a utility of less than 0.10 and a mean 
utility of minus 0.12. This was designated as equivalent to requiring full-time 
institutional care, which was the most costly health state and readily valued by 
bed day costs. The health state of the remaining six children with severe 
handicap had a mean utility of 0.55. In order to keep the analysis conservative, 
this group was combined with the cases of less severe handicap to whom a 
utility of 0.90 had been conservatively assigned, to constitute a combined 
category of persistent handicap requiring special educational assistance but not 
institutional care. The weighted average utility for this category was 
approximately 0.8, which was used as the utility for the base (best estimate)
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case. The utility for this combined category therefore contained considerable 
uncertainty, as did the proportion of meningitis patients in this category, which 
was estimated from the Sydney data, as it was not possible to classify the WA 
children equivalently. Hearing aids and less severe hearing loss had base case 
utilities of 0.86 and 0.94, in accordance with the scales of Torrance.121,122 
Temporary health states related to hospitalisation or of adverse vaccine 
reactions were disregarded as the life time quality-adjusted life years (QALY) 
estimation would not be sensitive to the short-term reduction in quality of life.
The total QALYs experienced by the birth cohort in each program was 
calculated from the product of life expectancy of 50 years, discounted at 5 % 
(18.3 years), the proportion of the birth cohort experiencing each outcome and 
its utility, summed across all outcome categories. As the marginal effectiveness 
of each program to NOV AC was the unit of comparison, it was assumed that 
the impact of other causes of mortality and morbidity before the age of 50 
years was equivalent in all programs. A 5% discount rate was chosen because 
this is the rate most commonly used in other economic analyses and required 
by Australian government authorities for submissions for new therapeutic
agents.
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4.24 Cost Analysis
The cost analysis considered direct costs only, both short and long-term, 
defined as those arising from resources used to detect, treat or prevent 
disease.122 Indirect costs arising from loss of productive output from impaired 
function or premature mortality of the children122 were not evaluated. The cost 
of time (as lost income from time off work), travel and care for other children, 
based on interviews with parents, was included as a direct cost. The distress felt 
by families was also assessed by questionnaire, (Appendix 3) but no attempt 
was made to value these intangibles.
Short-term costs
The cost of hospital care was measured at three levels - ordinary ward care, 
high dependency ward care and intensive care. The costs measured at the ward 
level included salaries, goods and services and housekeeping. Salaries were 
calculated from full-time equivalents for medical staff and ward budgets for 
nursing salaries, goods and services costs were derived from ward budgets for 
disposables and equipment and housekeeping costs included those for meals, 
cleaning and linen. An average cost per occupied bed-day was derived, 
representing the resources used, on average, by each ward type. The number of 
bed-days was calculated using data from prospective and retrospective studies 
in Sydney in the categories meningitis, epiglottitis and other.
As children with Hib disease constitute a small proportion of total hospital or
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intensive care admissions, the marginal savings in overhead and capital costs 
were negligible and not included in the estimates of disease cost.122 The mean 
use of transportation from outlying hospitals, laboratory, imaging and pharmacy 
services by disease category was calculated from a data base including 163 
cases of Hib disease (meningitis = 84, epiglottitis = 45, other = 34) occurring 
1989-90 in the Sydney region (Appendix 4). Costs were calculated for these 
services using scheduled fees or charges for hospital services and data from 
Careflight Sydney and the NSW Ambulance Service for transportation costs. 
The time taken off work and for travel and child-care during the child’s 
hospitalisation and in follow-up visits to health professionals by parents, the 
number of medications and investigations after discharge were determined from 
interviews with the families of cases in 1989-90. These were valued using 
average weekly earnings, fees and charges.122
All costs were summed and averaged within disease categories. The calculated 
mean cost of meningitis was $7380, of epiglottitis $5789 and for other types of 
Hib disease $2130. The detailed cost analysis is shown in Appendix 5.
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Long-term costs
The costs of long-term handicap are difficult to estimate with precision and 
estimates of the cost of caring for children with different degrees of handicap 
in Australia are not available. The cost of severe handicap (institutional care 
above) was valued as the annual bed cost of residential care ($55480 Western 
Sydney Developmental Disability Service 1991), discounted at 5% to age 50 
years - $1,013 million. The cost of less severe handicap was estimated from the 
annual marginal cost of special education ($5400 in NSW in 1990) for 20 years 
at 5% discount - $65,000. The cost of hearing aids was estimated at $2,000 to 
$3,000, including annual follow-up by an audiologist of 5.5 hours per year and 
replacement of aids every three years at a cost of $800; a cochlear implant is 
estimated to cost $16000 (R Lovegrove, National Acoustic Laboratories 
personal communication). As a conservative estimate, the cost of a cochlear 
implant was used as the base estimate of the additional cost of hearing aids. 
The cost of initial assessment and fitting of hearing aids ($1470) was used to 
cost the assessment of hearing loss not requiring hearing aids.
4.25 Distress
Parents of children who had recovered from Hib disease were asked to state 
how their child’s illness affected them and their family using a free form 
questionnaire. (Appendix 3) These responses were later evaluated by three 
observers as either very distressing (the worst thing that has ever happened to 
me, devastating), moderately distressing (a severe stress but not the worst thing
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that has happened to me) or mildly distressing (responses indicating lesser 
degrees of distress).
4.26 Vaccination programme
All vaccination strategies were assumed to be incorporated into the existing 
vaccine schedule, with no significant additional costs for vaccine 
administration. The marginal cost of additional equipment and staff time for 
administration was allowed for as a component of the vaccine cost. At 18 
months and subsequently, one dose was given with triple antigen. In the 12 
month program two doses were given - with MMR and subsequently with triple 
antigen at 18 months. In the infant program, vaccination commenced with the 
two month triple antigen and was modelled as three doses. As it was assumed 
that vaccine marketing would keep the cost of three or four doses of vaccine 
similar, and as the additional administrative costs are minimal (above), the 
marginal costs of three vs four doses were not considered.
For "catch-up" programmes, the assumption that additional administrative costs 
are minimal may not be reasonable. The cost of immunisation, if additional 
medical visits were required, was set at $15 per attendance. Assuming that one 
of the immunisations could be given with either MMR or the 18 month triple 
antigen, this would increase the vaccine cost by $15 for children aged over 12 
months and $30 for children less than 12 months. The cost-utility and threshold 
vaccine cost for immunisation of children six to 48 months of age at the time
immunisation were commenced was calculated both with and without this
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additional administrative cost.
The best estimate of vaccine cost was derived from the price per dose charged 
in the public sector by vaccine providers to the Centers for Disease Control in 
the US (approximately $A12, personal communication) and $3 for 
administrative costs in the public sector, a total of $15 per dose.
Vaccine uptake was estimated from data on uptake of two or more doses of 
triple antigen by 7 months (92%), MMR vaccine by 18 months (90%) and four 
doses of triple antigen by 24 months (85%) among community control subjects 
recruited for a study of risk factors for Hib disease in Sydney (Chapter 5).
Vaccine efficacy
Vaccine efficacy after a completed program was set at 90% in the best- 
estimate analysis at all ages, based on the point estimates from vaccine trials 
and case-control studies.123'130 The uncertainty of trial estimates of vaccine 
efficacy was addressed by sensitivity analysis (see below), which considered 
the point estimates and confidence intervals from case-control studies of 
immunisation with conjugate vaccines at 18 months in the US,126-130 and the 
published values for vaccine efficacy in trials of the diphtheria toxoid,123 mutant 
diphtheria toxin124 and Neisseria meningitidis outer membrane protein125 
conjugate vaccines in infants. The latter values were also used to estimate the 
95% CIs for vaccine efficacy in a 12 month program, as no data are available 
on this strategy. Based on follow-up data on immunogenicity, it was assumed
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that adequate protective immunity was maintained in all programs until the fifth 
birthday.131 The possible impact of herd immunity resulting from decreased 
carriage of Hib among immunised children132 was not considered, resulting in a 
conservative estimate of the effectiveness of vaccination, especially at older 
ages.
Vaccine safety
Conjugate Hib vaccines are probably the least reactogenic vaccines in current 
use, with data from vaccine trials and several large post-marketing surveillance 
studies indicating that serious reactions attributable to Hib vaccines are rare. A 
controlled study comparing PRP-D vaccine or placebo with triple antigen found 
no significant difference in mild to moderate reactions between the two 
groups.133 The number of medical attendances for reactions following 
immunisation with a conjugate Hib vaccine was estimated from a Canadian 
study of 5,000 children.(Table 4.3)134 The additional cost of each vaccine 
reaction was set as the scheduled fee for a standard consultation, as it is 
unlikely that any medication, other than antipyretics, would be prescribed.
Table 4.3 OTHER VARIABLES USED IN THE BASE CASE 
COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS
Variable! Best estimate 95% Cl or
+ /- 10%
COSTS
Cost Of meningitis $7380 $6642 - $8118
Cost Of epiglottitis $5789 $5210 - $6368
Cost of other Hib disease $2130 $1917 - $2443
Cost of vaccine $ 15 $ 13.5 - 16.5
Cost of vaccine reaction $ 25 $ 22.5 - 27.5
VACCINE UPTAKE
At 6 months 0.92 0.83 - 1.0
At 12 months 0.90 0.81 - 0.99
At 18 months 0.85 0.77 - 0.94
or greater
VACCINE REACTION 0.0023 0.0012 - 0 .
UTILITIES
Severe handicap 
Less severe handicap 
Hearing aid
Less severe hearing loss
0.12 -0.27 to CO0O1
0.80 0.68 to 0.92
0.86 0.74 to 0.98
0.91 0.79 to 1.0
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4.3 RESULTS
4.31 Best estimate analysis
With the assumptions in the model (above and Tables 4.1 to 4.3), 625 cases of 
invasive Hib disease are estimated to occur in the 1990 Australian birth cohort 
by the age of five years (Table 4.4). The 6MVAC strategy prevents the greatest 
proportion of cases (80%) followed by 12MVAC (62%) and 18MVAC (46%) 
(Tables 4.4 and 4.5). However, immunisation beginning under six months of 
age was modelled as preventing morbidity and mortality in similar proportions 
to cases, whereas immunisation of older children was modelled as preventing a 
lesser proportion of mortality and severe morbidity than cases (Methods and 
Table 4.4). The number of QALYs saved by each program gives a summary 
measure of prevention of long-term morbidity and mortality. The percentage of 
QALYs saved by each program relative to 6MVAC is less than the percentage 
of cases. (Table 4.5)
The estimated costs of each program are shown in Table 4.5. The cost of 
treating Hib disease in the 1990 birth cohort without an immunisation program 
is estimated to be $10.2 million. This total is dominated by the cost of long­
term handicap, which is almost double the estimated direct short-term costs. In 
the vaccination alternatives, the number of doses has the greatest effect on 
vaccine costs. The net costs of each program (compared with NO VAC) are 
strongly influenced by the large difference in vaccine costs; the net cost of 
18MVAC is less than 10% that of any alternative strategy (Table 4.5).
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Cost-effectiveness is greatest for 18MVAC with a cost per case prevented less 
than one fifth that of the next most favourable program, 6MVAC (Table 4.5). 
This degree of difference and the ranking of other programs is very similar 
when cost-utility, in dollars per QALY saved, is considered (Table 4.5). The 
strong influence of vaccine cost on these results is illustrated when the 
threshold for the vaccine cost below which the cost of each programme 
becomes less than NO VAC is considered. The threshold cost per vaccine dose 
for 18MVAC ($13.98) is only 17% higher than for 6MVAC ($11.10), despite 
the large difference in cost per case or QALY prevented between the two 
programs. Nevertheless, it is clear from these results that 18MVAC is the most 
cost-effective strategy with the baseline parameters chosen for the model, 
whether assessed by cost-effectiveness or cost-utility.
Immunisation of older children in a "catch-up" programme was comparable in 
cost-effectiveness (dollars per case prevented) to 6MVAC for two year old 
children, but rose rapidly after three years of age and reached 15 times the 
marginal cost per case of 6MVAC at four years. Immunisation of older children 
was relatively less effective in cost-utility terms because of the weighting 
favouring a higher rate of long-term handicap in younger children.
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Table 4.4 SUMMARY OF MAJOR OUTCOMES FOR EACH VACCINATION PROGRAMME
OUTCOME PROGRAMME
NOVAC§ 6MVAC
CASES”
Total 625 128
Meningitis 288 65
Epiglottitis 225 39
Other 112 24
SEQUELAE”
Deaths 15 3
Severe
handicap 5 1
Less severe
handicap 23 5
Hearing aid 11 2
Less severe
hearing loss 11 2
12MVAC* 18MVAC" 24M* 36M* 48M*
240 338 420 506 575
139 191 216 246 275
51 72 112 160 202
50 75 92 100 110
6 9 10 12 14
3 4 5 5 5
11 15 17 20 22
5 7 8 9 11
5 7 8 9 10
Legend
§ NOVAC
# 6MVAC
* 12MVAC 
I! 18 MV AC
► 24M, 36M
No vaccination programme 
Vaccination before 6 months of age 
Vaccination at 12 months of age 
Vaccination at 18 months of age 
, 48M Vaccination of children in a catch-up programme
CASES AND SEQUELAE ESTIMATED TO OCCUR IN THE COHORT BY FIVE YEARS OF AGE
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Table 4.5 SUMMARY OF ECONOMIC OUTCOMES FOR EACH VACCINATION PROGRAMME
OUTCOME PROGRAMME
NOVAC* 6MVAC# 12MVAC* 18MVAC" 2 4M* 36M* 4 8M*
CASES PREVENTED 0 497 385 287 205 119 38
% PREVENTED 0 (100) (78) (58) (41) (24) (8)
(Cf 6MVAC)
QALYs SAVED 0 389 254 176 127 73 24
(% SAVED) (0) (100) (65) (45) (33) (19) (6)
(Cf 6MVAC)
VACCINE COST“ 0 10.3 6.7 3.2 3.2 3.2 3.2
TOTAL COST“ 10.2 12.8 12.4 10.4 11.5 12.3 13.1
NET COST“ 10.2 2.6 2.2 0.2 11.1 2.0 2.8
$/CASE PREVENTED 0 5431 6045 987 5330 16600 74000
$/ QALY SAVED 0 6930 9136 1231 8630 27060 117100
THRESHOLD COST1 0 11.1 9.8 14.0 9.9 5.6 1.8
Legend
§ NOVAC No vaccination programme
# 6MVAC Vaccination before 6 months of age
* 12MVAC Vaccination at 12 months of age 
fl 18MVAC Vaccination at 18 months of age
► 24M,36M,48M Vaccination at X months in "catch-up" 
** MILLIONS OF DOLLARS
program
<1 VACCINE COST IN DOLLARS BELOW WHICH THE PROGRAM IS COST-SAVING
82
4.32 Sensitivity analysis
The sensitivity of these results to changes in assumptions and parameter 
estimates in the cost-utility model was examined in two ways. First, the change 
in the net cost-utility (NCU) in dollars per QALY was calculated and expressed 
as a percentage of the baseline estimate for each variable (incidences of disease 
and handicap, utilities of handicap and vaccine efficacy) when set to its lower 
and upper 95% confidence interval. Second, the percentage change in NCU 
when each variable was set to plus or minus 10% of its baseline value was 
calculated; this was the only calculation for cost variables. The aim of this 
analysis was to identify which variables had greatest influence on the NCU 
when varied across their 10% or 95% Cl range (Table 4.6). Sensitivity analysis 
was not performed for cost-effectiveness estimates because these had varied in 
the same direction as cost-utility results in the best estimate analysis (Table 
4.5). Sensitivity analysis of estimates for "catch-up" immunisation was only 
undertaken for the key variables disease incidence and vaccine cost. (Table 4.5)
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Table 4.6 FIVE MOST INFLUENTIAL VARIABLES
6MVACM 18 MV AC"
VARIABLE 95% Cl1 + / -  10%§ 95% Cl + /-  10%
VACCINE
Rank (%)* *§ Rank (%) Rank (%) Rank (%;
EFFICACY
DISEASE
INCIDENCE
1 (134-300) 1 (78) 1 (605-3350) 2 (263)
Meningitis 5 (47) 3 (61) 3 (254) 1 (284)
Epiglottitis 
HANDICAP RATE
- (8) 8 (12) 9 (80) 5 (110)
Severe
AGE
DISTRIBUTION
2 (220) 5 (26) 5 (224) - (38)
all Nib disease 
severe
10 (23) * (6) 6 (192) 4 (229)
handicap
DISCOUNT
5 (48) - (4) 2 (256) - (27)
RATE
COST
Severe
3 (92) 7 (20) 7 (92) - (20)
handicap 9 (27) 4 (27) 10 (72) 8 (72)
Vaccine 4 (77) 2 (77) 4 (247) 3 (247)
*  6MVAC Vaccination before 6 months of age
n 18MVAC Vaccination at 18 months of age
5 difference in net cost utility (dollars per QALV) between the lower and upper 95 % confidence limits for the indicated variable
§ difference in net cost utility (dollars per QALY) between 90% and 110% of the value of the indicated variable
* the ordinal rank from one to ten of the magnitude of the change in net cost utility
* the percentage change in net cost utility = upper limit - lower limit / baseline value
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Vaccine efficacy had the greatest impact on outcomes for both programmes. 
The incidence of meningitis and severe handicap was also important; the age 
distribution of both these variables was significant in both programmes. The 
cost per vaccine dose had a large impact on NCU, particularly when 10% 
variations in model variables were compared, as the 95% Cl range of some 
variables (incidence of handicap, age distribution of handicap and meningitis, 
vaccine efficacy), exceeded a 10% change in their baseline value.
The incidence of epiglottitis and the cost of hospitalisation were important only 
in the 18MVAC programme, while the mortality rate was significant only for 
6MVAC. Change in utility values and the rate of handicap other than severe 
handicap was not important, except for the utility of less severe handicap (in 
6MVAC) and the incidence of less severe handicap following meningitis (in 
18MVAC). Varying the discount rate between 3% and 10% had an important 
impact on model outcomes, which was most significant for 6MVAC.
All programmes have increasing cost-utility with increasing values of vaccine 
efficacy, disease incidence and rate of severe handicap. However, their cost 
utility relative to each other does not change over their 95% Cl range except 
for the incidence of serious handicap following meningitis. If the rate of serious 
handicap is below 0.8%, 12MVAC has more favourable cost utility than 
6MVAC while if serious handicap occurs in more than 2.8% of meningitis 
cases, the cost-utility of 6MVAC is greater than 18MVAC.
The threshold cost per vaccine dose where each programme becomes cost-
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saving increases by approximately $1.50 for 18MVAC and $1.20 for 6MVAC 
for each 10% increase in vaccine efficacy. The cost threshold increases by a 
similar amount for each five unit increase in annual disease incidence between 
40 and 65 per 100000 per year.
Thus it is clear that 6MVAC and 18MVAC are the two preferred programmes 
and 18MVAC has a higher cost-utility over a wide range of values for key 
model variables. If 18MVAC is used as the baseline for comparison, rather than 
NO VAC, the marginal cost for each case prevented by 6MVAC becomes 
$11,499 and the cost for each additional QALY saved is $11,664.
Vaccine efficacy was examined separately, because of its importance and the 
wide range of efficacy estimates from available studies. The point estimates of 
vaccine efficacy at 18 months from all studies, except that of Wegner et al, 
yield a NCU superior to that for vaccination at six months. The wide 95% Cl 
of the case control studies of 18 month immunisation (lowest estimate 28%) 
results in the worst case cost utility for two of these studies being more 
unfavourable than that for the worst case vaccine efficacy at six months. The 
lowest estimate of vaccine efficacy under six months is 53%; the cost utility of 
18MVAC becomes more unfavourable than this if vaccine efficacy is below 
40%.
The threshold for incidence or cost variables above which 6MVAC and 
18MVAC became cost-saving was also compared (Table 4.8). There was no 
variable for which these thresholds were lower for 6MVAC than 18MVAC. A
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total annual disease incidence of more than 54 and a meningitis incidence of 
more than 25 (per 100,000 under five years per year) was the estimated 
threshold for 18MVAC, with the corresponding figures for 6MVAC 68 and 33 
respectively. Clearly the threshold at which 18MVAC becomes cost-saving 
includes the 95% Cl for many variables. Disease incidence would have to be 
greater that 76 per 100,000 per year for 6MVAC to dominate 18MVAC, an 
incidence considerably higher than that reported from any Australian centre. 
The cost of vaccine is crucial - 6MVAC dominates 18MVAC if the cost per 
vaccine dose is below $9.80 and all other model variables are held constant.
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Table 4.7 THRESHOLDS1 FOR KEY VARIABLES IN 6MVAC AND 18MVAC
VARIABLE
6MVAC*
THRESHOLD
18MVAC"
DISEASE INCIDENCE5 68
MENINGITIS INCIDENCE5 33
EPIGLOTTITIS INCIDENCE5 
SEVERE HANDICAP (%)* 2.8
ODDS OF SEVERE HANDICAP11
COST OF MENINGITIS** ($ ' 000) 22.6
COST OF EPIGLOTTITIS“ 20.5
COST OF SEVERE HANDICAP’ ($M) 1.8
COST OF DEATH55 ($ ' 000) 237
COST OF VACCINE” ($) 11.1
VACCINE EFFICACY1 (%)
54
25
22
2.5
10.2
7.2
1.3 
42 
14 
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Legend
# 6MVAC Vaccination before 6 months of age 
fl 18MVAC Vaccination at 18 months of age
1 The value of the indicated variable above which the program is cost-saving compared to no 
vaccination
§ Incidence per 100,000 children under 5 years per year
T Percentage of children having handicap severe enough to require institutional care following 
meningitis
il Odds of serious handicap in children over 18 months of age following meningitis vs children under 
this age
## Direct cost of meningitis (see methods)
** Direct cost of epiglottitis
* Direct cost of severe handicap requiring institutional care following Hib disease
§§ Indirect cost of death necessary to make the programme cost saving if it were included in model
calculations
Cost per vaccine dose in dollars 
! Percentage vaccine efficacy in preventing Hib disease
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The model was also varied to create a worst case and best case scenario by 
setting all variables to the value within 10% of their baseline estimate which 
was most favourable or unfavourable to the cost utility of vaccination. The 
results when no additional medical attendances were included are shown in 
Table 4.8. The results when costs of additional medical visits were included are 
shown in Table 4.9. Under the best case scenario, all programmes up to catch­
up immunisation at two years, were cost saving and remained so when any one 
variable was varied over its 95% Cl. The threshold cost per vaccine dose rose 
most steeply for 18MVAC, because severe long-term handicap was modelled as 
equally frequent at all ages in the best case scenario for 18MVAC. These 
conclusions were significantly changed by including additional administrative 
costs. There was no threshold vaccine cost which would render many programs 
cost-saving, and immunisation of children in the second year of life became the 
most favourable option. (Table 4.9)
Under the worst case scenario, the NCU of 6MVAC increased more than 
fivefold to $37,400 and the NCU of 18MVAC more than twentyfold to 
$25,700. The marginal cost for each additional QALY saved by 6MVAC 
compared to 18MVAC rose from $11,700 to $45200. The potential impact of 
attributing an indirect cost to death, as has been done using willingness to pay 
estimates in US analyses,112'113 was also considered as part of the worst case 
scenario. If the indirect cost of death was set at approximately $0.6 million for 
18MVAC or $1.0 million for 12 or 6MVAC, these programs all became cost­
saving even in this worst case scenario. This is much higher than the threshold 
cost for the indirect cost for death above which the programme became cost-
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saving in the base case analysis (Table 4.7) but still well below the willingness 
to pay costs quoted in other analyses.112'113
The questionnaires administered to parents indicated that considerable distress 
was experienced by the families of children who had had Hib disease. Seventy 
two families (53%) stated that this was the most traumatic event they had 
experienced, only 16 families (12%) considered the illness to have been only 
mildly traumatic for them. The families of children who had had meningitis 
reported that the illness had been very traumatic for them in two thirds of 
cases, compared to 47% of families whose children had had epiglottitis and 
31% of families whose children had had other types of Hib disease.
Table 4.8
WORST CASE AND BEST CASE SCENARIOS FOR IMMUNISATION AT THE AGE 
SIX, 12, 18, 24, 36 AND 48 MONTHS (NO ADMINISTRATION COSTS)
OUTCOME PROGRAMME
6MVAC* 12MVAC* 18MVAC" 24M" 36M* 4 8M*
BEST ESTIMATE
$/ QALY SAVED 6930 9136 1231 8630 27060 117100
THRESHOLD COST1 11.1 9.8 14 . 0 9.9 5.6 1.8
BEST CASE
$/ QALY SAVED 0 0 0 0 2750 46100
THRESHOLD COST1 17.3 20.5 32.5 18.3 10.6 3.4
WORST CASE
$/ QALY SAVED 37381 43115 25732 27347 59849 219143
THRESHOLD COST1 5.7 4.9 7.0 6.5 3.7 1.2
§ NOVAC No vaccination programme
# 6MVAC Vaccination before 6 months of age
* 12MVAC Vaccination at 12 months of age 
I! 18MVAC Vaccination at 18 months of age
► 24M,36M,48M Vaccination at X months in "catch-up" program 
** MILLIONS OF DOLLARS
SI VACCINE COST IN DOLLARS BELOW WHICH THE PROGRAM IS COST-SAVING
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Table 4.9
WORST CASE AND BEST CASE SCENARIOS FOR IMMUNISATION AT THE AGE OF 
SIX, 12, 18, 24, 36 AND 48 MONTHS WITH ADMINISTRATION COSTS
OUTCOME PROGRAMME
6MVAC* 12MVAC* 18MVAC1 2 4M* 36M* 48M*
BEST ESTIMATE
$/ QALY SAVED 24684 22414 19291 33763 70441 213498
THRESHOLD COST1 1 .1 2.3 NONE NONE NONE NONE
BEST CASE
$/ QALY SAVED 5069 0 0 7819 27125 109145
THRESHOLD COST1 COr- 13.0 17.5 4.1 NONE NONE
WORST CASE
$/ QALY SAVED 71898 43115 25732 27347 59849 219143
THRESHOLD COST1 NONE NONE NONE NONE NONE NONE
§ NOVAC No vaccination programme
# 6MVAC Vaccination before 6 months of age
* 12MVAC Vaccination at 12 months of age 
I! 18MVAC Vaccination at 18 months of age
► 24M,36M,48M Vaccination at X months in "catch-up" program 
** MILLIONS OF DOLLARS
<31 VACCINE COST IN DOLLARS BELOW WHICH THE PROGRAM IS COST-SAVING
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4.4 DISCUSSION
The results of this analysis provide a basis for decisions on the value of 
immunisation against Hib in Australia and the relative value of immunisation 
beginning at various ages, as assessed by cost utility and cost-effectiveness. As 
the baseline estimates used in the analysis were deliberately conservative, 
immunisation against Hib appears to be a good investment of health dollars in 
Australia.
Vaccination at 18 months of age with a single dose of Hib conjugate vaccine 
was clearly the most efficient strategy over a wide range of key variables in 
this study and was cost saving within the estimated range of a number of 
variables, such as the incidence of all Hib disease and meningitis and vaccine 
efficacy. This was despite the analysis being weighted against vaccination at 18 
months in that a low proportion of cases were assumed to occur before 
vaccination in the six month programme (four percent) and severe handicap 
was modelled as being more common in younger children. The efficiency of 
18 month vaccination would be significantly enhanced if a reduction in disease 
incidence in unvaccinated younger children through reduction in 
nasopharyngeal colonisation132 was confirmed.
The marginal cost per case prevented or QALY gained by immunisation under 
six months compared to 18 month immunisation was approximately ten times 
greater than the marginal cost of 18 month vaccination compared with no 
vaccination. The superior cost-utility of 18 month over six month immunisation
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held over a wide range of values for key variables such as disease incidence 
and vaccine efficacy, being reversed only by significant increases in the 
baseline incidence of severe handicap following meningitis or decreases in the 
cost of delivery of vaccine. If the incidence of severe handicap doubled to over 
three percent or the cost to deliver each vaccine dose fell from $15 to below 
$11, a six month programme became cost saving compared to no vaccination. 
If the cost per vaccine dose was below $10, the cost-utility of a six month 
programme became superior to 18 month vaccination.
The present study is similar to previous economic analyses in that decision 
analysis was used to model the experience of a birth cohort to the age of five 
years.111'116 There are however many differences in the epidemiologic variables 
used in the Australian analysis, particularly compared to US data.111'113 The age- 
specific incidence rates of Hib disease in the US studies are almost twofold 
estimates from non-Aboriginal Australian children, particularly for meningitis28 
30 as are the estimated costs of hospital care.111'113 These differences have a 
major impact on the estimates from immunisation at various target ages. In 
particular, immunisation of older children, requiring only one dose, appears an 
attractive option in Australia because of the greater disease burden at older 
ages.
Vaccine efficacy, disease incidence and vaccine cost were key variables in this 
and other studies.111'114 The estimated long-term direct costs of handicap without 
an immunisation programme ($ 6.5 million) dominated the short-term costs of 
hospitalisation ($ 3.7 million) in this and other studies.111'116 However, previous
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studies have not drawn attention to the importance of long-term handicap in 
their analyses.
Long-term handicap following Hib disease is primarily due to meningitis and is 
difficult to estimate with precision because of referral bias, later improvement 
of deficits at hospital discharge and loss to follow-up.54 Both Hay and Daum112" 
113 and Cochi et al111 used a high estimate of total (28%) and severe (7%) 
handicap following meningitis derived from the same hospital-based study.94 In 
contrast, the Dutch study114 used rates of mortality (2%) and severe morbidity 
(0.75%) following meningitis which were included in the confidence intervals 
of the Australian estimates. Previous studies have not considered the age 
distribution of severe handicap following meningitis; if handicap following 
meningitis had been considered equally prevalent after 18 months, 
immunisation at this age would have become cost-saving in our analysis.
Cost-utility analysis is valuable when both morbidity and mortality are 
important and different programs are being compared.122 The cost per QALY 
has been widely used to compare the value of different health interventions in 
QALY league tables. This is open to criticism because of the widely varying 
methods employed to estimate the cost per QALY in different studies.135 It is, 
however, appropriate to compare the cost per QALY of alternative strategies 
examined in one study. The utility values in this study were obtained from the 
use of a published, validated scale which had been used to evaluate the 
outcome of neonatal intensive care.121122 The measurement of utilities was
somewhat arbitrary but sensitivity analysis showed that changing the utility
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values for handicap did not have a significant impact on the outcome, with the 
possible exception of the utility of less severe handicap following meningitis in 
the infant programme. The estimate of less severe handicap following 
meningitis used by us was conservative, because mild handicaps not evident 
initially in children recovering from meningitis are frequently socio­
economically determined.54
The analyses of Hay and Daum112'113 also included indirect costs of death and 
handicap which were more than fourfold the long-term direct costs. The high 
rates of handicap following meningitis and high cost estimates used probably 
account in large part for the favourable estimates of cost-benefit112'113 and cost- 
effectiveness111 concluded by these studies, despite the factors unfavourable to 
immunisation such as the small proportion of cases occurring after the target 
age for immunisation, additional costs for vaccine administration at a separate 
visit, relatively low baseline estimates of vaccine efficacy, and a limited 
duration of immunity.111'113
Indirect costs were not included in this analysis, but would have a large impact 
on the results. Sensitivity analysis demonstrated that even under a worst case 
scenario for Hib immunisation, an indirect cost of death of $0.6 to $1.0 million, 
considerably less than willingness-to-pay estimates for the value of life used in 
other studies,112113 would make immunisation programs at six, 12 or 18 months 
cost saving.
Overhead and capital costs were not included in this analysis because the
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relatively small number of cases of Hib disease in any one hospital would not 
allow any significant savings in these areas. It could also be argued that wage 
and salary costs should not be included in the marginal costs of hospitalisation 
for the same reason, leaving only the costs of resources consumed, such as 
drugs and non reusable equipment and investigations. If so, the costs of Hib 
disease would be primarily the indirect costs of hospitalisation, handicap and 
death. The justification of Hib immunisation would then depend on indirect 
costs and the intangible costs of family distress.
The marginal administrative cost of Hib immunisation in the public sector was 
assumed to be minimal if given at the same age as other scheduled vaccines. It 
was clear from the importance of vaccine cost in the sensitivity analysis that 
increases in administration costs would have a large effect on the efficiency of 
Hib immunisation and would affect infant immunisation more because of the 
larger number of doses required. This is clearly seen in the analysis of "catch­
up" immunisation, where consideration of additional visits for Hib 
immunisation significantly changed the relative benefits of immunisation of 
children aged more and less than 12 months, and immunisation of children over 
the age of three years became an even less efficient use of resources. This is 
also an important consideration for infant Hib immunisation when this becomes 
part of the immunisation schedule - if Hib immunisation by private 
practitioners is administered at a separate visit to other routine immunisations, 
this would represent a very significant additional cost burden for the
community.
97
In summary, the analysis presented in this chapter shows that universal 
publicly-funded immunisation against Hib disease, given at the same time as 
other vaccines currendy included in the immunisation schedule, is economically 
justified. Immunisation at 18 months is more cost-effective than infant 
immunisation, because of the lesser number of vaccine doses required, although 
it prevents many fewer cases. Similarly, "catch-up" immunisation of children 
older than six months appears to be readily justifiable to the age of two years 
and not justified over the age of four years.
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CHAPTER FIVE
A CASE CONTROL STUDY OF RISK FACTORS 
FOR INVASIVE Haemophilus influenzae type b disease
5.1 INTRODUCTION
The previous chapters in this thesis have documented the age-specific incidence 
of all invasive Hib disease in the Sydney Statistical Division, the morbidity and 
mortality from Hib meningitis and the estimated economic costs and benefits of 
alternative programmes for prevention of Hib disease by immunisation. This 
chapter addresses an important remaining question - whether any groups can be 
defined who are at special risk of Hib disease and may benefit from targeted 
preventive efforts.
A number of risk factors for invasive Hib disease in children have been 
described. Although a number of uncontrolled case series had suggested that 
race and socio-economic disadvantage were risk factors for Hib disease,6 at the 
time of the design and conduct of this study, only two case-control studies of 
risk factors for Hib disease in the US had been published.20,136 Subsequently, a 
study from Finland137 and three further studies from the US have become 
available138140 as well as preliminary findings from a hospital-based case- 
control study from Melbourne.141 The date, design and size of each of these
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studies is summarised in Table 5.1
Table 5.1 CASE CONTROL STUDIES OF RISK FACTORS
FOR INVASIVE Haemophilus influenzae type b DISEASE
STUDY AND SITE SUBJECTS (N) RECRUITMENT OF CASES 
AND CONTROLS
RESPONSE RATE AND COMMENTS
Istre, Conner, Broome et a!13* 
Colorado 1981-82
110 cases 
166 controls
Population-based surveillance 
Controls from birth register
Questionnaire mailed to cases and controls 
85% of cases and 74% of controls 
Mailing within one week of case onset
Arnold, Makintube and Istre’”  
Oklahoma 1986-87
295 cases 
590 controls
Population-based surveillance 
Controls from birth register
Questionnaire mailed to cases and controls 
79% of eligible cases, contact within 2 weeks. 
67% of controls first choice
Cochi, Fleming et al”  
Atlanta 1983-84
89 cases 
530 controls
Population-based surveillance 
Controls from random-digit dialling
Questionnaire administered by telephone 
114 eligible cases, 102 interviewed, 89 with 
telephones. Control response rate 93%.
Cases contacted median of 3 months after 
onset; controls recruited after all cases were 
obtained. Reference date was date of onset.
Takala, Eskola, Palmgren et al137 
Finland 1985-86
117 cases 
225 controls
Population-based surveillance 
Controls from case’s health care centre
Cases filled out questionnaire during a home 
visit; controls received mailed questionnaire. 
Response rate cases 96%; controls 91%. 
Interview median 3 days after onset for cases 
and 13 days after onset for controls.
Clements’*’
Royal Childrens Flospital Melbourne 
1988-89
210 cases 
367 controls
Hospital-based recruitment 
Controls from day surgery unit
Cases and controls were interviewed face to 
face. Dates of admission and interview 
differed widely
Berg, Shapiro and Capobianco’39 
Yale-New Haven Hospital 1984-86
46 cases 
46 controls
Hospital-based recruitment 
Controls from hospital birth register
To be eligible, cases and controls 
must have been born at the hospital 
Interview within two weeks of case onset
Vadheim, Greenberg, Bordenave et al’40 
Los Angeles 1988-89
80 cases 
223 controls
Population-based surveillance 
Controls from random-digit dialling
Part of a case-control study of vaccine 
efficacy. Eligible cases were 18 months to 
5years; 91% interviewed. 98% of controls 
interviewed and indexed by month of case 
disease onset.
Present study 
Sydney 1989-90
133 cases 
395 controls
Population-based surveillance 
Controls from random-digit dialling
Questionnaire administered by telephone to 
94% of eligible cases, 95% of controls.
Cases contacted median of 3 months after 
onset; controls recruited simultaneously.
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The first two published studies20,136 had found day care attendance to be an 
independent risk factor for Hib disease with an odds ratio of 2.3 to 12.8 in 
different age groups. The odds ratio increased inversely with age in Atlanta20 
but proportionately to age in Colorado.136 The presence of school-aged siblings 
in the household was a risk factor only in the Colorado study.136 A dose- 
response relationship was observed for both day care centre size and degree of 
household crowding in Atlanta where the attributable risk of day care was 
estimated to be 50%.20 Breast feeding was protective in both studies.20,136 The 
differences between the findings of the Atlanta and Colorado studies made 
household age composition of particular interest for this study. Household 
crowding, care with other children, parental smoking and race and ethnicity 
were of interest as risk factors while breast-feeding was a potential protective 
factor. A possible relationship between these factors and age of disease onset 
was suggested from the demographic differences in the descriptive study29 and 
was another focus of interest for the analysis.
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5.2 METHODS
The design used for this study was a population-based case-control study. The 
aim was to investigate the factors associated with increased or decreased risk of 
developing invasive Haemophilus influenzae type b (Hib) disease in children 
under five years of age, who represent the great majority of cases.6 A case- 
control design was considered most appropriate because invasive Hib disease is 
uncommon, making a cohort study impractical. The study design was 
population-based in order to minimise bias in the identification of cases and 
controls.
5.21 Study Population
The study population was defined as the Sydney Statistical Division, (SSD) 
which includes the outer Sydney region from the Central Coast and Gosford in 
the north to Campbelltown and Camden in the south and Katoomba in the west. 
This region has natural geographic boundaries; hospital admission of cases 
residing in the area outside it is minimal, because all referral centres are within 
the region.29 The total population of this region was 3364858 in 1986 of whom 
229165 were children under the age of five years.92
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5.22 Case selection
Case definition and case ascertainment
The methods of case ascertainment and the case definition have been described 
previously.29,119 A culture positive case of Hib disease was defined as a child 
aged 0-4 years in whom Hib was isolated from blood, cerebrospinal fluid or 
any normally sterile site. A culture-negative case was defined as a child with 
endoscopically proven epiglottitis or with Hib antigen identified in 
cerebrospinal fluid, urine or joint fluid in the presence of features of pyogenic 
meningitis or a syndrome commonly caused by Hib, such as facial cellulitis or 
septic arthritis.
Cases were identified by active laboratory surveillance specifically established 
for this study. A nominated member of staff in all laboratories processing 
bactériologie specimens from hospitals where children were admitted in the 
study area (N=22) was contacted by telephone each one to four weeks 
depending on the size of the hospital to establish whether Haemophilus 
influenzae type b had been isolated from a normally sterile site. All hospitals 
were also asked to notify cases as they occurred between contact times. All 
three paediatric intensive care units in the study area were also contacted 
weekly, primarily to identify cases of epiglottitis not detected by laboratory 
surveillance. It had been previously established that few additional cases 
occurred outside these hospitals or would be identified by other means, such as 
medical record review.29 Participating hospitals were sent regular updates on
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the progress of the study and numbers of cases from their institution and others.
Eligible cases were children under the age of five years who had resided in the 
SSD for at least two weeks prior to disease onset, survived the acute illness and 
had a personal telephone.
Case interviews
The physician caring for the patient was contacted and asked to approach the 
parents of an eligible case for permission to interview them. Once permission 
was obtained, initial contact was made with the parents by telephone by the 
chief investigator or a research assistant. This was at least two weeks after 
discharge from hospital to minimise any ongoing family disruption. An initial 
questionnaire administered at this time seeking details of the case’s illness and 
its impact on the family, as part of an economic analysis of Hib disease 
(Appendix 3, Chapter 4). The parents were then advised that another person 
would be contacting them to administer a further questionnaire within the next 
few weeks. (Appendix 6).
5.23 Control selection
Alternative sampling frames for controls
As case ascertainment was population-based, in that all cases were assumed to 
be identified by hospital laboratories, controls should be selected from the same
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study base, the SSD. The use of hospital controls was both inappropriate and 
impractical because of the large number of geographically dispersed hospitals 
in the case surveillance area. The sampling frames considered were door-to- 
door interviews and telephone sampling, using either random digit dialling or 
the telephone directory. Door-to-door interviewing in a stratified random 
sample of Collectors’ Districts in the SSD would have given all potential 
controls an equal probability of selection and allowed all cases to be included. 
However, logistic problems such as the wide geographic area involved and 
consequent long travelling times required, made this method of sampling 
impractical.
Telephone based methods of sampling were feasible because 93% of occupied 
private dwellings in the SSD had a telephone connected in 1986.142 The 
disadvantage of telephone sampling is that households without telephones differ 
from others in that they have a disproportionate level of socio-economic 
disadvantage. In 1986, among low income groups (less than $150 per week) 
coverage was 83%, among households with an unemployed head, 80% and in 
single-parent households, 84%.142 Although households with persons living 
alone and households of unrelated individuals are also less likely to have 
telephones,142 these were of little concern for this study. Low response rates 
have been a concern in telephone-based sampling compared with face-to-face 
methods143 but are likely to be less of an issue when the target group has a 
specific interest in the subject of inquiry, such as the health status of young 
children. In Atlanta, response rates of greater than 90% were achieved.20
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In Random Digit Dialling (RDD), telephone numbers are generated at random 
from among all three digit exchange prefixes in current use. The major 
disadvantage of this method is the high proportion of ineligible numbers 
including inactive, disconnected and business numbers. Modifications of RDD 
have been used to reduce the number of non-residential numbers sampled. 
Waksberg144 described a modified form of cluster-based RDD, which involved 
discarding exchange prefixes where the first number dialled was non- 
residential. Telephone exchange-based RDD is a further modification of the 
Waksberg method, which uses the exchange prefix of the case as the unit for 
control selection. This has been used in other studies in the US,145 but not 
previously in Australia. Exchange-based RDD has the advantage of partially 
controlling for unknown confounders which are related to locality, particularly 
indicators of socio-economic status.146 The disadvantage of this method is the 
potential for over-controlling for variables of interest, reducing the magnitude 
of the effect detected. Exchange-based RDD was the method of control 
selection chosen initially for this study because of ease of use, inclusion of 
unlisted numbers and the assumption that each telephone exchange, covering 
several suburbs, contained sufficient diversity to avoid over-controlling for the 
variables of interest.
The telephone book is the most straightforward sampling instrument. This 
sampling frame was not used initially in the study because of concern about 
unlisted numbers, estimated at 18%142, and inaccurate entries, estimated at 20% 
(B. O’Toole, personal communication). More recent estimates, based on the 
ratio of residential numbers listed to the number of private occupied dwellings
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from Census data, indicates that 89% of dwellings had a directory listing.147 To 
evaluate the possibility of over-matching of controls by exchange-based RDD, a 
second smaller group of controls was recruited in 1991, after recruitment of the 
first control group was complete, using telephone directory-based methods.
5.24 Recruitment of controls by exchange-based RDD
A roster of telephone numbers to be dialled was obtained by holding the area 
code and first four or five numbers of the case telephone number constant and 
generating a roster of 100 possible numbers in random order from the last two 
digits. The numbers were then dialled sequentially, initially during working 
hours to identify businesses, and subsequently out of hours on three occasions. 
Numbers which did not answer and were identified by Telecom as live numbers 
were recontacted one week later before being discarded. Eligible families had 
one or more children five years of age or less, Three such families were 
recruited from each case telephone number.
The interview was either conducted at the time of contact or an appointment 
arranged to interview families who agreed to participate. The questionnaire was 
completed for all children in the household five years of age or less. If the 
interviewer was unable to ascertain whether the household contacted was 
eligible because of a language barrier, an effort was made to determine the 
language spoken. A qualified interpreter from the Western Sydney Area Health 
Service Interpreter Service or the Telephone Interpreter Service was then used 
to contact the number and establish eligibility and willingness to participate. If
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appropriate, a three way telephone hook up was then arranged between the 
client, one of the three interpreters and the interviewer.
Telephone directory-based control recruitment
The roster of numbers was derived from the appropriate telephone directory in 
proportion to the number of case telephone numbers in each directory. Page 
numbers were chosen at random and the first residential number from each 
column of that page selected. The dialling procedure was identical to that for 
the RDD group.
5.25 Blinding of interviewers
Three trained interviewers were used for the duration of the study. The 
interviewers were initially blinded to case status, with the case telephone 
number included within the first 10-20 numbers on the list. However, it became 
apparent during the first six months of the study that the interviewers usually 
became aware of the identity of the cases despite the case parents having been 
warned not to divulge this and that blinding to case status sometimes caused 
the case telephone number to be discarded from the roster of numbers. This 
could occur if there was difficulty in contacting the case number or four 
eligible households were recruited before the case number was reached. 
Consequently, the interviewers were unblinded after the first six months of the 
study. Interviewers remained blind to the study hypotheses. They were told in 
general terms that the study was to determine any differences between children
with and without Hib disease.
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5.26 MEASUREMENT OF STUDY VARIABLES 
Questionnaire Development
The questions concerned use of child care, immunisation status, household size 
and structure, racial and ethnic background and social and demographic 
variables. The questions on child care and immunisation were based on the 
Australian Bureau of Statistics child care questionnaire (Catalogue No. 
4401.0)148 and the children’s immunisation survey (Catalogue No. 4351.0). The 
remaining questions concerned socio-demographic variables and included all the 
indicators used in the socioeconomic status index developed by the Australian 
Bureau of Statistics (based on 1986 census data). Families were also asked 
about receipt of medical care. This included whether the child had any problem 
for which he or she needed regular medical attention and the number of visits 
to the doctor in the previous six months. The questionnaire was piloted for 
comprehension and acceptability among parents of age-appropriate children at 
Westmead Hospital with no difficulties encountered. Cases and controls were 
asked for contact addresses for day care centres and general practitioners to 
enable these data to be verified.
The questionnaire was ordered such that the most important and readily 
answered questions, those concerning eligibility and child-care status, were 
asked first followed by questions concerning medical care and immunisation. 
Demographic questions and those concerning the ethnic background and socio­
economic status of the subject were left until last.
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Exposure Variables
The actual questions asked are given in Appendix 6. These pertained to six 
main areas, all of which had been previously suggested as possible factors 
associated with increased risk of or protection against invasive Hib disease. 
These were family size and crowding, care with other children, previous health, 
breastfeeding, birthplace and country of origin including Aboriginality and 
smoking. Age and sex and a variety of indicators of socioeconomic status 
which might confound any of these exposure-disease relationships were also 
ascertained.
Family size and crowding
Family size and crowding have been evaluated in a number of ways in the 
literature. Crowding has been measured as the number of persons per room of 
the house,20 the number of persons per bedroom139 and the number of children 
sharing a bedroom with the index child.140 Family size has been looked at as 
the number of children under five years of age in the household,137 the number 
of school-age children in the household136 and the total number of persons in 
the household.140 In this study, crowding was measured by the number of 
persons sleeping in the house divided by the total number of rooms in the 
house (persons per room) and the number of children sleeping with the index 
child (none or one or more). Family size was measured as the number of 
children under five years of age (one or more than one), the number of children 
of school age (none versus any) and the number of other persons in the
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household, designated adults (one or two versus more than two).
1. Family size
(i) Number of children under the age of five years
Respondents were asked the number of children under five years in the 
household, with sex and ages recorded in years and months for each child. This 
was classified as one, two or more than two children under five years. Children 
who were not siblings were included, to account for multi-family households.
(ii) Number of children attending school (over five years)
Subjects were first asked if there were any older children in the household who 
attended school. If so, they were asked for their ages in whole years. If a child 
over the age of five years who did not yet attend school was identified, he or 
she was also classified as school-aged. This variable was classified as none, one 
and more than one.
(iii) Number of adults living in the household
Respondents were asked the number of adults, including themselves, living in 
the house at present. Respondents were also asked the number of persons who 
usually sleep in the house later in the questionnaire. This was also used as a 
separate variable (the total number of persons in the household). If the total 
number of persons was larger than the sum of adults and all children, it was 
assumed that there were older children present in the household who did not 
attend school; they were classified as adults.
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2. Crowding
(i) Number of children sleeping in the same room as the index child
This was as classified as a binary variable (none or any) as there were few 
households where more than two children slept in the same bedroom. The 
reference control child was the one closest in age to the case.
(ii) Persons per room
This was measured as the number of persons sleeping in the house divided by 
the number of rooms in the house. The number of rooms was obtained using 
the same categories of room as in the Census form and summing these 
categories. The resulting variable, persons per room, was examined in quintiles 
derived from its distribution in control families and as a binary variable with 
the highest quintile (more than 0.8 persons per room) as the exposure variable.
3. Care with other children
(i) Number of hours of care with other children
A broad definition of care with other children was used in this study. Receipt 
of child care was defined as any regular care with one or more unrelated 
children by someone other than a parent. Respondents were initially asked 
whether the child had been looked after in the past week, and if they replied no 
to this, were asked about any regular care in the previous six months. A series 
of further questions then established the total number of hours of care per week 
by asking the number of different locations where the child was cared for, the
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type of care (own home, another home, daycare centre, preschool and 
occasional care or playgroup), the days of the week on which the child attended 
care and the number of hours each day. The total number of hours per week 
was then derived from summing across categories. This information was 
verified by asking for the name, address and telephone number of each centre 
attended by the child in order to validate the number of hours attended, the 
number of children at the centre and the date on which the child had first 
attended. This was more likely to be available for formal than informal child­
care and for larger centres and was not attempted if the total number of hours 
of care was less than four per week.
(ii) Number of children less than five years attending childcare
Information on child-care attendance was obtained for the siblings of cases and 
controls, to investigate the proportion of cases and controls whose siblings 
attended child-care. This was classified as a binary variable, one or more than 
one child under five years attending child-care, restricted to case and control 
families with more than one child under five years.
(iii) Length of time attending child-care
This variable was included because one study had suggested that cases were 
more likely to have begun to attend child-care in the month before disease 
onset.137 Data on the number of months attending care were available only for 
cases and controls with written confirmation of the date of commencement, as
this question had not been asked in the questionnaire.
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(iv) Number of children on the roll
These data were obtained to evaluate the hypothesis that risk of care with other 
children was increased in care facilities where a larger number of children 
attend. This variable was also only available for cases and controls with 
confirmed data. It is closely related to type of child-care received and therefore 
to total hours of care and age, with very limited data available for younger 
children.
(v) Type of child-care facility
These data were classified by the primary type of care if more than one centre 
was attended. This was classified in three broad categories: family-day care, 
preschool or day-care centre and occasional care or playgroups. The type of 
child-care received was closely related to age, hours of care and numbers of
children attending.
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4. Previous illness and medical care
(i) Previous illness
Respondents were asked whether there was any medical problem for which 
they were regularly seeing a doctor or hospital. These largely fell into two 
groups - asthma and respiratory infections including otitis media and tonsillitis. 
The medical condition was classified as significant if there was a 
neurodevelopmental problem, such as developmental delay or cerebral palsy or 
if substantial medical care including hospital admission was likely to be 
needed, such as congenital heart disease and malignancy.
(ii) Recent health
This was measured as the number of doctor visits in the previous 12 months 
(with reference to admission date in cases and interview in controls). As well 
as total visits, the number of visits for which antibiotics were prescribed was 
also ascertained, in an attempt to evaluate the number of possible infective 
episodes. Data were only available for cases and controls with written 
documentation from a medical practitioner.
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5. Breast feeding
Breastfeeding data were sought only for children under the age of 24 months. 
This was because of concern about recall inaccuracy and possible bias for older 
children, as well as lack of biological plausibility, with any effect in older 
children likely to be related to other correlates of breast-feeding. Respondents 
were asked first whether the child was breast fed; children for whom the 
months of breast feeding was equal to the current age were classified as 
currently breast feeding.
Dose response relationships were evaluated by the proportion of the child’s life 
for which he or she had been breast fed and the total number of months of 
breast-feeding. The proportion of life breast fed was calculated as the number 
of months of breast-feeding divided by the age in months and classified as 
none, half or less and more than half the child’s life. The number of months of 
breast feeding was classified as none, six months or less and seven months or 
more; this could only be evaluated in children seven months to two years of 
age.
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6. Birthplace and ethnicity
(i) Aboriginally
Respondents were asked whether they or the other parent were of Aboriginal or 
Torres Strait origin.
(ii) A language other than English usually spoken at home
Respondents were asked what language they usually spoke at home. If this was 
other than English, they were asked what language was spoken.
(iii) Ethnicity and other language usually spoken
Respondents who were identified as having at least one overseas-bom parent 
and who spoke a language other than English at home were further classified 
according to the language spoken and their country of origin. This was 
classified in two ways. First in a more general classification with those 
speaking English or European languages (predominantly Mediterranean) as the 
reference group, compared with Arabic-speaking (predominantly Lebanese), and 
Asian and other which consisted of those of Chinese origin (Vietnam, China, 
Korea, Japan, Singapore) and other Asian which included the Indian 
subcontinent and the Philippines and Pacific Islanders.
Because of the diversity of the Asian and other group, this was sub-classified 
into Chinese origin (Vietnam, China, Korea, Japan, Singapore) and other Asian 
(Indian subcontinent and the Philippines) and Pacific Islanders. This more 
specific classification was of interest because of the impression of some
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paediatricians that Hib disease was disproportionately frequent among children 
of Lebanese origin and the suggestion that Hib disease may be less common 
among ethnic Chinese children.55
7. Passive smoking
Respondents were asked how many adults in the household smoked tobacco. 
Three classifications were used - none versus any smokers, none versus one 
and two or greater and no or one smoker versus two or more smokers.
Possible confounding variables
1. Age
Age was very important as a potential effect modifier or confounder of most 
exposures. There was partial matching in that the child closest in age to the 
case was used as the index child. Age was defined as age in months at the date 
of admission for cases and age at the date of interview for controls.
2. Sex
Male sex has been identified as a risk factor for many infectious diseases, 
including invasive Hib disease.6
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3. Season of the year
There is marked seasonality in the occurrence of Hib disease, with a 
pronounced winter peak described in the Sydney region.29 The influence of 
seasonality was thought to be minimal for most of the variables of interest, 
either because they were fixed family characteristics or because the duration of 
measurement extended over a calender year. The number of months of child­
care was the variable most likely to be influenced by season because of the 
tendency to commence childcare at the beginning of the calender year, 
particularly for more organised types of care.
Seasonality was classified as the colder months (May to August) vs the other 
two four month periods. The reference date was the date of admission in cases 
and date of interview in controls.
4. Mobility
Respondents were asked what the family’s address was one year ago and were 
classified as mobile if this was different to their current address.
5. Marital status
Respondents were asked about marital status in the categories single, married, 
divorced, separated, defacto or widowed, to conform with the Census 
classification. Marital status was then classified as a binary variable with 
married or defacto as the reference variable against all other categories (single
parents).
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6. Unemployment
Respondents were asked whether they or their partner had a full-time or part- 
time paid job at present. Families where no person in the household had a job 
were classified as unemployed.
7. Low educational level of parents
Respondents were asked what was the highest level of education they and their 
partner had achieved in the eight Census categories. This was then classified as 
a binary variable with a low level of education defined as no person in the 
household having achieved at least School Certificate level.
8. Low income
Respondents were asked what the total family income was before tax, classified 
according to strata used in the 1986 Census, the highest of which was more 
than $50,000 per year and the lowest of which was less than $9000 per year. 
Pensioners were a separate category. Families were classified as low income if 
the income stated was below $15000 or if they identified themselves as a 
pensioner. Respondents who had stated that they did not know their income 
were reassigned to the low income category if they were unemployed and 
receiving either unemployment or supporting parent benefits.
9. Vehicle ownership
Respondents were asked whether anyone in the household owned a motor 
vehicle. Vehicle ownership was classified as no or any vehicle in the
household.
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5.27 STATISTICAL METHODS
Sample size
Australian Bureau of Statistics data148 show that 11% of children under 3 years 
and 42% of children 3-5 years of age use formal child care. With 100 cases 
and 3 controls per case, an odds ratio for day care attendance of 2.0 or greater 
can be detected with 90% power, based on the tables of Schlesselman149.
Specification of variables
As the outcome variable in this study was dichotomous (case or control) 
methods of categorical data analysis were necessary. The statistical methods 
used to analyse the data from this case-control study include crude, stratified 
and multivariate techniques to produce odds ratios for the association between 
the development of Hib disease and exposure variables. The confidence ratios 
for odds ratios are 95% confidence intervals. EGRET (Epidemiologic Graphics, 
Estimation and Testing Package, Epidemiologic Research Corporation, Seattle) 
was used for all analyses. EGRET uses a conditional likelihood method for 
estimating the confidence intervals of odds ratios in stratified analyses and has 
an exact method available for calculation of confidence intervals where there 
are small numbers in individual cells, including zero cells.
Most of the exposure variables in this study were treated as categorical. Even 
variables which could be regarded as continuous, such as age, hours of child-
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care and number of persons per room, had markedly skewed distributions. 
Categorisation of these variables in quintiles was both more readily 
interpretable and avoided the need to assume an exponential dose-response 
relationship or to transform the data in order to achieve a distribution more 
closely approaching linearity.150 It has been shown that the use of five or more 
categories has almost the same power to detect an effect as leaving the variable 
in a continuous form.151 If particular variables had been specified in a 
particular form in previous published studies, this was also considered.
Age was treated as categorical in four age-groups (0-12 months, 13-24 months, 
24-36 months and 37-60 months) for analyses of the whole data set. For sub­
group analyses and stratified analyses, the data were too sparse to treat age in 
this way; two age groups (less than and greater than two years) were used.
Crude and stratified analyses
The crude odds ratios were obtained from the factor function in logistic 
regression in EGRET. The confidence intervals for the crude odds ratios and 
the age-adjusted odds ratio were then obtained from maximum likelihood 
estimation of the logistic model containing that variable only or with age.
Each of the exposure variables was evaluated by stratified analysis with age in 
two categories. The major stratification variables were focus of infection, 
number of children in the household and receipt of child-care. Interaction 
between variables in these pair-wise analyses was evaluated by the chi-square
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heterogeneity test, with a p-value of 0.05 as the critical value.
Multivariate analysis
Multiple logistic regression models were used to simultaneously adjust for 
multiple confounding variables. Variables in the model were selected either a 
priori because of previously described associations20,136 or because the odds 
ratio in univariate analysis was significant.
Conditional logistic regression was used for models including all subjects, and 
for cases and controls less than or greater than two years, with the telephone 
exchange prefix as the matching variable. Variables which were subsets of each 
other, such as numbers of children under five years, children of school age and 
adults and total number of persons in the household, were not used in the same 
model. Age, sex and month of the year (admission or interview) were included 
in all models regardless of P value. All remaining variables, including first 
order interactions with age, were included in the model and eliminated by 
backward stepwise procedure, beginning with the variable whose P value was 
closest to one, until all variables remaining in the model had an associated P 
value of less than 0.10.
The Likelihood Ratio Statistic (LRS) was used to test the significance of 
interactions between variables in the reduced model, which were retained if the 
LRS had an associated P value of 0.10 or less.151 All variables which had 
previously been eliminated from the model were then added singly to the
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reduced model and retained if the associated LRS had a P value of 0.10 or less.
Logistic regression was used to analyse models restricted to one focus of 
infection, such as meningitis and non-meningitis cases. All controls were 
compared with only the eligible category of cases (eg meningitis) and evaluated 
irrespective of matching by telephone exchange. This was done in order to 
avoid the possibility of chance bias in small subsets of matched cases and 
controls and to improve precision.
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5.3 RESULTS
5.31 STUDY SUBJECTS
5.311 Cases
A total of 171 cases were identified from the participating hospitals during the 
period February 1989 to August 1990. Case interviews were conducted between 
September 1989 and December 1990. An interpreter was required for two case 
interviews (1.5%); one Arabic and one Vietnamese. Thirteen cases (7.9%) 
were ineligible because they were over the age of five years at the date of 
admission, one of whom died. Eight of these children had epiglottitis, five had 
other foci of infection; none had meningitis. Another five (2.9%) of age-eligible 
children had been resident in the study area for less than two weeks.
Of the 153 cases eligible by age and residence, three died (2.0%) and eight 
(5.2%) did not have a telephone connected, leaving 142 eligible according to 
the study criteria. Of these 142 cases, four (2.8%) refused to be interviewed 
and four (2.8%) were lost to follow-up after hospital discharge. One child was 
a secondary case (meningitis in the sibling of a child with epiglottitis) and was 
excluded. The characteristics of all cases during the study period are shown in
Table 5.2.
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TABLE 5.2 CASE SERIES
CATEGORY N %
All cases 171 100
Reside in study area 167 97.7
Age eligible 153 89.5
Cases eligible by
age and residence 153 100
Deaths 3 2.0
Secondary case 1 0.7
No telephone 8 5.2
Cases eligible by
study criteria 141 92.8
Refusal 4 2.8
Loss to follow-up 4 2.8
TOTAL CASES IN STUDY 133 94.3
(of study eligible) 
86.9
(of age eligible)
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The final case series consisted of 133 children of whom 75 (56%) had 
meningitis, 32 (24%) had epiglottitis and 26 (20%) had bacteraemia with other 
sites of infection. The incidence of invasive Hib disease based on the 153 cases 
eligible by age and residence was 41.0 per 100,000 children under five years 
per year, almost identical to that found in the retrospective study (Chapter 2). 
The age, sex and ethnicity of cases in each of three disease categories 
(meningitis, epiglottitis and other ) is shown in Table 5.3.
Table 5.3 CASES - AGE, SEX, ABORIGINALLY AND ETHNICITY
AGE (months) MENINGITIS EPIGLOTTITIS OTHER TOTAL
N %' N %‘ N %' N %“
0-12 mths 34 72 1 2 12 26 47 35
13-24 mths 22 67 6 18 5 15 33 25
25-36 mths 8 33 10 42 6 25 24 18
37-48 mths 6 43 8 57 0 0 14 11
49-60 mths 5 33 7 47 3 20 15 11
TOTAL 75 56 32 24 26 20 133 100
SEX
Male 44 59 12 38 10 38 66 50
ETHNICITY
Aboriginal 0 0 0 0 0
Non English 
speaking 8 11 5 16 1 38 14 11
Legend
Percentage of total for each age group or focus 
Percentage of total cases
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5.312 Controls 
Random digit dialling
A total of 395 control families were identified by exchange-based RDD from a 
total of 4135 answered telephone numbers during the period June 1989 to 
December 1990. The number and distribution of outcomes from the total 
telephone numbers contacted is shown in Table 5.4.
TABLE 5.4 CONTROL SERIES - RANDOM DIGIT DIALLING
N %
TOTAL NUMBERS CONTACTED 4268
SUBTRACTING CASES 133
POTENTIAL CONTROLS 4135 100.0
No answer 279 6.7
Disconnected 214 5.2
Business 693 16.8
Language problem 6 0.15
Refused 19 0.46
Ineligible 2529 61.2
CONTROLS 395 9.6
REFUSAL RATE 19/414 4.6
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Although 11.9% of telephone numbers either were not able to be contacted 
(6.7%) or were disconnected (5.2%), households containing young children are 
unlikely to be amongst this group. This is because such households are likely to 
be contactable at home with repeated calls and less likely to have a telephone 
which is disconnected. If all 19 refusals are assumed to have been eligible for 
the study, the refusal rate is 4.6%. In 66 (49.6%) of case-control sets, two or 
more of the control families resided in the same suburb as the case and in 86 
(64.7%), the suburb in which the case resided was the same as at least one of 
the controls.
The mean number of telephone numbers contacted to recruit one control family 
was 11.7, with a wide range of three to 47. The number of telephone numbers 
contacted to recruit three control families was less than 20 in the lowest 
quintile and more than 46 in the highest quintile. This resulted in considerable 
inefficiencies, such that recruitment of the last 20% of control families recruited 
required 43% of the total number of telephone numbers contacted. Two control 
interviews required an interpreter (0.5%); both were families of Chinese origin. 
The age, sex and ethnicity of RDD controls in Table 5.5.
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Table 5.5 RANDOM DIGIT DIALLING CONTROLS 
- AGE, SEX, ABORIGINALITY AND ETHNICITY
AGE MENINGITIS EPIGLOTTITIS OTHER TOTAL
N %* N %* N %' N %"
0-12 MTHS 53 62 18 21 15 17 86 22
13-24 MTHS 58 67 11 13 18 21 87 22
25-36 MTHS 41 51 26 32 14 17 81 20
37-48 MTHS 49 57 19 22 18 21 86 22
49-60 MTHS 25 45 20 36 10 18 55 14
TOTAL 226 57 94 24 75 19 395 100
SEX
Male 112 50 42 45 36 48 190 48
ETHNICITY
Aboriginal
Non-English
speaking 36 16 11 12 11 55 14
Legend
Percentage of total for each age group or focus 
Percentage of total cases
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Telephone directory
One hundred and one controls were recruited. Recruitment of these controls 
was between February and October 1991. The refusal rate was similar to the 
RDD series (0.5% of total and 4.8% of eligible subjects) as was the proportion 
of disconnected numbers and of numbers from which no answer was obtained. 
The proportion of business was less than for RDD (4.9%) and the proportion of 
ineligible numbers higher (75.0%). The mean number of telephone numbers 
contacted to recruit one control family was 9.6, slightly less than for the RDD 
series. An interpreter was used for one control interview (1.0%), a family of 
Chinese origin. The age, sex and ethnicity of these controls is shown in Table
5.6.
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Table 5.6 TELEPHONE DIRECTORY CONTROLS
- AGE, SEX, ABORIGINALITY AND ETHNICITY
AGE TOTAL
N %
0-12 MTHS 29 28
13-24 MTHS 30 30
25-36 MTHS 20 20
37-48 MTHS 16 16
49-60 MTHS 6 6
TOTAL 101 100
SEX
Male 45 45
ETHNICITY
Aboriginal 0 0
Non-English
speaking 15 15
Legend
Percentage of total for each age group or focus 
Percentage of total cases
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5.32 DATA QUALITY
5.321 Selection bias
As the method of control recruitment for the RDD controls was based on the 
residence of cases, differences in variables which are closely related to 
geographic area of residence may be underestimated. In order to evaluate this 
further, the number of cases observed in statistical subdivisions within the SSD 
was compared with the expected number of cases, based on the mean number 
of children 0-4 years residing in these statistical subdivisions, using the average 
of the 1986 and 1991 census estimates as the denominator. Table 5.7 shows the 
expected and observed number of cases from each statistical subdivision. The 
number of cases was greater than expected in the Outer Western areas of 
Sydney and the Central Coast and less than expected in the Western and South- 
Western regions, but did not achieve statistical significance except for the Outer 
West.
Table 5.7 EXPECTED AND ACTUAL NUMBERS OF CASES IN STATISTICAL 
SUBDIVISIONS IN THE SYDNEY STATISTICAL DIVISION
S T A T IS T IC A L P O P U LA T IO N E X PE C TE D A C T U A L O D D S
S U B D IV IS IO N 0-4 Y E A R S C AS ES C A S E S R A T IO P
N orthern 40579 21.7 23 re fe ren t
C entra l, E aste rn  
and S ou the rn 58791 31.4 28 0 .84 0.54
W este rn 45334 24.2 18 0 .70 0.26
O ute r w es t 25460 13.6 26 1.80 0.04
South  w est 61959 33.1 23 0 .65 0.15
C entra l coas t 16680 8.9 15 1.59 0.16
TO TA L 248803 132.9 133
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The variable of interest most likely to have been influenced by this discrepancy 
was ethnicity, which shows considerable geographic variation. The outer 
western and central coast regions had the lowest proportions of all non-English 
speaking persons and of Arabic-speaking and Chinese or Vietnamese-speaking 
persons, while the south-western and western regions the highest proportions in 
the 1986 census. (Appendix 7, Table Al) However, the census data relate to all 
households and age groups, rather than households with at least one child under 
the age of five years.
In the 1991 census, there was a slightly higher proportion of persons under the 
age of 26 years who spoke any language other than English at home (21% vs 
20%), and specifically Arabic or Chinese/Vietnamese, than over this age. This 
suggests that the proportion of non English-speaking households is likely to be 
higher among those with young children than the general population. The 
proportion of interviews requiring an interpreter was lower in both control 
groups (0.5 and 1%) than cases (1.5%). In 1991, 3.0% of persons aged 12 years 
and older in the SSD stated that they spoke English not at all well or not at all. 
Although the proportion of households requiring an interpreter might be lower 
than 3% among households containing young children, it seems likely that 
households where there was a language difficulty were less likely to be 
selected. Again, this would tend to underestimate differences in ethnicity
between cases and controls.
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5.322 Contemporaneity
A number of factors resulted in a delay between the date of admission and date 
of interview for cases, especially in the first six months of the study. First, 
enrolment of cases began four months before control enrolment. Second, the 
low numbers of children in some areas resulted in long periods being required 
to recruit eligible subjects from the corresponding exchange prefixes. Third, 
blinding of interviewers to case status meant that the date of case admission 
could not be used as the reference date for variables which were affected by 
time of interview, such as age and, primarily through age, child-care status. 
Fifty two (39%) of cases were interviewed within three months of disease onset 
and another 45 (33.8%) within six months; five cases (3.8%) were interviewed 
more than 12 months after the date of admission.
The problems with contemporaneity were addressed for the most important 
variables, those relating to child-care, by obtaining independent confirmation of 
the date of commencement. In addition, a convenience sample of cases was re­
contacted to check daycare status at the date of admission. Confirmation of 
daycare status and date of commencement was not available for cases or 
controls who reported less than four hours of child-care per week but was 
available for 48/56 (85.7%) of cases and 100/122 (81.9%) of controls reporting 
more than four hours per week. There were seven cases (5.3%) for whom no 
confirmation of child-care status was available and there had been six or more
months between the date of admission and date of interview.
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Forty four cases were recontacted to ascertain child-care status. Of 24 cases 
who reported no child-care at the time of interview, three (12.5%) were found 
to have been attending child-care at the time of admission. Of 20 cases who 
reported attending child-care at the time of interview, one (5% of total and 10% 
of those interviewed more than six months after admission), had not been 
attending child-care at the time of admission. This suggested that any 
misclassification was likely to be non-differential. Misclassification would be 
largely limited to those attending for less than four hours per week, for whom 
confirmation was not available.
5.323 Missing values
All the cases who refused to participate in the study were in the meningitis 
group (4/85, 4.7%). This was not significantly different from epiglottitis or 
other cases (P= 0.46 and 0.5 respectively). There was a trend for more 
epiglottitis cases to be lost to follow-up (3/37, 8.1%) than meningitis (1.2%) or 
other foci (0%); this was almost achieved significance at the 5% level (P=0.17, 
homogeneity test P=0.07). Higher loss to follow-up was probably related to the 
short duration of admission for epiglottitis cases, which often resulted in 
considerable efforts being necessary to obtain consent for participation in the 
study after hospital discharge. Cases without telephones were evenly distributed 
throughout different disease types - meningitis three (3.5%), epiglottitis two 
(5.4%, P=0.96 vs meningitis) and other foci three (9.7%, P=0.39 vs meningitis).
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Table 5.8 shows data for the variables available for all cases (age, sex and 
ethnicity) for cases in the study (133) and all age and residence eligible cases 
including the one secondary case (N=153).
Table 5.8 SEX AND ETHNICITY OF CASES IN THE STUDY AND ALL AGE 
AND RESIDENCE ELIGIBLE CASES BY FOCUS OF INFECTION : 
EFFECT ON THE ODDS RATIO
FOCUS
MENINGITIS EPIGLOTTITIS OTHER
STUDY 
N OR'*
TOTAL 
N OR
STUDY 
N OR
TOTAL 
N OR
STUDY 
N OR
TOTAL
N OR
TOTAL 75 85 32 37 26 31
FEMALE 31 1.0 38 1.0 20 1.0 23 1.0 16 1.0 18 1.0
MALE 44 1.44 47 1.25 12 0.4 14 0.82 10 0.68 13 0.78
ENGLISH
SPEAKING: 67 71 27 31 25 29
NON-ENGLISH
SPEAKING: 8 14 5 6 1 2
Legend
Odds ratio relative to RDD controls
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5.33 STRATIFIED ANALYSES
All stratified analyses are shown in tables with the stratifying variables, usually 
age, in the first column and numbers of cases and controls in each stratum in 
the next two columns. The odds ratio (OR) and 95% confidence interval (95% 
Cl) appear in the next two columns. The chi square test for homogeneity 
between strata is shown if the associated P value is 0.10 or less.
5.331 Family size and household crowding
Number of children less than five years
The number of children less than five years of age in case and control 
households, with age in two strata, is shown in Table 5.9. There was a 
significant association between an increasing number of young children in the 
household and Hib disease with odds ratios from 2.78 to 7.04. There was a 
highly significant dose-response with increasing numbers of children in both 
age strata, more prominent among older children. The association between 
increasing number of children less than five years and Hib disease remained 
with stratification by disease type (Appendix 7, Table A2).
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TABLE 5.9 NUMBER OF CHILDREN LESS THAN FIVE YEARS
IN THE HOUSEHOLD BY AGE GROUP
AGE GROUP CASES CONTROLS OR (95% Cl)
0 to 24 months'
One child 32 114 1.0 (referent)
Two children 39 50 2.78 (1.5-5.1)
Three or more 9 9 3.56 (1.2-10.8)
25 to 60 months’
One child 25 176 1.0 (referent)
Two children 23 41 3.95 (1.9-8.1)
Three or more 5 5 7.04 (1.6-31)
Both strata'
One child 57 290 1.0 (referent)
Two children 62 91 3.47 (2.2-5.5)
Three or more 14 14 5.09 (2.2-12)
* Test for trend significant (P<0.001)
139
Number of school-age children
There was marked effect modification by age in the association between the 
number of older children in the household and Hib disease. Among young 
children, the presence of increasing number of school-age children was a 
significant risk factor, with a significant dose-response relationship. In older 
children, the presence of increasing numbers of school-age children was 
apparently protective, with protection increasing with increasing numbers of 
children (Table 5.10). The heterogeneity test was highly significant for the 
stratum with two or more school-aged children (P < 0.001). When younger and 
older children were combined and two children and more than two children 
compared against one child as the reference group, similar effect modification 
was seen, but only among the oldest children (more than 36 months of age).
(Appendix 7, Table A3)
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TABLE 5.10 NUMBER OF SCHOOL-AGE CHILDREN IN THE HOUSEHOLD BY AGE GROUP
AGE GROUP 
test
CASES CONTROLS OR (95% Cl) H o m og e
0 to 24 months
None 46 123 1.0 referent
One child 16 32 1.34 0.6 - 2.8
Two or more 18 18 2.67 1.2 - 6.0
25 to 60 months
None 27 77 1.0 referent
One child 21 82 0.73 0.4 - 1.5
Two or more 5 63 0.23 0.1 - 0.7
Both strata
None 73 200 1.0 referent
One child 37 114 0.89 0.6 - 1.5 P = 0.21
Two or more 23 81 0.78 0.4 - 1.4 P < 0.001
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Number of adults in the household
Case households were more likely to contain three or more adults (11.2% vs 
6.8%), however the crude odds ratio of 1.73 was not significantly different 
from one (P=0.10). Following stratification for age and the number of children 
under five years, the odds ratio for three or more adults in the household 
became significant (Table 5.11). In households with an index child over two 
years of age and only one child less than five years, six (24%) of case 
households but only 15 (9%) of control households contained three or more 
adults, giving a significant odds ratio of 3.41.
Total number of persons in the household
There was a strong association between the total number of persons in the 
household and disease risk in children under two years of age, with a 
significant dose-response effect (Table 5.12). Effect modification by age was 
again evident, with children over two years of age showing no apparent effect 
of increasing household size. The odds ratio for the stratum with the largest 
household size (seven or more persons) was significantly different in younger 
and older children (heterogeneity test P=0.02).
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TABLE 5.11 NUMBER OF ADULTS IN THE HOUSEHOLD BY AGE GROUP AND
NUMBER OF CHILDREN UNDER FIVE YEARS IN THE HOUSEHOLD
AGE GROUP AND 
NUMBER < 5 YEARS
0 to 24 months
CASES CONTROLS OR (95% Cl)
One child < 5 years :
Two or less adults 30 106 1.0 referent
Three or more
Two or more children < 5 years
2 8 0.88 0.1 - 4.9
Two or less adults 42 56 1.0 referent
Three or more 
25 to 60 months
6 3 2.67 0.6 - 14.4
One child < 5 years :
Two or less adults 19 162 1.0 referent
Three or more
Two or more children < 5 years
6 15 3.41 1.0 - 10.9
Two or less adults 27 44 1.0 referent
Three or more 
All strata
1 1 1.63 0.0 - 62.8
Two or less adults 118 368 1.0 referent
Three or more 15 27 2.17 1.0 - 4.7
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TABLE 5.12 TOTAL NUMBER OF PERSONS IN THE HOUSEHOLD BY AGE GROUP
AGE GROUP CASES CONTROLS OR (95% Cl) Homogeneity 
test (P)
0 to 24 months
Four or less 46 129 1.0 referent
Five or six 26 41 1.78 0.9 - 3.4
Seven or more 8 3 7.48 1.7 - 27.4
25 to 60 months
Four or less 33 136 1.0 referent
Five or six 17 72 0.97 0.5 - 2.0
Seven or more 3 14 0.88 0.2 - 3.6
Both strata
Four or less 79 265 1.0 referent
Five or six 43 113 1.34 0.9 - 2.1 0.18
Seven or more 11 17 2.40 0.97 - 5.7 0.02
" Test for trend significant (P< 0.01)
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Number of persons per room
The distribution of cases among quintiles of persons per room is shown in 
Table 5.13. There is effect modification by age, with a significantly elevated 
odds ratio for the most crowded households among children less than two years 
of age and a significant test for homogeneity between age strata (P=0.04). This 
makes the significance test for trend seen when persons per room is evaluated 
for all ages less meaningful, although the odds ratios for less crowded strata did 
not show significant heterogeneity. The odds ratios for the highest level of 
household crowding remained similar and significantly heterogeneous when it 
was treated as a binary variable (Appendix Table A4).
TABLE 5.13 NUMBER OF PERSONS PER ROOM IN THE HOUSEHOLD BY AGE GROUP
AGE GROUP CASES CONTROLS OR (95% Cl) Homogeneity test (P)
0 to 24 months
Less than 0.42 12 39 1.0 (referent)
0.43 to 0.50 29 55 1.71 0.7 - 4.1
0.51 to 0.62 12 33 1.18 0.4 - 3.3
0.63 to 0.80 15 35 1.39 0.5 - 3.7
0.80 and higher 11 12 3.55 1.1 - 11.5
25 to 60 months
Less than 0.42 6 32 1.0 (referent)
0.43 to 0.50 9 71 0.68 0.2 - 2.4
0.51 to 0.62 14 44 1.70 0.5 - 5.6
0.63 to 0.80 22 53 2.21 0.7 - 6.9
0.80 and higher 2 22 0.48 0.1 - 3.1
Both strata'
Less than 0.42 18 71 1.0 (referent)
0.43 to 0.50 38 126 1.27 0.6 - 2.6
0.51 to 0.62 26 77 1.39 0.7 - 2.9
0.63 to 0.80 37 88 1.72 0.9 - 3.5 P = 0.50
0.80 and higher 14 33 1.88 0.8 - 4.9 P = 0.04
Test for trend P= 0.03
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The difference in impact of household crowding with age is made clearer when 
the distribution of the most crowded households is examined in cases and 
controls. Among cases, 17% of children 12 months of age or less are in 
crowded households, falling to 4% after two years of age, a trend which was 
significant (P = 0.03). Among controls, no such trend was evident, with from 
six to 13% of households being in the most crowded category, the proportion 
tending to increase with age (Appendix 7, Table A5). There was a significant 
association between all the family size variables and household crowding in 
cases and controls combined, which was most marked for the total number of 
children and the total number of persons in the household and least marked for 
the number of children under five years of age. (Appendix 7, Table A6).
Children sharing a bedroom
Effect modification by age was also seen when the number of children sharing 
a bedroom was used as a measure of household crowding. Among case children 
less than two years of age, 25 (31%) shared a bedroom with at least one other 
child compared with 31 (18%) of control children, which gave a significantly 
elevated odds ratio of 2.08, while among older children an equal proportion of 
cases and controls shared a bedroom (36%) (Appendix 7, Table A7).
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5.332 Care with other children 
Any care with other children
As verification of child care attendance was available only for children 
classified as receiving child care for four or more hours per week, child care 
for up to three hours per week was used as the reference level (Table 5.14). 
Child care was associated with an increased disease risk at all ages and the 
odds ratios obtained were similar for both classifications. The odds ratios were 
higher in younger children and fell progressively with age (Table 5.14), with 
the odds ratio among the oldest children failing to achieve significance. The 
age-corrected odds ratio was almost the same (3.42 vs 3.31) whether no or less 
than four hours of child care per week was used as the reference level 
(Appendix 7, Table A8).
When child care was examined using all controls to compare with each focus 
of infection (Table 5.16), the crude odds ratio for other foci of infection was 
1.00, in contrast to both meningitis (1.56) and epiglottitis (3.59). With 
correction for age by logistic regression, these differences became less marked, 
the odds ratio for other foci of infection increasing to 1.86, which included the 
odds ratios for meningitis within its confidence interval.
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TABLE 5.14 CHILD CARE BY AGE GROUP WITH NO CHILDCARE DEFINED 
AS LESS THAN FOUR HOURS PER WEEK
AGE GROUP CASES CONTROLS OR (95% Cl)
0 to 12 months:
No child care 37 81 1.0 referent
Any child care 10 5 4.38 1.3 - 16.0
13 to 24 months:
No child care 15 68 1.0 referent
Any child care 18 19 4.29 1.7 - 11.1
25 to 36 months:
No child care 12 61 1.0 referent
Any child care 12 20 3.1 1.1 - 8.7
36 to 60 months:
No child care 5 48 1.0 referent
Any child care 24 93 2.48 0.8 - 7.9
ALL STRATA
No child care 69 258 1.0
Any child care 64 137 3.42 2.1 - 5.9
149
TABLE 5.15 CHILD CARE BY FOCUS OF INFECTION
FOCUS CASES CONTROLS CRUDE OR
(95% Cl)
Meningitis
No child care 41 258 1.0 referent
Any child care 34 137 1.56 1.0-3.1
Epiglottitis
No child care 11 258 1.0 referent
Any child care 21 137 3.59 1.7-7.7
Other foci
No child care 17 258 1.0 referent
Any child care 9 137 1.00 0.4 - 2.4
AGE-CORRECTED OR 
(95% Cl)
4.12 2.2 - 7.8
3.49 1.5-8.2
1.87 0.7 - 5.0
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TABLE 5.16 CHILD CARE BY NUMBER OF SIBLINGS
NUMBER OF CASES CONTROLS OR (95% Cl)
SIBLINGS __________________________
No siblings 
No child care 6 79 1.0 referent
Any child care 16 52 4.05 1.4 - 12.5
Young siblings 
No school-age siblings 
No child care 20 47 1.0 referent
Any child care 31 22 3.31 1.4 - 7.6
School- age siblings 
No young siblings 
No child care 15 80 1.0 referent
Any child care 20 79 1.35 0.6 - 3.0
School-age and 
young siblings
No child care 18 26 1.0 referent
Any child care 7 10 1.01 0.3 - 3.6
All strata 
No child care 59 232 1.0
74 163 2.14
Homogeneity test (P)
Any child care 1.4 - 3.4 P= 0.11
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Stratified analysis according to the presence of siblings was examined, because 
of the suggestion that child care is associated with an increased disease risk 
only among children without siblings.141 The data shown in Table 5.16 suggest 
this applies to children who have any school-age siblings, but not children who 
have only young siblings, for whom the odds ratio for child care was similar to 
those with no siblings. Tabulation by age and young vs school-aged siblings 
suggested that heterogeneity of odds ratios for childcare between those with and 
without siblings was confined to children over two years and to those with 
school-age siblings (Appendix Tables A 9-11).
Number of hours of care with other children
A dose response effect was found with increasing number of hours of child 
care, which was most marked in the youngest children (less than 12 months), 
but was present in all age strata (Table 5.17).
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TABLE 5.17 NUMBER OF HOURS OF CHILD CARE BY AGE GROUP
AGE GROUP AND CASES CONTROLS OR (95% Cl)
HOURS PER WEEK
0 to 12 months'
0 - 3 hours 37 81 1.0 referent
4 - 24 hours 4 4 2.19 0.4 - 11.2
More than 24 hours 6 1 13.1 1.5 - 300
13 to 24 months
0 - 3 hours 15 68 1.0 referent
4 - 24 hours 10 11 4.12 1.3 - 13.0
More than 24 hours 8 8 4.53 1.3 - 16.2
25 to 36 months’
0 - 3 hours 12 61 1.0 referent
4 - 24 hours 6 10 3.05 0.8 - 11.6
More than 24 hours 6 10 3.05 0.8 - 11.6
37 to 60 months'
0 - 3 hours 5 48 1.0 referent
4 - 24 hours 17 74 2.21 0.7- 7.4
More than 24 hours 7 19 3.54 0.9 - 15.0
All strata'
0 - 3 hours 69 258 1.0 referent
4 - 24 hours 37 99 2.83 1.6 - 5.5
More than 24 hours 27 38 4.37 2.2- 8.5
' Chi- square test for trend significant (P<0.05)
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Number of siblings attending childcare
It was of interest to assess whether cases who did not attend daycare, but had 
siblings who did, were at increased risk and similarly whether cases who did 
attend child care were at increased risk if their siblings also attended child care. 
The power to detect an effect was limited by small numbers (Table 5.18). 
Among children not attending child care there was no increased risk associated 
with siblings attending child care. There was some evidence of an increased 
risk in younger children who attended child care and whose siblings also 
attended (odds ratio 2.13), but the 95% confidence limits were very wide. No 
effect was apparent in children older than two years whose siblings attended 
child care.
Type of child care facility
Case children under two years of age were significantly more likely than 
controls to attend all types of child care (family day care, child care centres and 
playgroups). These differences were less marked among older children, 
particularly for child care centres (day care centres and preschools) for which 
the odds ratio in younger children was 7.0 compared to 1.7 in those over two
years of age (Table 5.19).
154
TABLE 5.18 NUMBER OF SIBLINGS ATTENDING DAYCARE BY DAYCARE STATUS 
OF THE INDEX CASE IN FAMILIES WITH MORE THAN 
ONE CHILD LESS THAN FIVE YEARS
CATEGORY CASES CONTROLS OR (95% Cl)
INDEX CASE DOES
NOT ATTEND CHILDCARE 
Age 0 - 24 months
No siblings attend 
One or more siblings
11 20 1.0
attend daycare 
Age 25 - 60 months
19 30 1.15 0.4 - 3.3
No siblings attend 
One or more siblings
7 14 1.0
attend daycare 1 9 0.22 0.0 - 2.5
INDEX CASE ATTENDS 
CHILDCARE
Age 0 - 24 months
One child attends 
Two or more
1 1 1.0
children attend 
Age 25 - 60 months
17 8 2.13 0.1 - 92
One child attends 
Two or more
11 11 1.0
children attend 9 12 0.75 0.2 - 3.0
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TABLE 5.19 TYPE OF CHILD CARE CENTRE BY AGE GROUP
AGE GROUP AND CASES CONTROLS OR (95% Cl)
CHILD CARE
N (%) N (%)
0 to 24 months
No child care 44 140 1.0 referent
Family day care 15 (19) 16 (9) 2.98 1.3 - 7.0
Child-care centre 11 (14) 5 (3) 7.00 2.1 - 24.7
Occasional care 10 (13) 12 ( 7 ) 2.65 1.0 - 7.1
25 to 60 months
No child care 15 92 1.0 referent
Family day care 7 03) 15 ( 7 ) 2.86 0.9 - 9.2
Child-care centre 26 (49) 93 (42) 1.71 0.8 - 3.7
Occasional care 5 (9) 22 (10) 1.39 0.4 - 4.7
Both strata
No child care 59 232 1.0 referent
Family day care 22 31 2.94 1.5 - 5.8
Child-care centre 37 98 2.51 1.4 - 5.1
Occasional care 15 34 2.0 1.0 - 4.2
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Number of children attending centre and duration of attendance
Among cases and controls attending a day care centre or pre school and for 
whom data were available, cases were under-represented in smaller centres with 
less than twenty children (odds ratio 5.19 for larger centres, Table 5.20A), but 
this did not achieve statistical significance. Data were available for the duration 
of child care for 46 cases and 100 controls (Table 5.20B). Only nine (6%) of 
cases or controls had been attending child care for one month or less. There 
was some evidence that recent commencement of child-care was associated 
with an increased disease risk in the early part of the year when the largest 
number of children start at a new centre (18% of cases and 5% of controls, 
odds ratio 3.75). No cases with disease onset at any other time of the year had 
commenced within the previous month.
TABLE 5.20A NUMBER OF CHILDREN ATTENDING DAYCARE 
CENTRE OR PRESCHOOL
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NUMBER
ATTENDING CENTRE
CASES CONTROLS OR (95% Cl)
Less than 21 1 12 1.0 referent
More than 20 32 74 5.19 0.7 - 41.6
TABLE 5.20B NUMBER OF MONTHS ATTENDING CHILD-CARE AND DISEASE RISK
BY MONTH OF ADMISSION OR INTERVIEW
CASES CONTROLS OR (95% Cl)
Month of disease/intemew 
and length of attendance
January to May
More than one month 14 35 1.0 referent
One month or less 3 2 3.75 0.4 - 36.9
June to August
More than one month 19 28 1.0 referent
One month or less 0 3 0.0
September to December
More than one month 10 31 1.0 referent
One month or less 0 1 0.0
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5.333 Previous illness and medical care
Eight cases (6.0%) and four matched controls (1.0%) had a significant 
underlying illness. In the cases these were developmental delay or cerebral 
palsy (3), Downs syndrome (1), hydrocephalus with a shunt (1), osteogenesis 
imperfecta (1) and congenital heart disease (2). Two of the cases had 
unlocalised bacteraemia which could have been influenced by identification 
bias, because of greater willingness to obtain blood cultures in febrile children 
with significant conditions (osteogenesis imperfecta and aortic valve stenosis); 
the other cases had cellulitis (1), epiglottitis (2) meningitis (3). In the controls 
the conditions were hydrocephalus with a shunt (1), retinoblastoma (1) 
congenital heart disease (1) and near miss sudden infant death syndrome (1). 
Significant underlying illnesses were significantly more common in cases (odds 
ratio 7.09, Table 5.21).
Other medical conditions requiring regular medical review but not 
hospitalisation were common among cases but not significantly so. The number 
of medical visits in the previous twelve months was evaluated only among 
those cases and controls who did not require regular medical review; no 
significant differences in total visits or visits requiring antibiotics was found.
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TABLE 5.21 MEDICAL CARE AND UNDERLYING ILLNESS AND DISEASE RISK
CASES CONTROLS OR' (95% Cl)
PROBLEM REQUIRING REGULAR 
MEDICAL REVIEW
No 115 351 1.0 referent
Yes 18 44 1.48 0.8 - 2.7
SIGNIFICANT UNDERLYING 
ILLNESS 
No
Yes
MEDICAL VISITS IN 
THE PAST 12 MONTHS 
Less than two 
Two to eight 
More than eight
ANTIBIOTICS IN 
THE PAST 12 MONTHS
None 62 64 1.0 referent
Any 32 43 1.11 0.56 - 2.2
Age-adjusted by logistic regression
7 7 1.0 referent
61 70 0.82 0.29 - 2.39
26 30 0.74 0.26 - 2.58
125
8
391 1.0 referent
7.09 2.0 - 24.6
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5.334 Breast feeding 
Any breast feeding
Overall, 79% of cases and 87% of controls had ever breast fed, giving a 
protective odds ratio of 0.57 (Table 5.22). The protective effect was much more 
marked among children over 12 months of age, among whom it was significant, 
whereas in children less than one year of age, the protective effect was weak.
Current vs previous breast feeding
It was hypothesised that current breast feeding would be more protective than 
previous breast feeding if breast feeding was providing protection with a 
biological basis, rather than a protective effect because of confounding family 
or socioeconomic factors. Current breast feeding was less strongly protective 
than previous breast feeding in children 12 months of age or less, but there was 
a significant trend towards increased protection from current breast feeding 
among children in the second year of life, suggesting that duration of breast­
feeding was important (Appendix 7, Table All).
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TABLE 5.22 BREAST-FEEDING BY AGE GROUP IN CHILDREN
LESS THAN 24 MONTHS OF AGE
AGE GROUP AND 
BREAST-FEEDING
CASES CONTROLS OR (95% Cl)
0 to 6 months*
No breast-feeding 3 5 1.0 referent
Any breast-feeding 14 29 0.80 0.1 - 5.1
7 to 12 months*
No breast-feeding 6 10 1.0 referent
Any breast-feeding 24 42 0.95 0.3 - 3.4
13 to 24 months
No breast-feeding 8 7 1.0 referent
Any breast-feeding 25 80 0.27 0.1 - 0.9
All strata*
No breast-feeding 17 22 1.0 referent
Any breast-feeding 63 151 0.57 0.3 - 1.2
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Duration of breast-feeding
As the duration of breast-feeding, measured as the proportion breast-feeding for 
more than six months137 precluded evaluation of cases less than six months of 
age, the proportion of the child’s life for which they were breast fed was used 
to evaluate the duration of breast-feeding. This variable was derived from the 
number of months of breast-feeding divided by the age in months and 
expressed as half or less of life breast feeding and more than half of life breast 
feeding.
Although the odds ratio was less than one in all but one age stratum, the effect 
was again most prominent among children over one year of age, with a 
significant protective effect and a significant trend seen only in the oldest 
stratum, 19 to 24 months of age (Table 5.23). This variable was also examined 
for meningitis and other cases (Table 5.24). A significant protective effect was 
found for meningitis, with a significant trend towards increased protection with 
an increasing proportion of life breast feeding and significant protection in the 
children who had breast fed for more than half of their life. No significant 
protective effect or trend was found for foci other than meningitis.
TABLE 5.23 PROPORTION OF LIFE SPENT BREAST-FEEDING BY AGE GROUP
AGE GROUP AND 
BREAST-FEEDING
CASES CONTROLS OR (95% Cl)
0 to 6 months
No breast-feeding 3 5 1.0 referent
Less than half life 3 6 0.83 0.1 - 9.3
More than half life 
7 to 12 months
11 23 0.80 0.1 - 5.2
No breast-feeding 6 10 1.0 referent
Less than half life 10 12 1.39 0.3 - 6.2
More than half life 
13 to 18 months
14 30 0.78 0.2 - 3.0
No breast-feeding 4 2 1.0 referent
Less than half life 13 24 0.27 0.0 - 2.1
More than half life 
19 to 24 months’
5 12 0.21 0.0 - 2.1
No breast-feeding 4 5 1.0 referent
Less than half life 7 35 0.25 0.0 - 1.5
More than half life 0 9 0.00 P = 0.03
All strata*
No breast-feeding 22 17 1.0 referent
Less than half life 33 77 0.61 0.2 - 1.4
More than half life 30 74 0.47 0.2 - 1.1
Number of months breast-feeding / Age in months on a scale from 0 to 1 
Test for trend significant (P = 0.051)
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TABLE 5.24 PROPORTION OF LIFE" SPENT BREAST-FEEDING BY FOCUS
AGE GROUP AND 
BREAST-FEEDING 
STATUS
CASES CONTROLS OR (95% Cl) Homogeneity test (P)
Meningitis*
No breast-feeding 13 12 1.0 referent
Less than half life 24 46 0.49 0.2 - 1.4
More than half life 19 53 0.34 0.1 - 0.95
Other foci
No breast-feeding 4 10 1.0 referent
Less than half life 9 31 0.73 0.2 - 4.0
More than half life 11 21 1.30 0.3 - 7.0
Combined
No breast-feeding 17 22 1.0 referent
Less than half life 33 77 0.55 0.2 - 1.3 P = 0.70
More than half life 30 74 0.53 0.2 - 1.2 P = 0.12
" Number of months breast-feeding / Age in months on a scale from 0 to 1.0 
* Test for trend significant (P = 0.017)
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5.335 English-speaking (ESB) and non-English speaking (NESB) households 
Household crowding
The prevalence of crowded households, defined as those in the highest quintile 
of number of persons per room (>0.8), was markedly different among ESB and 
NESB households, when stratified by age (Table 5.25). In NESB households 
with a case child under 36 months of age, 36% were in the most crowded 
category, compared with 6% of NESB control households and 7% and 10% of 
ESB control and case households respectively. Household crowding was not a 
risk factor in NESB or ESB households over 36 months of age. The 
heterogeneity test was almost significant at the P<0.05 level.
Care with other children outside the family
Child care outside the home was similarly prevalent among control ESB (25%) 
and NESB (22%) households, but was uncommon among NESB cases (1/10) 
compared with ESB cases (52%) under the age of three years. There were no 
NESB cases who attended childcare under the age of 30 months. Over the age 
of three years, childcare was much less prevalent among NESB control 
households (22%) compared with ESB households (79%). There was significant 
heterogeneity by age and childcare status between strata (P=0.04).
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Passive smoking
The proportion of households with two or more smokers was identical among 
ESB and NESB case households under three years (18%), but associated with 
an odds ratio of 3.64 in NESB households because of the low number of NESB 
control households with two or more smokers (6%). In NESB households with 
index children over three years, the proportion with two or more smokers was 
similar but substantially more than in ESB case or control households (30-33% 
vs 12-14%).
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TABLE 5.25 HOUSEHOLD CROWDING AND LANGUAGE SPOKEN AT HOME BY AGE
AGE GROUP AND CASES CONTROLS OR (95% Cl) Homogeneity test (P)
CROWDING __________________________
(>0.8 PPRoom)
0 to 36 months
English
No crowding 84 203 1.0 referent
Crowding 9 15 1.45 0.5 - 3.7
Other language 
No crowding 7 34 1.00 referent
Crowding 4 2 9.1 1.1 - 119
37 to 60 months
English
No crowding 25 111 1.0 referent
Crowding 1 7 0.64 0.01 - 5.3
Other language 
No crowding 3 14 1.00 referent
Crowding 0 9 0.00 0.0 - 4.6
Combined 
No crowding 119 362 1.0 referent
Crowding 14 33 1.45 0.7 - 3.0 P = 0.068
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T A B L E  5 .26  C H IL D  C A R E  A N D  L A N G U A G E  S P O K E N  A T  H O M E  BY A G E
A G E  G R O U P  A N D C A S E S C O N T R O L S O R (9 5%  C l)
C H IL D  C A R E
0 to  36  m on ths
E ng lish
No c h ild  ca re 45 163 1.0 re fe ren t
A ny  c h ild  ca re 48 55 3 .15 1.8 - 5.4
O th e r lan g u a g e  
No c h ild  ca re 10 28 1.00 re fe ren t
A ny  c h ild  ca re 1 8 0 .36 0 .0  - 3 .3
37  to  60  m on ths
E ng lish
No ch ild  ca re 4 25 1.0 re fe re n t
A ny c h ild  ca re 22 93 1.47 0 .4  - 6.4
O th e r lan g u a g e  
No c h ild  ca re 0 16 1.00 re fe ren t
A ny c h ild  ca re 3 7 in fin ity 0 .7  * in fin ity
C o m b in e d  
No ch ild  ca re 59 232 1.0 re fe re n t
A ny ch ild  ca re 74 163 2.61 1.6 - 4.2
H o m o g e n e ity  te s t (P)
P = 0.041
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TABLE 5.27 SMOKING AND LANGUAGE SPOKEN AT HOME BY AGE
AGE GROUP AND CASES CONTROLS OR (95% Cl)
LANGUAGE SPOKEN
0 to 36 months' 
English
No or one smoker 78 188 1.0 referent
Two or more smokers 15 30 1.20 0.6 - 2.0
Other language 
No or one smoker 9 34 1.00 referent
Two or more smokers 2 2 3.64 0.2 - 56.9
37 to 60 months 
English
No or one smoker 23 101 1.0 referent
Two or more smokers 3 17 0.78 0.1 - 3.0
Other language 
No or one smoker 2 16 1.0 referent
Two or more smokers 1 7 1.14 0.0 - 25.4
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5.336 Socioeconomic variables
The distribution of adverse socio-economic variables ( unemployment, low 
income, low educational level, single parent) varied considerably with age 
(Table 5.28). Unemployment, low level of education and marital status were 
associated with an increased disease risk in the youngest age group (one year of 
age or less) with a progressive reduction in the odds ratio in successive age 
groups. Of these, only being the child of a single parent in the age group of 
one year or less was associated with a significantly increased disease risk (odds 
ratio 12.4). There were no households of cases over three years of age which 
were in the lowest income category. Social mobility was not strongly related to 
disease risk in any age category, but was also associated with disease risk only 
in children less than three years of age. Vehicle ownership was protective in all
age strata.
TABLE 5.28 AGE AND SOCIOECONOMIC VARIABLES
AGE GROUP AND CASES CONTROLS OR (95% Cl)
SOCIO-ECONOMIC
VARIABLES
Employment
Less than 12 months
Employed 41 83 1.0 referent
Unemployed 6 3 4.05 0.8 - 21.7
13 to 36 months 
Employed 50 155 1.0 referent
Unemployed 7 13 1.67 0.6 - 4.8
More than 36 months 
Employed 28 130 1.00 referent
Unemployed 1 11 0.42 0.0 - 3.4
Income'
Less than 12 months 
Other or unstated 41 81 1.0 referent
Low income 6 5 2.35 0.6 - 10.4
13 to 36 months 
Other or unstated 48 157 1.0 referent
Low income 9 11 2.66 0.9 - 7.6
More than 36 months 
Other or unstated 29 126 1.00 referent
Low income 0 15 0.00 0.0 - 1.3
Homogeneity test for difference between odds ratios among different age-groups 
for low income households significant (P = 0.02 by exact test)
TABLE 5.28 (continued) AGE AND SOCIOECONOMIC VARIABLES
AGE GROUP AND CASES
SOCIO-ECONOMIC
VARIABLES
Educational level
Less than 12 months
More than 10 years 43
Low educational level 4
13 to 36 months
More than 10 years 53
Low educational level 10
More than 36 months
More than 10 years 28
Low educational level 1
Marital status
Less than 12 months
Married 41
Single parent 6
13 to 36 months
Married 52
Single parent 5
More than 36 months
Married 26
Single parent 3
CONTROLS OR (95% Cl)
81 1.0 referent
5 1.51 0.3 - 6.9
158 1.0 referent
4 1.19 0.3 - 4.4
131 1.00 referent
10 0.47 0.0 - 3.8
85 1.0 referent
1 12.4 1.4 - 283
160 1.0 referent
8 1.92 0.5 - 6.9
127 1.00 referent
14 1.05 0.2 - 4.3
TABLE 5.28 (continued) AGE AND SOCIOECONOMIC VARIABLES
AGE GROUP AND 
SOCIO-ECONOMIC 
VARIABLES 
Social mobility
CASES CONTROLS OR (95% Cl)
Less than 12 months
Resident less than one year 11 16 1.0 referent
Resident more than one year 
13 to 36 months
36 70 0.75 0.3 - 1.9
Resident less than one year 12 25 1.0 referent
Resident more than one year 
More than 36 months
45 143 0.66 0.3 - 4.6
Resident less than one year 4 23 1.0 referent
Resident more than one year 
Vehicle ownership
25 118 1.22 0.4 -4.6
Less than 12 months
No vehicle 3 3 1.0 referent
Motor vehicle 
13 to 36 months
44 83 0.53 0.1 - 3.5
No vehicle 5 9 1.0 referent
Motor vehicle 
More than 36 months
52 159 0.59 0.2 - 2.1
No vehicle 4 7 1.0 referent
Motor vehicle 25 134 0.33 0.1 - 1.5
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5.337 Random digit dialling controls vs directory controls
Table 5.29 shows a comparison of the distribution of all major variables among 
the RDD and directory controls, with odds ratios. Of the variables listed, only 
the number of children under five years of age in the household and the 
proportion of households with more than two adults were associated with a P 
value of less than 0.10. The variables of major interest in comparing the two 
control groups were smoking and ethnicity which were most likely to show the 
most marked regional variation and hence most liable to be over-controlled by 
matching according to residence.
The number and percentage of households containing two or more smokers in 
cases and the two control groups stratified by the number of adults in the 
household is shown in Table 5.30. There is a lower proportion of smokers in all 
categories in the directory controls compared with cases and RDD controls, 
which contain nearly identical proportions of smokers. In households with more 
than two adults, the odds ratio for two or more smokers in the household is 
almost significant using phonebook controls as the reference group. This 
suggests that over-matching on smoking status between cases and controls may 
have occurred, diluting the effect of smoke exposure. The percentage of NESB 
households was however identical (15%) in the two control groups.
COMPARISON OF RANDOM-DIGIT DIALLINGTable 5.29
AND TELEPHONE DIRECTORY CONTROLS
VARIABLE RDD CONTROLS 
N = 395
N (%)
DIRECTORY CONTROLS OR' 
N = 101
N (%)
P
Female 190 (48) 56 (56) 0.87 0.52
Resident for more than
one year 331 (84) 86 (86) 1.74 0.13
Non-English speaking 59 (15) 15 (15) 0.98 0.95
Single parent 23 (6) 5 (5) 0.97 0.95
Own a motor vehicle 376 (95) 94 (94) 0.65 0.35
Two or more children <5 105 (27) 40 (40) 1.59 0.055
Any school-age children 195 (49) 52 (52) 1.43 0.14
Any child-care 163 (41) 36 (36) 1.10 0.71
Six or more persons in
the household 17 (4) 4 (4) 1.36 0.60
Any breast-feeding" 151 (87) 47 (47) 0.57 0.15
More than two adults 27 ( 7 ) 16 (16) 2.81 0.003
Unemployed 27 ( 7 ) 11 (11) 1.67 0.16
Low level of education 25 (6) 3 (3) 0.48 0.24
Low income 31 (8) 10 (10) 0.41
More than one smoker 56 (14) 9 (9) 0.64 0.24
Corrected for age (0-12, 13-24, 25-36, >37 months) by logistic regression 
" Corrected for age (<12 vs >12 months) by logistic regression
Table 5.30 NUMBER OF SMOKERS IN THE HOUSEHOLD - 
COMPARISON OF RDD AND DIRECTORY CONTROLS 
STRATIFIED BY THE NUMBER OF ADULTS IN THE HOUSEHOLD
SMOKERS IN THE CASES CONTROLS OR CONTROLS OR
HOUSEHOLD (RDD) (95%CI) (DIRECTORY) (95% Cl)
N (%) N (%) N (%)
One or two adults:
No or one smoker 103 323 1.00' 78 1.0“
(referent) (referent)
Two or more smokers 15 (13) 45 (12) 1.05 7 (8) 1.62
(0.5-2.0) (0.6-4.6)
Two or more adults:
No or one smoker 9 16 1.0 14 1.0
(referent) (referent)
Two or more smokers 6 (40) 11 (41) 0.97 2 (13) 4.67
(0.2-4.2) (0.6-43.5)
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Ethnicity as defined by language spoken is shown in cases and both control 
groups in Table 5.31. When Asian was defined as any Asian language, the odds 
of Asian children developing Hib disease obtained using RDD or directory 
controls were almost identical and not significantly different from cases. When 
the Asian languages were separated into the subgroups Chinese or Vietnamese 
and others, the odds ratios obtained using the RDD controls remained 
unchanged. The odds of Hib disease in Chinese/ Vietnamese children using 
directory controls were, however, reduced and were statistically significant. 
This finding is made more difficult to interpret by the increasing number of 
immigrants from this ethnic group in Sydney during the study period. It is 
possible that more cases would have been found among this group if case 
recruitment had been at the same time as the directory controls were recruited.
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TABLE 5.31 ETHNICITY DEFINED BY LANGUAGE SPOKEN AT HOME
RANDOM DIGIT DIALLING VS TELEPHONE DIRECTORY CONTROLS
CASES CONTROLS OR (95% Cl)
LANGUAGE GROUP __________________________
Random digit dialling controls :
English or European languages 123 358 1.0 referent
Arabic languages 8 15 1.55 0.6 - 4.0
Asian languages 2 22 0.27 0.03 - 1.10
Directory controls :
English or European languages 123 90 1.0 referent
Arabic languages 8 4 1.46 0.4 - 6.8
Asian languages 2 7 0.21 0.02 - 1.14
Random digit dialling controls :
English 119 340 1.0 referent
Other European languages 4 18 0.64 0.15 - 2.0
Arabic languages 8 15 1.52 0.6 - 3.9
Chinese/Vietnamese 1 10 0.29 0.01 - 2.1
Other languages 1 12 0.24 0.01 - 1.6
Directory controls :
English 119 86 1.0 referent
Other European languages 4 4 0.72 0.13 - 4.0
Arabic languages 8 4 1.44 0.4 - 6.8
Chinese/Vietnamese 1 7 0.10 0.0 - 0.8
Other languages 1 0 infinity
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5.34 MULTIVARIATE ANALYSIS
All multivariate analyses are shown in tables with the variables of interest in 
the left column and the odds ratio and 95% Cl shown in the next two columns 
with the associated P value. All variables shown have been corrected for all 
other variables appearing in the table.
5.341 Family size and household crowding
Increasing family size was an important risk factor for Hib disease in all age 
groups and for all types of Hib disease (Table 5.32). The presence of young 
siblings and more than two adults were risk factors for all disease and age 
categories, but as in the univariate analysis, the presence of school-age children 
in the household was more important in children under two years and in foci 
other than meningitis. Household crowding was not a significant risk factor 
after family size was taken into account in any age or disease category; it was 
most prominent for young children and for meningitis. Indeed, lack of 
household crowding was associated with disease for epiglottitis.
Table 5.32 FAMILY SIZE AND HOUSEHOLD CROWDING
CHILDREN LESS THAN TWO YEARS 
More than one child less than 5 years 
Any school-age children 
More than two adults in the household 
Household crowding (more than 0.8 PProom)
CHILDREN MORE THAN TWO YEARS 
More than one child less than 5 years 
Any school-age children 
More than two adults in the household 
Household crowding (more than 0.8 PProom)
ALL AGE GROUPS 
More than one child less than 5 years 
More than two adults in the household 
Household crowding (more than 0.8 PProom)
ODDS RATIO 95% Cl P value
7.98 2.44 - 26.1 <0.001
2.95 0.83 - 8.08 0.10
3.50 0.2 -57.3 0.38
1.58 0.30 - 8.41 0.59
4.11 1.48 - 11.4 0.007
1.61 0.57 - 4.53 0.37
4.72 1.06 - 21.0 0.04
0.16 0.02 - 1.31 0.09
5.89 3.25 - 10.7 <0.001
4.62 1.7 - 12.5 0.002
0.74 0.28 - 1.92 0.54
Corrected for month of the year, age, sex, significant underlying illness, period of residence, 
vehicle ownership, educational level, childcare, smoking, breastfeeding (under two years)
and all other variables in the table
Table 5.32 (continued) FAMILY SIZE AND HOUSEHOLD CROWDING
ODDS RATIO 95% Cl P value
MENINGITIS ONLY
More than one child less than 5 years 
Any school-age children 
More than two adults in the household 
Household crowding (more than 0.8 PProom)
EPIGLOTTITIS CASES ONLY
More than one child less than 5 years
Any school-age children
More than two adults in the household
Household crowding (more than 0.8 PProom)
5.05 2.6 - 9.6 <0.001
0.93 0.5 - 1.8 0.84
2.17 0.7 - 7.1 0.20
1.73 0.6 - 4.8 0.29
8.08 3.1 - 21.0 <0.001
2.21 0.9 - 5.5 0.09
4.33 1.2 - 16.2 0.03
0.05 0.03 - 1.0 0.05
OTHER FOCI ONLY
More than one child less than 5 years 6.79 2.4 - 19.4 <0.001
Any school-age children 4.45 1.6 - 12.5 0.005
More than two adults in the household 2.63 0.3 - 20.9 0.36
Household crowding (more than 0.8 PProom) 0.26 0.03 - 2.1 0.21
Corrected for month of the year, age, sex, significant underlying illness, period of residence, 
vehicle ownership, educational level, childcare, smoking, breastfeeding (under two years)
and all other variables in the table
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5.342 Care with other children
Care with other children was associated with Hib disease in all age groups and 
disease categories, although this did not achieve significance for foci other than 
meningitis and epiglottitis or for less than 24 hours child care per week in older 
children (Table 5.33). The odds ratios were higher for younger children and for 
meningitis (with correction for age) than other categories. A dose-response 
effect with increasing duration of care was apparent in all categories. In accord 
with the univariate analysis, when only children who had commenced daycare 
in the first four months of the year were considered, commencement less than 
one month previously was associated with a significantly increased disease risk, 
after correction for duration of care, age and presence of young siblings. (Table 
5.33) However, this finding was based on a small number of cases and is 
vulnerable to small changes in absolute numbers.
Table 5.33 CARE WITH OTHER CHILDREN
CHILDREN LESS THAN TWO YEARS ODDS RATIO 95% Cl P value
Childcare for 4 to 24 hours 13.49 1.57 --116.2 0.02
Childcare for 25 hours or more 45.59 6.11 •- 340 <0.001
CHILDREN MORE THAN TWO YEARS
Childcare for 4 to 24 hours 3.29 0.90 •- 12.1 0.07
Childcare for 25 hours or more 10.32 2.26 ■- 47.2 0.003
ALL AGE GROUPS
Childcare for 4 to 24 hours 5.06 2.31 •- 11.1 <0.001
Childcare for 25 hours or more 11.25 4.64 •- 27.3 <0.001
One month or less at centre 14.5 1.09 •- 193 0.043
Footnote* : Restricted to cases (N=13) and controls (N=29) who were attending daycare with
reference date between January and April
Corrected for month of the year, age, sex, family size and household crowding variables, 
underlying illness, period of residence, vehicle ownership, educational level, 
smoking, breastfeeding (under two years) and all other variables in the table
Table 5.33 (continued) CARE WITH OTHER CHILDREN
ODDS RATIO 95% Cl P value
MENINGITIS ONLY
Childcare for 4 to 24 hours 4.82 2.0 - 11.6 <0.001
Childcare for more than 24 hours 10.47 4.1 - 26.9 <0.001
EPIGLOTTITIS CASES ONLY
Childcare for 4 to 24 hours 5.34 1.7 - 16.4 0.003
Childcare for more than 24 hours 6.21 1.9 - 20.2 0.002
OTHER FOCI ONLY
Childcare for 4 to 24 hours 2.46 0.7 - 9.3 0.18
Childcare for more than 24 hours 3.25 0.7 - 15.6 0.14
Corrected for month of the year, age, sex, significant underlying illness, period of residence, 
vehicle ownership, educational level, smoking, breastfeeding (under two years)
and all other variables in the table
185
5.343 Underlying illness
Significant underlying illness as defined above was significantly associated with 
an increased risk of disease in all age groups and disease categories (Table 
5.34). This effect was particularly marked in older children and disease types 
other than meningitis; however the confidence intervals around these estimates 
were wide and it is not possible to draw any firm conclusions about these 
differences.
Table 5.34 SIGNIFICANT UNDERLYING ILLNESS
ODDS RATIO 95% Cl P value
Under two years 7.43 0.16 - 352 0.31
Over two years 11.94 1.0 - 149 0.054
All age groups 6.72 1.4 - 31.1 <0.001
Meningitis only 10.78 1.3 - 84.7 0.02
Epiglottitis only 28.31 3 .3 - 243 0.002
Other foci of infection 35.5 3.1 -403 0.004
Corrected for month of the year, age, sex, child care, period of residence, vehicle ownership 
educational level, smoking and breastfeeding (under two years)
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5.344 Breast feeding
The proportion of the child’s life spent breast-feeding was chosen as the most 
informative variable to examine, as it allowed all age-groups to be included in 
an assessment of dose-response relationships. A protective effect of breast­
feeding, which was greater with increasing duration of breast feeding was 
found, after correction for age, family size, underlying illness and socio­
economic variables (Table 5.35). Protection from breast feeding was only 
demonstrable for meningitis, as it had been in the univariate analysis, although 
the small numbers of non-meningitis cases and confidence intervals which 
overlap those for meningitis preclude any definite conclusions about differences 
according to type of infection.
Breast feeding, family size, household crowding and care with other children 
were examined in more detail for meningitis cases (Table 5.36). Evidence of a 
protective effect was seen in all age strata, at least for longer duration of breast 
feeding. Family size and household crowding were most strongly associated 
with disease risk among the youngest children (those less than six months of 
age), where no cases or controls attended child care.
Table 5.35 MULTIVARIATE MODELS OF BREAST FEEDING
CATEGORY
ALL CHILDREN LESS THAN TWO YEARS
ODDS RATIO 
N=80
95% Cl P value
Breastfeeding for less than half life 0.54 0.13 - 2.28 0.40
Breastfeeding for more than half life 
MENINGITIS CASES ONLY N=56
0.20 0.05 - 0.81 0.03
Breastfeeding for less than half life 0.46 0.16 - 1.3 0.14
Breastfeeding for more than half life 
NON-MENINGITIS CASES ONLY N=24
0.25 0.09 - 0.73 0.01
Breastfeeding for less than half life 1.85 0.27 - 12.8 0.53
Breastfeeding for more than half life 2.00 0.31 - 12.8 0.46
Corrected for underlying illness, family size, child care, vehicle ownership and social mobility
Table 5.36 BREAST FEEDING BY AGE STRATA IN CHILDREN 
WITH MENINGITIS N=56
188
AGE GROUP
0 to 6 months (N=13 cases, 34 controls)
Breastfeeding for less than half life 
Breastfeeding for more than half life 
Number of children less than five years 
Household crowding 
Childcare
7 to 12 months (N=21 cases, 51 controls)
Breastfeeding for less than half life 
Breastfeeding for more than half life 
Number of children less than five years 
Household crowding 
Childcare
13 to 24 months (N=22 cases, 87 controls)
Breastfeeding for less than half life 
Breastfeeding for more than half life 
Number of children less than five years 
Household crowding 
Childcare
ODDS RATIO 95% Cl P value
0.43 0.02 - 8.8 0.58
0.15 0.01 - 2.1 0.16
16.0 1.2-211 0.04
5.9 0.5 - 72 0.16
No cases or controls in childcare
2.97 0.5 - 17.9 0.24
0.27 0.04 - 1.9 0.19
13.6 2.6 - 71 0.002
3.9 0.6- 24 0.15
13.8 1.5 - 131 0.02
0.16 0.04 - 0.8 0.02
0.12 0.01 - 1.03 0.05
2.7 0.7- 10.6 0.04
1.3 0.2- 10.7 0.82
8.8 2.4 - 32.6 0.001
Corrected for sex, month of the year and period of residence
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5.345 Differences between ESB and NESB cases
In the multivariate analysis, only cases and controls less than three years were 
evaluated (Table 5.37). The findings suggested by the univariate analysis were 
supported, with household crowding a risk factor in NESB but not in ESB 
households and care with other children a risk factor among children of ESB 
only. In this model, the presence of two or more smokers was significantly 
associated with disease in NESB children, even after correction for the number 
of adults in the household. However the sample size limits these conclusions, 
with the confidence intervals for the estimates in NESB and ESB households 
showing substantial overlap.
Table 5.37 NON-ENGLISH SPEAKING BACKGROUND (NESB) VS ENGLISH-SPEAKING (ESB)
( UNDER THREE YEARS OF AGE)
VARIABLE CRUDE ODDS RATIO CORRECTED OR 95% Cl
NESB:
More than one child less than 5 years 9.17 8.73 1.2 - 63.3
Childcare for 4 hours or more 0.35 0.70 0.05 - 9.4
Household crowding (>0.8 pproom) 9.71 9.30 0.96 - 89.7
Two or more smokers in household 3.78 11.75 1.1 - 123
ESB:
More than one child less than 5 years 2.72 3.50 2.0 - 6.2
Childcare for 4 hours or more 3.16 3.77 2.1 - 6.4
Household crowding (>0.8 pproom) 1.45 0.79 0.3 - 2.2
Two or more smokers in household 1.21 1.12 0.5 - 2.4
Footnote : NESB cases (N=11) and controls (N=36); ESB cases (N=93) and controls (N=218)
In the model with both ESB and NESB children, the interaction terms 
for language group and hours and language group and household crowding 
were significant (LRS P=0.05 and 0.06)
Corrected for number of adults in the household and age
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5.346 Variables significant in all age groups
Backward elimination of non-significant terms, including all first order 
interactions with age, resulted in a model with significant underlying illness, 
more than one child under five years, more than two adults in the household, 
childcare outside the home and not owning a motor vehicle as highly 
significant predictors of disease risk (Table 5.38). In particular, the presence of 
an underlying illness , which is best estimated using all cases, had an odds ratio 
of 6.72 (1.5 - 31.1).
The results of multivariate analysis for each of the age groups less than and 
greater than two years are shown in Tables 5.39 and 5.40. The presence of 
school-aged siblings was a risk factor in younger but not older children, in 
whom the presence of more than two adults in the household was a risk factor. 
Social mobility was a significant risk factor in younger but not older children. 
Childcare was a risk factor in both age groups, with a dose response effect
evident for the number of hours of childcare.
Table 5.38 VARIABLES SIGNIFICANT IN MODEL INCLUDING ALL AGE GROUPS
VARIABLE ODDS RATIO 95% Cl P value
Significant underlying illness 6.72 1.45 - 31.1 <0.001
More than one child less than 5 years 5.52 2.97 - 9.25 <0.001
More than two adults in the household 4.65 1.78 - 12.2 0.002
Childcare for 4 to 24 hours 4.80 2.20 - 10.5 <0.001
Childcare for 25 hours or more 10.47 4.45 - 24.7 <0.001
Not owning a motor vehicle 2.76 1.04 - 7.33 0.04
Corrected for month of the year, age, sex, number of school-age children
and interaction term between age and number of school-age children and all other variables in the table
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Table 5.39 REDUCED MODEL RESTRICTED TO CHILDREN LESS THAN TWO YEARS
VARIABLE ODDS RATIO 95% Cl P value
Significant underlying illness 7.43 0.16 -352 0.31
More than one child less than 5 years 7.03 2.33 - 21.3 <0.001
Any school-age children 2.60 0.84 - 8.08 0.095
Childcare for 4 to 24 hours 7.54 1.26 - 45.2 0.03
Childcare for 25 hours or more 40.3 5.80 - 280 <0.001
Residence for more than one year 0.27 0.07 - 0.97 0.05
Not owning a motor vehicle 9.92 0.72 - 137 0.09
Breastfeeding for less than half life 0.54 0.13 - 2.28 0.40
Breastfeeding for more than half life 0.20 0.05 - 0.81 0.03
Corrected for month of the year, age, sex and all other variables in the table
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Table 5.40 REDUCED MODEL RESTRICTED TO CHILDREN OVER THAN TWO YEARS
VARIABLE ODDS RATIO 95% Cl P value
Significant underlying illness 11.94 0.96 - 149 0.054
More than one child less than 5 years 2.86 1.23 - 6.64 0.014
More than two adults 4.98 1.23 - 20.2 0.03
Childcare for 4 to 24 hours 3.99 1.25 - 12.8 0.02
Childcare for 25 hours or more 9.66 2.43 - 38.4 0.001
Not owning a motor vehicle 2.83 0.62 - 13.0 0.18
Corrected for month of the year, age and sex
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5.54 Model with controls from telephone directory
Multivariate analysis using logistic regression and controls from the telephone 
directory is shown in Table 5.41. As suggested by the univariate analysis 
(Table 5.29), the only variable which was unequivocally in a different direction 
was the presence of two or more adults in the household, which was protective 
in the current model and a risk factor in the model using RDD controls (Table 
5.38). Although a different trend was also evident for some other variables 
(vehicle ownership, educational level and the number of smokers), the 
confidence intervals overlapped; interpretation is again limited by power 
considerations. There was a definite trend towards an increased risk for children 
of Arabic descent and a decreased risk for children of Chinese descent, but this 
was not significant in either case after correction for the other variables in the
table.
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Table 5.41 ALL VARIABLES IN MODEL WITH DIRECTORY CONTROLS
VARIABLE ODDS RATIO 95% Cl P value
More than one child less than 5 years 2.24 1.1 - 4.6 0.03
More than two adults in the household 0.37 0.1 - 1.1 0.07
Any school-aged children 0.62 0.3 - 1.3 0.20
Household crowding 2.19 0.7 - 7.0 0.18
(more than 0.8 PProom)
Childcare for 4 to 24 hours 1.73 0.8 - 4.0 0.20
Childcare for 25 hours or more 11.07 2.9 - 42.6 <0.001
Resident for more than one year 0.18 0.07 - 0.5 0.001
Not owning a motor vehicle 0.98 0.3 - 3.3 0.97
Low level of education in household 2.82 0.5 - 16.4 0.25
Two or more smokers in household 1.62 0.5 - 3.9 0.33
Arabic speaking household 2.87 0.6 - 13.1 0.17
Chinese/Vietnamese speaking household 0.12 0.1 - 1.6 0.11
Corrected for month of the year, age and sex and all other variables in the table
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5.6 DISCUSSION AND LITERATURE REVIEW
Information about risk factors for invasive Hib disease in childhood came 
initially from case series.152156 Subsequently, eight case-control studies from 
Western countries have appeared in the literature, summarised in Table 5.1.20, 
136"141 One study has been reported from an indigenous population (Alaskan
eskimos).62
Six studies were population-based (Table 5.1); all but one of these137 carried out 
in the United States. Two studies used similar methodology to the Sydney 
study, with recruitment of control families by random digit dialling in the study 
base.20,140 Other population-based studies used mailed questionnaires,136"138 with 
controls derived from birth registries136,138 or clinic rolls.137 The two hospital- 
based studies used controls bom at the same hospital139 or attending the same 
hospital for day surgery.141 The Sydney study is the second largest population- 
based study and the third largest study in number of cases.
Four studies were closely matched in time to the onset of disease in cases,136"139 
the remaining studies and the present study corrected for month of disease 
onset in the analysis. High rates of response from cases and eligible control 
subjects were achieved in all studies (Table 5.1). Two studies were conducted 
after immunisation for Hib disease was available for older age groups in the 
study population138,140 and controlled for this in the analysis. All other studies 
reflect the disease pattern before immunisation.
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The methods used in all studies, including the present study, would have led to 
under-representation of households of low socio-economic status among both 
cases and controls. Studies using birth registries for control recruitment were 
less likely to include mobile families and those of non-white background; this 
may have been partially balanced by difficulties in locating case families with 
similar characteristics. 136 138 All studies using telephone methods for recruitment 
cannot include cases or controls without telephones who are overwhelmingly of 
lower socio-economic status; selection bias should have been avoided by 
equivalent restrictions on eligibility for cases and controls. 143 The Sydney and 
Finnish studies selected controls from the same geographic area as cases, which 
is likely to have resulted in some over-matching of geographically determined 
factors such as ethnicity157 and socio-economic status. As socio-economic 
factors are primarily of interest as confounders of other exposure-disease 
relationships, such as breast feeding and tobacco smoke exposure, over­
matching for socio-economic variables is of less concern than for ethnicity. 
Overall, telephone recruitment and interview methods seem likely to have 
yielded a more timely and representative sample of the study base than the 
alternatives of birth or clinic registries. There were few significant differences 
between the controls from RDD and the telephone directory; efficiency would 
favour the latter method. 145
Despite all the being conducted in Western, developed countries, there are 
substantial differences between the populations studied in the available case- 
control studies with respect to age distribution, prevalence of different foci, 
especially epiglottitis, day care, breast-feeding, racial and ethnic composition
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and socio-economic disadvantage.61 The epidemiology of invasive Hib disease 
before immunisation in Sydney was similar to Finland and Melbourne29,53 but 
with some significant differences, such as the proportion of epiglottitis28 and 
ethnic composition.28,12 Compared with many populations in the US, the 
prevalence of breast-feeding in Australia and Finland is higher, while levels of 
daycare attendance and the incidence of Hib disease is lower, especially in 
younger age groups.61
The association between a larger number of siblings and Hib disease was 
suggested as early as 1950 by Ounsted, in contrast to meningococcal meningitis 
and other hospitalised patients of similar age.152 The associations between 
family size and household crowding and Hib disease in previous case-control 
studies is summarised in Table 5.42. As in the current study, the presence of 
other pre-school children in the household was a significant independent risk 
factor for Hib disease in most but not all20,136 studies. The presence of school- 
aged children in the household was significant in an early study136 and in a later 
study restricted to children older than 18 months of age140 but was not 
associated with disease risk in other studies.20,137 Vadheim et al found that the 
total number of persons in the household gave a more precise measure of 
disease risk than either of the above variables.140 An increased risk of disease 
with more than two adults in the household in the Sydney study has not been 
previously described, except as a component of increased household size.140 
Unlike household size, the presence of more than two adults in the household 
was associated with disease risk irrespective of the age of the index child. As 
the proportion of case and control households with two or more adults was
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twofold or more greater when indicators of socio-economic disadvantage, such 
as marital status, unemployment, and low income and educational level were 
present, it is likely that this variable is, at least in part, a proxy for lower socio­
economic status. However, the number of adults in the household was the only 
variable which differed significantly between the RDD and telephone directory 
control series; the apparent association between this variable and Hib disease 
may be a chance finding.
Measures of increased household crowding have been associated with disease 
risk in most studies where this has been examined (Table 5.42). In Sydney, the 
age of the case was an important effect modifier of household size and 
household crowding. However, crowding was not a significant risk factor after 
adjustment for household size, even in younger children. It may be that with 
Sydney climate and housing patterns, the number of rooms in the house does 
not represent available living space well. Effect modification by age has not 
been reported by other studies, although age-stratified odds ratios for household 
crowding were tabulated in one study and were lowest at the extremes of age.20 
Likewise, previous studies have not examined the relationship between the 
focus of infection and household size and crowding. The Sydney data suggest 
that household crowding may be important in meningitis, while children with 
other forms of Hib disease tended to come from households which are less 
crowded than expected, even after adjustment for age and other significant 
variables. An early study from Pittsburgh suggested that epiglottitis patients 
tended to come from smaller and more advantaged families than those with
• • • 153meningitis.
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Household crowding was highly correlated with adverse socio-economic factors 
such as unemployment, low income, being a single parent, social mobility and 
not owning a motor vehicle. The increased prevalence of all these factors 
among younger cases and the strong relationship between all these factors and 
age was noteworthy and consistent with the hypothesis that earlier, more 
intense exposure to respiratory pathogens including Hib, as would occur in 
larger, more crowded households, is associated with earlier disease onset. It 
may be that susceptible children from such households have developed Hib 
disease by two or three years of age, with the pool of susceptible children from 
more advantaged groups being relatively larger among older children, who are 
more exposed to Hib later. This is consistent with the demographic 
observations previously reported,29 where earlier disease onset was found in 
geographic areas with a high proportion of young children. These areas also 
have an over-representation of adverse socio-economic factors.
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Table 5.42 FAMILY SIZE AND HOUSEHOLD CROWDING IN CASE CONTROL STUDIES
STUDY AND VARIABLE Odds ratios (95% Cl) Comments
1. Number of children 
less than five years
Istre et al’ “ 1.2 (0.8 - 1.8) Univariate odds ratio comparing means 
Children 3-5 years only
Arnold et al’ “ 2.4 (1.4 - 3.9) Three or more children vs less than 3
Cochi et al20 0.8 (0.5 - 1.5) In multivariate model without crowding
Takala et al’37 2.1 (1.2 - 3.5) One sibling less than 5 years
3.2 (1.3 - 8.1) Two siblings less than 5 years
13.3 (2.7 - 64.5) Three or more siblings less than 5 years
Clements et a l'41 1.5 (0.9 - 2.7) Two or more siblings less than 5 years
Berg et al’38 Associated No odds ratio given
Vadheim et al’40 P < 0.001 No odds ratio given
Present study 5.5 (3.0 - 9.3) All age groups combined
2. S choo l-age ch ildren in househo ld
Istre et al’ “ 3.1 (1.6 - 5.8) Multivariate estimate
Did not vary with age (< > 12 months)
Arnold et al’ “ Not stated
Cochi et alM 1.2 (0.8 - 1.9) In multivariate model without crowding
Takala et al’37 No association No odds ratios given
Clements et al14’ Not stated
Berg et al’ 38 Associated No odds ratio given
Vadheim et al’40 P < 0.02 No odds ratio given
Present study 2.95 (0.8 - 8.1) Less than two years only
1.61 (0.6 - 4.5) More than two years only
3. Household crowding
Istre et al’ “ 1.0 (0.6 - 1.5) Univariate estimate
Arnold et al’ “ 1.4 (0.9 - 2.3) Referent level 1.5 persons per bedroom
2.0 (1.3 - 3.1) Referent level 2.0 persons per bedroom
Cochi et al70 2.6 (1.5 - 4.5) Referent level 1.0 person per room
Takala et al’37 Not stated Not stated
Clements et al14’ 1.75 (1.1 - 2.9) Persons per bedroom
Berg et al’ 38 Associated No odds ratio given
Vadheim et al140 3.71 (1.1 - 12.6) More than 6 persons in household 
No odds ratio for crowding given
Present study 1.58 (0.3 - 8.4) Less than two years only
0.16 (0.0 - 1.3) More than two years only
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Table 5.43 CARE WITH OTHER CHILDREN IN CASE CONTROL STUDIES
STUDY AND VARIABLE Odds ratios (95% Cl) Comments
1. Any care with other children 
outside the home
Istre et al’3® 1.9 (1.2 - 3.2) Univariate odds ratio comparing means
Arnold et al13® 2.9 (2.1 - 4.2) Adjusted for six other variables
Cochi et al” 3.9 (2.3 - 6.6)
Takala et al’37 5.0 (2.3 - 11.1)
Clements et al141 4.3 (2.3 - 8.3)
2.0 (0.6 - 2.4)
Berg et al’39 8.0 (1.0 - 64)
Vadheim et al140 No significant associai
Present study See below
Unadjusted odds ratio
Adjusted odds ratio for all ages
Without siblings < 6 years old 
With siblings < 6 years old
Overall odds ratio for group day care
Differing proportions of childcare attendance according to ethnicity
2. Age-stratified estimates
Istre et al Not significant Under 12 months
3.7 (1.6 - 8.5) Over 12 months
Arnold et al 7.1 (2.6 - 20) 0 - 5 months
3.0 (1.6 - 5.6) 6 - 1 1  months
3.8 (1.6 - 8.8) 1 2 - 1 7  months
6.5 (2.0 - 21) 1 8 - 23  months
9.9 (2.1 - 46) 24 months and over
Cochi et al 17.7 (5.8 - 54) 2 - 5 months
9.4 (4.3 - 21) 6 - 1 1  months
5.0 (2.7 - 9.3) 1 2 - 23  months
2.7 (1.3 - 5.5) 24 - 35 months
1.4 (0.5 - 4.0) 36 months and over
Takala et al 280 (8.5 - 9240) 0 - 1 1  months
3.8 (1.3 - 11.2) 1 2 - 23  months
2.4 (0.6 - 9.4) 24 months and over
Clements et al 4.3 CIs not given less than 12 months
9.4 1 - 2 years
5.0 2 - 3 years
2.7 3 - 4 years
1.4 4 - 5 years
Berg et al None given
Vadheim et al None given
Present study 13.5 (1.6 - 116) less than two years, 4-24 hours
45.6 (6.1 - 340) less than two years, > 25 hours
3.3 (0.9 - 12.1) more than two years, 4-24 hours
10.3 (2.3 - 47.2) more than two years, > 24 hours
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Table 5.43 (continued)
3. Number of hours of childcare
Istre et a l'3® Not examined
Arnold et a l’3® 2.5 (1.2 - 5.3) 1 - 1 5  hours
4.1 (1.8 - 9.1) 1 6 - 3 0  hours
7.4 (4.2 - 13.0) More than 30 hours
Cochi et al30 1.3 No CIs given 5 - 1 9  hours
2.0 20 - 39 hours
4.1 40 - 49 hours
Takala et al137 Not stated
Clements et a l'4’ Not stated
Berg et al’ 38 1.8 (1.1 - 3.1) Increase in the odds ratio for every 
category of number of hours
Vadheim et a l'40 Not stated
Present study 13.5 (1.6 - 116) less than two years, 4-24 hours
45.6 (6.1 - 340) less than two years, > 25 hours
3.3 (0.9 - 12.1) more than two years, 4-24 hours
10.3 (2.3 - 47.2) more than two years, > 24 hours
4. Childcare and focus of infection
Istre et al Not examined
Arnold et al 5.1 (3.1 - 8.2) Meningitis
1.6 (0.9 - 2.7) Other foci of infection
(4.2 - 13.0) Significant interaction term
Cochi et al Not examined
Takala et al No difference between foci Data not reported
Clements et al 8.3 (3.4 - 20.4) Meningitis without young siblings
3.2 (0.4 - 27.2) Meningitis with young siblings
4.4 (1.9 - 10.6) Epiglottitis
Berg et al Not examined
Vadheim et al Not examined
Present study 4.8 (2.0 - 11.6) meningitis, 4-24 hours
10.5 (4.1 - 27.0) meningitis, > 25 hours
5.3 (1.7 - 16.4) epiglottitis, 4-24 hours
6.2 (1.9 - 20.2) epiglottitis, > 24 hours
2.5 (0.7 - 9.3) other fod, 4-24 hours
3.3 (0.7 - 15.6) other fo d , > 24 hours
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As in all previous studies except one140, care with other children outside the 
home was a strong risk factor for Hib disease in Sydney (Table 5.43). The 
relationship between day care risk and age has varied, with some studies 
reporting progressively decreasing risk with increasing age20,137,141 and others the 
reverse136 or a bimodal pattern, with higher odds ratios at each end of the age
i r espectrum.
In Sydney, care with other children was an independent risk factor in both 
younger and older children and for all foci of infection, though not achieving 
statistical significance for foci other than meningitis and epiglottitis. Only three 
other studies have examined the association between focus of infection and 
childcare (Table 5.42). Two studies with a significant proportion of epiglottitis 
found no difference by focus137 or a significant odds ratio for epiglottitis.141 In 
Oklahoma, where epiglottitis was uncommon, the odds ratio for all non­
meningitis cases was significantly less than the meningitis estimate.138 Taken 
together, this study and others (Table 5.43) suggest a significant association 
between meningitis and epiglottitis and childcare outside the home, with a 
weaker but still positive association for other foci.
An increasing number of hours spent in daycare was associated with increased 
disease risk, especially in younger children. This is consistent with the findings 
of most other studies (Table 5.43). The exception was Finland, where it was 
argued that uniform childcare provision and the later age of commencement 
may have masked this effect.61 In the univariate analysis, all types of childcare 
(family day care, child care centres, and play groups or occasional care) were
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associated with disease risk in younger children, while among children over 
two years, family day care was associated most strongly with risk. The type of 
child care is strongly associated with the number of children attending and 
hours of attendance, making the interaction between these factors difficult to 
establish. Other factors associated with particular centres, such hygienic 
practices may also be important.158 Although based on a small number of 
assessable cases and controls, the Sydney data are consistent with the 
hypothesis of Takala et al that recent commencement of childcare is associated 
with disease risk,137 presumably because of recent colonisation with Hib and/or 
other respiratory pathogens.
207
Table 5.44 PREVIOUS ILLNESS AND MEDICAL CARE IN CASE CONTROL STUDIES
STUDY AND VARIABLE Odds ratios (95% Cl) Comments
1. Recent infection
Istre et a l'” 1.0 (0 .9 -1 .1 ) 
1.4 (0 .7 -2 .7 )
Otitis media - univariate odds ratio 
Pneumonia - univariate odds ratio
Arnold et al’” Not evaluated
Cochi et al*0 Not evaluated
Takala et al’37 2.0 (1.1 -3 .9)
1.1 (0 .9 -1 .5 )
Otitis media - adjusted odds ratio, all ages 
Respiratory symptoms in the last 6 months
Clements et al’4’ 1.6 (1 .0 -2 .6 ) III sibling - adjusted odds ratio
Berg et al’38 Not examined
Vadheim et al'40 Not examined
Present study Not examined
2. Previous illness and medical care
Istre et al b o (O Doctor visits (since birth)
Arnold et al Not examined
Cochi et al Not examined
Takala et al
o?COoCsj Previous hospitalisation
Clements et al Not examined
Berg et al Not examined Underlying conditions excluded
Vadheim et al Associated with disease risk 11 % cases; 0% of controls
Not included in the multivariate model
Present study 6.72 (1 .4 - 32.1) Significant pre-existing illness
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The marked seasonality of Hib disease in most areas6 and some experimental 
data*4 have suggested a relationship between recent viral infection and disease 
risk, although this has been questioned.159 The relationship between recent 
illness and Hib disease has also been examined by some epidemiologic studies 
Table 5.44). The importance of seasonality means that only studies in which 
cases and controls are closely matched in time can validly examine this. The 
findings have varied from no relationship136 to a strong relationship, particularly 
in younger children,137,160 between recent illness and Hib disease. A number of 
studies have looked for laboratory evidence of recent infection in cases and 
controls and their family members, with variable results.160'162 The present study 
examined only medical attendance and antibiotic prescription in the previous 
year and found no relationship, in common with other studies.136,137
Both conditions known to increase susceptibility to invasive Haemophilus 
influenzae type b disease, such as Downs syndrome and a ventriculo-peritoneal 
shunt, and other significant pre-existing illness, were significantly associated 
with disease risk. This was not reported in most other studies (Table 5.44). 
Previous hospitalisation was a risk factor in Finland137 and underlying 
conditions were significantly more frequent in cases in Los Angeles.140 
Although this association may be due in pan to diagnostic bias, the stronger 
association in older children is consistent with previously described findings29 
and the association remained when only meningitis and epiglottitis cases, which 
should not be subject to diagnostic bias, were examined separately.
Breast feeding has been a protective factor for Hib disease in all studies except
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one141 (Table 5.45). It is not clear whether this is a biologic effect or a proxy 
for one or more socioeconomic factors.6,138,139 Both antibody against the 
capsular polysaccharide163 and the outer membrane proteins164 of Haemophilus 
influenzae can be demonstrated in breast milk, although the amount of antibody 
present differs between mothers.164 Biologically mediated protection would be 
expected to be most evident in the youngest children and to show a dose- 
response effect. In the Sydney study, protection from breast-feeding was 
evaluated only in children less than 24 months of age and a protective effect 
was most evident in children over 12 months of age in the univariate analysis, 
among whom protection was significant. There was no difference between 
current and prior breast-feeding, the major effect again being confined to 
children over 12 months of age. In contrast, a number of US studies have found 
protection from breast-feeding to be limited to children less than six months of 
age (Table 5.45). In Finland, protection could only be demonstrated if the 
duration of breast-feeding was longer than six months and was similar in all 
age strata; the odds ratio decreased, indicating increased protection, after 
correction for other significant variables including household size and childcare 
outside the home.137
Dose-response effects from breast-feeding have been examined in other studies 
as the number of months of breast-feeding.137,138 In the present study, a 
different variable, the proportion of the child’s life for which he or she had 
been breast fed, was used and again showed a much stronger protective effect 
among children older than 12 months. Protection was largely limited to one 
type of Hib disease, meningitis, an observation not previously described. There 
was a significant dose-response effect both in the univariate analysis and after
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adjustment for significant variables in children younger than two years with 
meningitis. Multivariate analysis of breast-feeding among age strata of cases 
with meningitis showed protection from breast-feeding at all ages. Protection 
was statistically significant only over 12 months of age, with the effect of 
household crowding and family size diminishing and the effect of childcare 
increasing with age. Although the limited sample size (24 cases of non­
meningitis and 62 controls) necessitates caution in interpretation of this finding, 
the pathogenesis of meningitis, requiring higher levels of bacteraemia in 
contrast than other types of Hib disease,165 makes it biologically plausible that 
protection from breast feeding could be limited to meningitis. In contrast to 
some other studies,139 significant protection remained after adjustment for a 
range of indicators of adverse socio-economic status, which was already 
partially controlled for by the method of control selection.146
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Table 5.45 BREAST FEEDING IN CASE CONTROL STUDIES
STUDY Odds ratios (95% Cl) Comments
Istre et a)13* Not significant Under 12 months
0.1 (0.01 - 0.96) Under 6 months (adjusted odds ratio)
Arnold et a l'3® 0.2 (0.1 - 0.7) 0 - 5 months; SES and race not sig.
0.6 (0.4 - 1.2) 6 - 1 1  months; SES and race not sig.
Cochi et al20 0.08 (0.01 - 0.59) 2 - 5 months; adjusted odds ratio
0.7 (0.2 - 3.2) 6 - 1 1  months; univariate odds ratio
Takala et al137 0.6 (0.2 - 1.4) 0 - 1 1  months and > 6 mths breast feeding
0.6 (0.3 - 1.3) 1 2 - 2 3  months and > 6 mths breast feeding
0.7 (0.3 - 1.6) 24 months and over
0.62 (0.4 - 1.0) All ages combined
Clements et al14’ 1.9 (1.3 - 2.9) Univariate; adjusted OR not significant
Berg et al13® 0.4 (0.3 - 0.8) Not significant after adjustment for SES
Vadheim et al140 46% cases
55% controls Not significant; P=0.38
Present study 0.54 (0.1 - 2.3) less than half life breast feeding (<2 years)
0.20 (0.05 - 0.8) more than half life breast feeding (>2 years)
0.25 (0.09 - 0.73) more than half life breast feeding (meningitis only)
2.00 (0.31 - 12.8) more than half life breast feeding (non-meningitis only)
Table 5.46 PARENTAL SMOKING IN CASE CONTROL STUDIES
STUDY Odds ratios (95% Cl) Comments
Istre et al13® Not evaluated
Arnold et al13® 1.4 (1.0 - 2.1) Adjusted odds ratio; did not change other variables
Cochi et al20 1.0 (0.6 - 0.8) Not significant in multivariate model
Takala et al137 1.8 (0.8 - 3.8) Adjusted OR for all ages
Clements et al’4’ 1.5 (0.9 - 2.4) Univariate; not significant in the multivariate model
Berg et al’38 0.6 (0.1 - 2.4) Not significant after adjustment
Vadheim et al140 1.1 (0.5 - 2.4) One or two smokers in household
6.0 (1.5 - 24.1) Three or more smokers in household
Present study 11.8 (1.1 - 123) NESB and < 3 years
1.1 (0.5 - 2.4) ESB and < 3 years
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The pattern of Hib disease incidence and age distribution varies substantially 
among different racial and ethnic groups.6 In Australia, a very high incidence of 
invasive Haemophilus disease, particularly meningitis, has been documented 
among Aboriginal populations in the Northern Territory10 and Western 
Australia.30 In Sydney, the number of children 0-4 years identified as being of 
Aboriginal descent in the 1986 census was 2321, increasing to 2955 in 1991. 
No cases were identified as being of Aboriginal descent; one to two would 
have been expected during the period of the study if the incidence were the 
same or greater than in the general population. Four control families identified 
themselves as being of Aboriginal or Torres Strait Islander descent, suggesting 
that the incidence of invasive Haemophilus disease among urban Aboriginal 
children in Sydney is unlikely to be of the order identified in predominantly 
rural populations in other areas of Australia.10,30
Many US studies have found Hib disease to be more common among black 
children.6,18’20,137,140’153'4 Although some studies have found higher observed 
disease risk in blacks disappeared after adjustment for confounding socio­
economic variables,20, 138 one study found an increased disease risk not 
explained by socio-economic factors or immunisation status.140 However, the 
possibility that some of this difference can be accounted for by non-response or 
other bias138 cannot be ruled out. In the Sydney study, the use of exchange- 
based random digit dialling probably biased against the detection of ethnic 
differences because of the geographic concentration of ethnic groups, as 
suggested by the differing estimates found with the small sample of controls 
recruited by telephone directory based methods and the uneven geographic
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distribution of cases.157 However, as with black race in US studies, the apparent 
associations of Arabic and Asian background with increased and decreased 
disease risk respectively were not significant after adjustment for other 
significant variables. This may reflect a socio-economic gradient or inadequate 
sample size; recent evidence indicates that Hib disease is rare among Chinese 
children in Hong Kong166 as previously suggested from Seattle.55
Patterns of child care and socio-economic variables are markedly different 
among households from different racial and ethnic groups.140 There was 
significant heterogeneity in odds ratios for child care outside the home and 
household crowding between households from English (ESB) and non-English 
speaking background (NESB) in this study. Although the presence of other pre­
school age children in the home was a risk factor in both groups, crowding was 
a risk factor only in NESB households and child care only in ESB households 
which contained an index child less than three years of age.
Passive exposure to tobacco smoke is a risk factor for early childhood 
respiratory illness and hospital admission.167'8 A biological basis for cigarette 
smoke exposure as a risk factor for Hib disease is plausible through damage to 
the respiratory epithelium either directly or through potentiation of viral 
infection160 or both. Epidemiologic data on the strength of association between 
passive smoking with Hib disease have differed (Table 5.46). All studies which 
have examined smoke exposure as a risk factor have found an odds ratio 
greater than one, but in most the effect has been relatively weak, with a point 
estimate less than 2.0 (Table 5.46). In all but two studies,138,140 the increased
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risk observed did not achieve statistical significance, especially after adjustment 
in multivariate models.20,139 Smoking may be more strongly associated with 
other bacterial infections and viral infections than Hib.139
A dose-response effect of tobacco smoke exposure has been suggested, with a 
greatly increased risk when more than two smokers are present in the home.140 
The only significant association between smoking and Hib disease was found 
among children from NESB who were under three years of age in Sydney. 
Other studies have also suggested that the importance of smoking may be 
greater in younger children137 and certain ethnic groups.140
There are significant geographic differences in the prevalence of smoking in 
Sydney, with 55% of households containing at least one child under five years 
of age having at least one smoker in Western Sydney, as opposed to 37% in 
Northern Sydney.169 Therefore the design of the Sydney study may have led to 
underestimation of the importance of smoking as a risk factor because of over­
matching for smoking status. Against this, the prevalence of smoking among all 
households containing at least one child under the age of five years in 
metropolitan areas of New South Wales was 47% in the National Health 
Survey 1989-90,169 very similar to the proportion of such households among 
RDD controls in this study. All studies which have found a significant effect of 
smoking have been conducted after the introduction of Hib vaccines, with a 
vaccination rate among controls of around 25% and much lower rates in 
cases.138,140,170 The population of cases in these studies may have been biased
towards lower socio-economic status, which is correlated with under-
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vaccination171 and also towards a higher prevalence of smoking households. The 
burden of evidence, including the results of this study, point to tobacco smoke 
exposure being of minor importance only in determining the risk of Hib 
disease. A possible exception to this may be where there is a very high level of 
exposure,140 especially in the youngest children.
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5.7 SUMMARY OF SIGNIFICANT FINDINGS IN THE SYDNEY STUDY
In summary, this study has confirmed the findings of previous studies that 
factors which increase the opportunity for exposure to Hib, such as increasing 
family size and care with other children outside the home are important risk 
factors for Hib disease in children less than five years of age in Sydney. Two 
findings of the Sydney study, which have not been previously emphasised, were 
the importance of age and focus of infection as effect modifiers of family size 
and household crowding and protection from breast feeding respectively. The 
odds ratios associated with family size and daycare variables in the univariate 
and multivariate analyses are summarised in Table 5.47. The odds ratios for 
different foci of infection appear in Table 5.32. The relationship between age 
and socio-economic variables, shown in Table 5.26, is summarised in Table 
5.48.
Taken together, the data in these tthree tables suggest that children from more 
socio-economically disadvantaged households are likely to be exposed earlier 
and more intensively to Hib and to develop disease earlier, which is usually 
meningitis. This mimics the situation in indigenous communities, where disease 
occurs even earlier and meningitis predominates.1,6 By contrast, epiglottitis was 
associated with smaller, uncrowded households and later exposure to Hib.
Several other findings are new or support the findings of other studies which 
have been tentative. The relationship between recent commencement at a day
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care facility and onset of Hib disease made in Finland137 was supported. (Table 
5.33). The observations made in Los Angeles140 concerning the differing 
relationships among key variables, especially childcare, in different ethnic 
groups was confirmed and extended to younger age groups (Table 5.37). The 
effect of breast feeding was examined in a different way to previous studies, 
supporting the protective effect previously documented and suggesting that it 
was independent of family size and socio-economic status and largely limited 
to meningitis (Tables 5.36 and 5.37). The effect of tobacco smoke exposure 
appears to be no more than modest, except perhaps in the youngest children 
and among households of a non English-speaking background (Table 5.37). 
Although limited by small numbers, the findings suggest that the very low 
incidence of Hib disease found in children of Chinese descent in Hong Kong 
may also be present in Sydney (Tables 5.31 and 5.41). This implies that host 
susceptibility may be important as well as exposure opportunity.
The methodology of this study, particularly the emphasis on studying risk 
factors in age strata, is likely to be applicable to other invasive bacterial 
infections of childhood, such as pneumococcal disease, which are yet to be
studied.
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Table 5.47 Univariate and multivariate odds ratios for key variables by age group
VARIABLE
More than one 
child < 5 yrs
School age 
children
More than two 
adults
More than 0.8 
persons/room
4-24 hours 
childcare
More than 24 
hours childcare
Significant
UNDER TWO
Univariate 
OR (95% Cl)
2.90
(1.6 - 5.2)
2.0
(1.0 - 4.0)
I. 64
(0.6 - 4.6)
2.60
(1.0 - 6.7)
2.67
(1.1 - 6.3)
4.46
(1.7 - 12.0)
II. 47
(1.3 - -264)
YEARS
Multivariate OR 
(95% Cl)
7.98
(2.4 - 26.1)
2.95
(0.8 - 8. 1)
3.50
(0.2 - 57.3)
1.58
(0.3 - 8.4)
13.49
(1.6 - 116)
45.6
(6.1 - 340)
7.43
(2.3 - 21.3)
OVER TWO
Univariate 
OR (95% Cl)
4.41
(2.2 - 8.2)
0.51
(0.3 - 1.0)
1.96
(0.7 - 5.4)
0.36
(0.1 - 1.6)
1.76
(0.8 - 3.7)
2.87
(1.2 - 7.1)
4.38
(0.7 - 28.2)
YEARS
Multivariate OR 
(95% Cl)
4.11
(1.5 - 11.4)
1.61
(0.6 - 4.5)
4.72
(1.06 - 21.0) 
0.16
(0.02 - 1.3)
3.29
(0.9 - 12.1)
10.32 
(2.3 - 47)
11.94
(1.0 - 149)illness
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CHAPTER SIX
THE IMPACT OF IMMUNISATION ON INVASIVE 
Haemophilus influenzae type b DISEASE 
IN THE SYDNEY REGION
6.1 INTRODUCTION
In May 1992, the first vaccine against Hib disease was marketed in Australia, 
for use in children 18 months of age and older. In January 1993, Hib vaccines 
suitable for use in infants from two months of age became available. Several 
important changes in policy for immunisation against Hib disease have since 
occurred, culminating in a fully funded program of infant immunisation from 
July 1993 and catch-up immunisation of older children from August 1993
(Table 6.1).
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Table 6.1: CHRONOLOGY OF Hib VACCINES IN AUSTRALIA
Date V acc ine (s ) A va ilab ility
M ay 1992 P R P -D  (P roH ib it) M a rke ted  fo r use at 18 m on ths  o f age and ove r
Janua ry  1993 P R P -O M P  (PedvaxH ib )  
P R P -C R M  (H ibT ite r) M a rke ted  fo r use at 2 m on ths o f age and o lde r
A pril 1993 P R P -T  (Ac tH ib ) M arke ted  fo r use at 2 m on ths o f age and  o lde r
M ay 1993 P R P -O M P , PR P -C R M , PRP -T R e im bu rsem en t o f vacc ine  cost fo r ch ild ren  born  
Februa ry 1993
a fte r
Ju ly  1993 P R P -C R M A w arded  gove rnm en t con tra c t fo r in fan t im m un isa tion
Ju ly  1993 P R P -O M P , PR P -C R M , PRP -T R e im bu rsem en t of vacc ine  cos t fo r ch ild ren  born  
Feb rua ry 1988
a fte r
A ugus t 1993 P R P -C R M A w arded  gove rnm en t con tra c t fo r ca tch -up  im m un isa tion
A significant decline in the incidence of invasive Hib disease following the 
introduction of immunisation programs has been documented in the US172,173 
and in Finland.174 In the US, incidence of Hib disease in children less than 18 
months of age appeared to decline before immunisation was available in this 
age group.172'73 Documentation of the level of coverage with Hib vaccines 
associated with this decline has varied from numbers of doses distributed in the 
US,172 to countries such as Finland where almost universal vaccine coverage 
was achieved.174 The gradual introduction of Hib vaccines in Australia and the 
availability of long-term population-based surveillance data in the Sydney 
region29 offered an opportunity to correlate vaccine uptake with observed 
disease incidence, taking into account inter-annual variation in Hib disease.175
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In this chapter, the age-specific incidence of Hib disease in the Sydney region 
is compared with age-specific estimates of Hib vaccine uptake in the same 
population. The aim was to establish the level of community vaccine coverage 
required for a significant fall in disease and to assess the impact of 
immunisation of older children on the incidence of Hib disease in younger, 
unimmunised children.
6.2 METHODS 
6.21 Case ascertainment
The methods of case ascertainment and the case definition of invasive Hib 
disease have been described in chapters two, three and five. In brief, a case was 
any child, 0-14 years, from whom Haemophilus influenzae was isolated from 
blood, cerebrospinal fluid or any other normally sterile site. Culture-negative 
cases of epiglottitis were also accepted if they had a typical endoscopic 
appearance and antibiotic pre-treatment. Case ascertainment 1985-87 was 
retrospective, and although including all available sources of data,29 was 
necessarily incomplete. Case ascertainment was not carried out in 1988 and was 
by active laboratory surveillance 1989-93.119 Surveillance included all 
laboratories of all hospitals which admit children in the Sydney region and all 
paediatric intensive care units. Laboratories were contacted every two to four
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weeks by telephone and were asked to notify cases occurring between these 
times directly. Since 1991, when Hib disease became notifiable, surveillance 
has included cross-checking with Department of Health data. The population 
denominators were obtained from the 1986 and 1991 census data, with 
interpolation as necessary to estimate annual increments and population 
numbers between census years or in uneven age categories, eg 12 to 18 months.
6.22 Vaccine uptake
Vaccine uptake was estimated from telephone interviews conducted in the first 
two weeks of August, 1993 using a random sample of 4000 residential 
telephone numbers from the Sydney telephone directory obtained from 
electronic white pages. As 95% of Sydney households have a telephone 
connected and all but 5% of these are listed in the telephone directory,147 this 
sampling frame is both representative and efficient. Approximately 10% of 
households are not covered, including 5% with no telephone, who are likely to 
be of lower socio-economic status, and 5% with an unlisted telephone number, 
who are likely to be of higher socio-economic status. Households containing 
dependent children are also more likely to have someone at home when an 
interviewer calls. At least three attempts, at different times of the day and 
different days of the week, were made to contact these numbers by trained 
interviewers. Respondents were asked if one or more children under the age of 
five years resided in the household contacted and if so, were asked to complete 
a brief questionnaire. The questions used were similar to those used in a study
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in the Australian Capital Territory176 and consisted of 11 questions including 
the age of all children under five years, knowledge of Hib and whether and 
when immunisation against Hib had been received. If respondents indicated that 
any children had been immunised against Hib, they were asked to provide 
details of where and who had immunised their child(ren) and to consent to the 
investigators contacting their immunisation provider for verification of receipt 
and time of immunisation. Verification of immunisation and its timing was 
undertaken with a random sample of half of the vaccine providers nominated 
by telephone by a research nurse.
6.23 Statistical methods
Monthly Hib case incidence rates for children over 2 months and under 5 years 
were computed from January 1989 to December 1992. These 48 time series 
data points were modelled using the Box-Jenkins method of forecasting.177 A 
multiplicative seasonal model ARIMA(0,l,l)x(0,l,l)178 was chosen after 
examination of the autocorrelation and partial autocorrelation coefficients of the 
data and the least square estimates of the model parameters. The adequacy of 
the model was assessed by the modified Box-Pierce chisquare statistic. Data 
and results were presented in graphical form, highlighting the seasonal 
variation.
Vaccine uptake was calculated for three age strata (3-18 months, 19-36 months 
and 37-60 months) at four time points representing key changes in Hib 
immunisation availability and policy (Table 6.1). Age was adjusted to each of
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the four time points.
A non-parametric method of two factor analysis of variance (Friedman’s test) 178 
was used to assess difference in immunisation rates between health areas within 
Sydney over the four critical time points. Agreement between parental report of 
the date of immunisation and immunisation provider records was measured by 
quadratic-weighted kappa statistics.179,180
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6.3 RESULTS
6.31 Incidence of Invasive Hib Disease
Figure 6.1 shows the annual incidence of Hib disease from 1985 to 1993 in the 
three to 18 months age-group and the 19-60 months age-group. A wide inter­
annual range of disease incidence in the younger age-group is apparent, which 
is much less marked in older children.
Figure 6.2 shows the actual and fitted Hib incidence rates to December 1992, 
and the forecast and actual incidence rate to June 1994. The previously 
described winter peak in disease incidence is very apparent from this graph.29 
The actual incidence of Hib disease has been lower than forecast levels since 
February of 1993 but a definite winter peak in incidence was still observed. 
The modified Box-Pierce chisquare statistic (lag of 12) was 11.8 with 10 
degrees of freedom, giving a p-value of 0.3, which confirmed that the model
adequately described the data.
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The change in incidence of Hib disease is also shown in six month categories 
from January 1991 to June 1994 in Table 6.2.
Table 6.2: CHANGES IN THE AGE-SPECIFIC INCIDENCE OF
INVASIVE Hib DISEASE IN THE SYDNEY REGION 1991-1994
Six month time periods
January - June July - December
Age group cases incidence/100000 (95% Cl) cases incidence/100000 (95% Cl)
0-5 months old *
1991 5 22.4 ( 7.3 - 52.2) 7 31.3 (12.6-64.5)
1992 4 17.7 ( 4.8 - 45.3) 2 8.9 ( 1.1 - 32.0)
1993 1 4.4 ( 0.1 - 24.4) 7 30.7 (12.7- 63.2)
1994 1 4.3 (0.1 - 24.2)
6-18 months old § 
1991 26 58.2 (38.0 - 85.2) 33 73.8 (50.8 - 103.7)
1992 27 59.8 (39.4 - 87.0) 20 44.3 (27.1 - 68.4)
1993 17 37.3 (21.7 - 59.6) 9 19.7 (9 .0-37.4)
1994 6 13.0 ( 4.8 - 28.3) -
19-59 months old # 
1991 30 19.2 (12.9 - 27.4) 29 18.5 (12.4-26.6)
1992 29 18.3 (12.3 - 26.3) 24 15.2 ( 9.7 - 22.6)
1993 22 13.8 ( 8.6 - 20.9) 13 8.1 ( 4.3 - 13.9)
1994 10 6.2 ( 3.0 - 11.4) -
60-120 months old @ 
1991 8 3.5 ( 1.5 - 7.0) 6 2.7 ( 1.0 - 5.8)
1992 7 3.1 ( 1.2 - 6.3) 3 1.3 ( 0.3 - 3.9)
1993 2 0.9 ( 0.1 - 3.2) 6 2.6 ( 1.0 - 5.8)
1994 4 1.8 ( 0.5 - 4.4) -
* Chisquare for trend x2^  = 22 p-value = 0.13
§ Chisquare for trend x2 1 = 26.4 p-value < 0.001
# Chisquare for trend x2i = 16.0 p-value < 0.001 
@ Chisquare for trend x2i = 2.1 p-value = 0.15
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The incidence fell progressively in the age groups 6 to 18 months and 19 to 59 months, 
particularly during 1993, consistent with a vaccine effect (chi square for trend P <0.001). An 
inconsistent but suggestive fall was seen in the incompletely immunised youngest children (0-5 
months) but no change in children outside the recommended age group for immunisation (60- 
120 months). These data are also shown as the absolute numbers of cases in each category 
(meningitis, epiglottitis and other foci) for all children 6-60 months of age in Table 6.3.
Table 6.3: INVASIVE Hib DISEASE IN THE SYDNEY REGION 1991-1994 
BY DISEASE FOCUS IN CHILDREN 6 to 60 MONTHS OF AGE.
Number of cases in six months period
Focus January - June July - December
Meningitis
1991 28 32
1992 28 21
1993 15 8
1994 7 -
Epiglottitis
1991 18 16
1992 13 16
1993 12 6
1994 8 -
Others
1991 11 14
1992 16 7
1993 12 9
1994 3 "
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6.32 Hib Immunisation Uptake 
Response rate
A total of 412 households responded, containing 549 children under the age of 
five years. The expected proportion of eligible households, containing at least 
one child aged less than 5 years, was 15.4%, calculated from Australian Bureau 
of Statistics (ABS) 1991 census data in the Sydney statistical division (SSD).181 
Excluding disconnected (248), business/fax (86), language difficulty (63) and 
non contact (343), the sampling frame was 3,260 households. It is very likely 
that, among the households not contacted (because of disconnection or non­
response), substantially fewer than 15.4% contain children less than five years. 
Assuming that approximately 5% of households not contacted contained eligible 
children, this would only represent some ten additional households.
Using 3260 households as the denominator, ABS figures predict 501 
households (95% confidence interval 461 to 541 households) with one or more 
children aged less than five years. Therefore, the response rate based on ABS 
figures as a denominator is 82.1% (Cl 76.0%-89.4%). The refusal rate of 17.9% 
estimated in this way is higher than the refusal rate obtained assuming that all 
75 households who refused interview were eligible (15.4%). This suggests that 
up to 2.5% of eligible households may not have admitted to having 
appropriately aged children.
6.33 Validation of immunisation status
Of participating households, 189 reported one or more children vaccinated
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against Hib, 156 (89%) of those agreed to provide details of their General 
Practitioner (GP) to contact for confirmation of receipt and timing of Hib 
vaccination. Contact was attempted with a random sample of 80 GPs, of whom 
17 (21%) refused to participate and one (1%) had no records of immunisation 
available, leaving 62 practices with data for validation of immunisation. It was 
possible to validate Hib vaccination from General Practitioner records for 58 of 
the 62 households (94%) or 71 of 77 (92%) of children less than five years. 
One household incorrectly reported Hepatitis B vaccination as Hib vaccination.
The GP validation study data was compared with the stated vaccination date, 
using the reference dates for policy changes for Hib vaccine availability and 
cost (Table 6.1). The correlation between the parental report of date of 
immunisation and GP records was good with a quadratic weighted kappa 
statistics of 0.83, 95% Cl (0.69-0.93). This indicates excellent agreement 
between self-report and available records for time since vaccination.181
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6.34 Immunisation Rates
Table 6.4 shows the immunisation rates for three to 18 month olds and 19 to 
60 month olds and their 95% CIs at the four time points ascertained. 
Immunisation uptake among three to 18 month old children increased from 
three percent at the end of 1992 to 48% at the time of the survey in August 
1993. The estimated immunisation uptake among children older than 18 months 
rose from 17% at the end of 1992 to over 40% by the time of the survey. 
Figure 6.5 shows the immunisation rate for all children aged over 2 months and 
under 5 years for Northern Sydney health area compared to all other health 
areas in Sydney. Friedman’s test,179 after adjusting for the four time points, 
shows a significant difference between the Northern Sydney immunisation rate 
and the immunisation rate for the rest of Sydney (%2j = 4, p-value=0.046).
Table 6.4: AGE-SPECIFIC Hib VACCINE UPTAKE RATE 
AT TIMES OF VACCINATION POLICY CHANGE
Age categories
3-18 months old 19-60 months old
Time Rate/100 (95% Cl) Rate/100 (95% Cl)
August 1993 
July 1993 
May 1993 
December 1992
48.3 (40.3 - 56.3) 
33.1 (25.5 - 40.7)
9.0 ( 4.2 - 13.3)
3.0 ( 0.4 - 5.6)
45.3 (39.8 - 50.8)
42.6 (37.1 - 48.0)
30.6 (25.6 - 35.6)
18.4 (14.0 - 22.7)
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6.4 DISCUSSION
The manner in which Hib vaccines have been introduced into Australia is 
similar to North America, with licensure and commercial availability of a 
number of different conjugate vaccines in different age-groups preceding 
general availability through funded programs.4 In contrast to the US and 
Canada, this process occurred over a little more than 12 months in Australia, 
compared with almost three years. This differs markedly from the manner in 
which immunisation against Hib was introduced into the UK, where a 
nationwide program encompassing all children under the age of five years was 
initiated with full funding at the end of 1992.
The data from surveillance of Hib disease in the Sydney region suggest that 
year to year variation in the incidence of invasive Hib disease occurs here, as 
has been demonstrated elsewhere.175 Incomplete case ascertainment may 
account for some of the variation seen in Sydney during the eight years for 
which data are available, as the years for which data are most complete (1991-) 
show the highest incidence. However, as the incidence in children over the age 
of 18 months differed little during this time and the highest incidence was 
documented in 1986, when only retrospective data were available, under­
ascertainment cannot account for all the variability observed. The incidence of 
Hib disease in 1993 is lower than that in any previous year in both age-groups, 
most marked in over 18 months old children.
The time-series analysis method allows the trend in Hib disease incidence to be
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evaluated taking into account both annual and seasonal variation. These results 
suggest that the incidence of Hib disease in all children under five years of age 
has fallen to an extent not able to be accounted for by natural variability or 
seasonal factors from at least August of 1993. The results of the time-series 
analysis are strongly supported by the fall in incidence in six month periods 
1991-1994 shown in Table 6.2, demonstrating a highly significant linear 
decrease in Hib disease in the age-groups eligible for immunisation which was 
not seen in younger or older children. Although these data are early, the effects 
seen are marked and provide strong evidence for a vaccine effect.
The data obtained from parental interviews should be highly generalisable, as it 
comes from a random community sample taken from a sampling frame 
(electronic white pages) containing about 90% of the target population, with a 
high response rate. Parental interview has limitations as a means of determining 
vaccine uptake.182 However, this should be improved by the short period of 
recall required and the novelty of the vaccine concerned. This is confirmed by 
the high concurrent validity of parental interview compared with vaccination 
providers, with a high correlation for both receipt of vaccine as reported and 
time of vaccination.
The prevalence of vaccination for Hib among children in the Sydney region 
aged between 19 and 60 months, who require only one dose of vaccine, has 
risen steadily from 18% in December 1992 to 45% in August 1993. The age- 
specific immunisation rates documented in Sydney in May of 1993 are similar 
to those found in the Australian Capital Territory in March, 1993.176 In the
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absence of any general Commonwealth funding, the immunisation rate rose to 
18% from zero during the latter 9 months of 1992, and during the first 6 
months of 1993, it rose to 43%. It will be important to evaluate whether the 
introduction of a fully funded "catch-up" programme since these data were 
obtained results in any further significant increase in vaccine uptake among 
older children. However, among infants less than 18 months of age, for whom 
2 to 4 doses of Hib vaccine are required for immunisation, uptake increased 
minimally from 3% to 9% in the first four months during which suitable 
vaccines were available. Once funding became available, vaccination rates 
increased dramatically from 9% to 33%.
A prior hypothesis was that the higher the socio-economic status, the higher the 
vaccination rate, particularly prior to free immunisation. The difference between 
health areas was investigated as a proxy for socio-economic status. Children 
living in the Northern Sydney health area, an area of predominantly higher 
socio-economic status, were significantly more likely to be immunised than 
other children in the Sydney region. Although the available data are not 
sufficient for valid statistical evaluation, it is interesting to note that the 
difference between uptake rates in Northern Sydney and other areas has 
progressively decreased with introduction of various funding initiatives.
There was little evidence of a fall in the incidence of Hib disease in children 
over 18 to 60 months of age during 1992, when they were the only group 
eligible for immunisation. However, vaccine uptake was estimated to be less 
than 20% during most of 1992 in this age group. Although there was a steady
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decrease in disease incidence among children 6 to 18 months of age during 
1992, the Sydney data do not show a marked fall in disease incidence until the 
latter half of 1993. These data do not suggest an effect of Hib vaccination of 
older children on the incidence of Hib disease in younger children, as suggested 
in the US,172 although the level of vaccine uptake was low and the time 
available to observe an effect before the introduction of infant vaccines was 
short.
This is the first report of longitudinal changes in both Hib disease incidence 
and vaccine uptake in the same population. If the current trends in the 
incidence of Hib disease are confirmed, the Sydney data suggest that vaccine 
uptake approaching 50% in all age-groups is needed before a significant 
decrease in disease incidence is observed. This is still a much greater impact 
than would be expected from protection of vaccinated children alone, as has 
been observed in Finland.183 If confirmed, this suggests that conjugate Hib 
vaccines are very good value for money in the short-term.
Some questions remain about the long-term impact of reduced colonisation with 
Hib on immunity in older children and adults,184 but to date no difference in the 
pattern of Hib disease in older subjects have been observed.
It is important that surveillance of invasive Hib disease and vaccine efficacy 
continue for some time to come, which will be more readily achieved with Hib 
disease being notifiable in most States. This, the final chapter of this thesis, 
should herald the final chapter for invasive Hib disease, which is becoming a
239
rarity in the paediatric wards of Australian hospitals in 1994..
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APPENDIX ONE
CALCULATION OF ODDS OF HANDICAP BY AGE
The number of cases of serious handicap before and after the age of immunisation was 
calculated such that the total number of handicapped survivors estimated by the model remained 
unchanged as follows:
PROBABILITY OF SERIOUS HANDICAP AFTER THE AGE OF IMMUNISATION = 
PROBSCAP * ORx
PROBABILITY OF SERIOUS HANDICAP BEFORE THE AGE OF IMMUNISATION = 
[PROBMEN * PROBSCAP]
[PROPx * PMENPRx + ((PROBMEN - (PROPx * PMENPRx)) * ORx)]
where:
PROBSCAP
ORx
PROBMEN = 
PROPx =
PMENPRx
= probability of serious handicap after meningitis
= odds ratio of serious handicap after the age of vaccination
(x months = 6,12,18)
probability that Hib disease is meningitis
proportion of Hib disease occurring before the age of immunisation 
(x months = 6,12,18)
= probability that Hib disease before the age of immunisation 
(x months) is meningitis
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APPENDIX TWO
UTILITY OF DIFFERENT LEVELS OF DISABILITY
from : Drummond MF, Stoddart GL, Torrance GW Methods for economic 
evaluation of health care programmes Oxford University Press Oxford 1987 
pages 121 - 124
Table 6.1. Health state classification system (Age >2 years)
X, Physical function: mobility and physical activity*
Level x, Code Description
1 PI Being able to get around the house, yard, 
neighbourhood or community WITHOUT HELP 
from another person; AND having NO limitation 
in physical ability to lift, walk, run, jump or bend.
2 P2 Being able to get around the house, yard, 
neighbourhood or community WITHOUT HELP 
from another person; AND having SOME 
limitations in physical ability to lift, walk, run, 
jump or bend.
3 P3 Being able to get around the house, yard,
neighbourhood or community WITHOUT HELP 
from another person; AND NEEDING 
mechanical aids to walk or get around.
4 P4 NEEDING HELP from another person in order to 
get around the house, yard, neighbourhood or 
community; AND having SOME limitations in 
physical ability to lift, walk, run, jump or bend.
5 P5 NEEDING HELP from another person in order to 
get around the house, yard, neighbourhood or 
community; AND NEEDING mechanical aids to 
walk or get around.
6 P6 NEEDING HELP from another person in order to 
get around the house, yard, neighbourhood or 
community, AND NOT being able to use or 
control the arms and legs.
X2 Role function: self-care and role activity*
Level x2 • Code Description
1 R1 Being able to eat, dress, bathe,*and go to the toilet 
WITHOUT HELP; AND having NO limitations 
when playing, going to school, working or in other 
activities.
2 R2 Being able to eat, dress, bathe and go to the toilet 
WITHOUT HELP; AND having SOME 
limitations when playing, going to school, working 
or in other activities.
3 R3 Being able to eat, dress, bathe and go to the toilet 
WITHOUT HELP; AND NOT being able to 
play, go to school or work
4 R4 NEEDING HELP to eat, dress, bathe or go to the 
toilet; AND having SOME limitations when 
playing, going to school, working or in other 
activities.
R5 NEEDING HELP to eat, dress, bathe or go to the 
toilet; AND NOT being able to play, attend 
school or work.
X3 Social-emotional function: emotional wellbeing and social activity
Level x3 Code Description
1 SI Being happy and relaxed most or all of the time, 
AND having an average number of friends and 
contacts with others.
2 S2 Being happy and relaxed most or all of the time, 
AND having very few friends and little contact 
with others.
3 S3 Being anxious or depressed some or a good bit of 
the time, AND having an average number of 
friends and contacts with others
4 S4 Being anxious or depressed some or a good bit of 
the time, AND having very few friends and little 
contact with others.
X4 Health problemi*
Level x4 Code Description
1 H I Having no health problem.
2 H2 Having a minor physical deformity or disfigurement 
such as scars on the face.
3 H3 Needing a hearing aid.
4 H4 Having a medical problem which causes pain or 
discomfort for a few days in a row every two 
months.
5 H5 Needing to go to a special school because of trouble 
learning or remembering things.
6 H6 Having trouble seeing even when wearing glasses.
7 H7 Having trouble being understood by others.
8 H8 Being blind OR deaf OR not able to speak.
* Multiple choices within each description are applied to individuals as appropriate 
for their age. For example, a 3-year-old child is not expected to be able to get around the 
community without help from another person.
* Individuals with more than one health problem are classified according to the 
problem they consider the most serious.
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APPENDIX THREE
FAMILY QUESTIONNAIRE - CASES
263
1A. Was a drug called RIFAMPICIN prescribed for you or your household 
Co take after ______________ 's illness?
Yes 1 
No 0
if yes
2A Did all members of your household take RIFAMPICIN?
Yes 1 
No 0
if no, specify who took it
3A Did everyone who was prescribed RIFAMPICIN finish the course.
Yes 1 
No 0
If yes
4A How many days did you take RIFAMPICIN?
5A How many doses did you take each day?
6A Were you warned about any problems that can occur when taking 
RIFAMPICIN?
Yes 1 
No ‘ 0
\ If yes specify
8A Did any of your household have any problems when taking RIFAMPICIN?
Yes 1 
No 0
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9A. If yes, specify
10A. Did anyone in your household have to take time off work because of
's illness?
Yes 1 
No 0
11A If yes specify
12A. Did you have to make any alternative child care arrangements while 
______________________ was in hospital?
Yes 1 
No 0
13A If yes specify
14A Could you describe for me how _______________' s illness affected your
family/household?
15A Since ____________  left hospital how many visits to doctors or
clinics have you had to make for follow up?
Paediatrician __________________
G.P. __________________
Audiology __________________
Other therapist
Specify _______________________________________________
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APPENDIX FOUR
HOSPITALISATION DATA FOR CASES
HIB INFECTION - CONFIDENTIAL DATA 266
Study number
SURNAME ____
FIRST NAME _
STREET _____
SUBURB _____
PHONE NUMBER
POSTCODE ___
HOSPITAL I _  
Number --
HOSPITAL 2
Number
HAEMOPHILUS INFLUENZAE TYPE B INFECTION 267
BACKGROUND DATA
I. Study number
2. Hospital first seen 
Number
3. Patient residential postcode
4. Patient residential L.G.A. 
Number
5'. Sex Male 1
Female 2
6. Date of birth -------
7. Date of admission -------
8. Age (months) -------
9. Personal private phone Yes I
10. Significant past illness Yes 1
if yes
11. Specify
No 0
TRANSPORT
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12. Transferred Yes 1
No 0
If yes, go to Q.13 
if no, go to Q.1?
13. Transferred to hospital ______
Number ------
14. Transport team Retrieval team --------- 1
Referring hospital Dr ----------2
Referring hospital nurse ----------3
Ambulance, no escort  4
Other
Specify ___________________________ 5
15. Mode of transport Aeroplane-------------------------- 1
Helicopter ------------------------- 2
Road ambulance -------------------- 3
Other
Specify ____________________________ 4
16. Date of transfer -----------------------
17. Transferred back to referring hospital Yes 1
No 0
18. Date of transfer
INTENSIVE CARE 269
19. Admitted to ICU Yes ____ 1
No ____ 2
If yes, go to Q.2Q 
if no, go to Q.26
20. Intubated Yes I
No _____ 2
If yes
21. Days of intubation __________
22. Ventilated Yes 1
No 0
if yes
Days of ventilation
23. Complications in ICU Yes 1
No 0
if yes
24. Specify
25. Total ICU days
26. Admitted to high dependency area Yes I
No 0
if yes
27. Days of high dependency
DRUG THERAPY 270
28.
29.
1.
2.
3.
4
5.
Intravenous antibiotic therapy 
If yes,
Yes 1
No 0
Ampicillin
mg/day x days = total mg
Chloramphenicol
Cefotaxime
30. Oral antibiotic therapy Yes 1 
No 0
If yes
mg/day — -----x days = total mg
Amoxycillin
Chloramphenicol
Other
32. Other medications Yes 1 
No 0
33. If yes specify route mg/day days total
IMAGING 271
34. Chest X-rays
35. Other plain X-rays
36. C/T scans
37. Ultrasound
38. Nuclear scan
39. Other specify
LABORATORY TESTS
40. CSF me + s
41. CSF antigen
42. Blood c+s
43. Urine me + s
44. Urine antigen
45. Throat swab
46. Full blood count
47. Biochemistry
48. Other laboratory tests
if yes
49. Specify
MICROBIOLOGY
50. Focus of infection
Specify
Number
Number
Yes 1 
No 0
MEN 1
EPI 2
CEL 3
ARTH 4
PNEUMONIA 5
BACTERAEMIA 6 
OTHER
7
51. Haemophilus isolate
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Blood only 1 
csf only 2 
blood and csf 3 
other sterile 4 
epiglottic swab only 5 
urine Ag only 6 
no positive isolate 7 
no cultures taken 8
52. Capsular typing b
non b 
not done
1
2
3
53. Biotype
54. Sensitivity
Amp S Chi S 1 
Amp R Chi S 2 
Amp S Chi R 3 
Amp R Chi R 4
DATA ON DISCHARGE
55. Patient died Yes 1
No 0
if yes
56. Date of death ______
57. Date of discharge ______
58. Hospital days ______
59. Complications in hospital
Yes 1 
No 0
60. If yes
fits in first 48 hours 1
■ fits after 48 hours 2
focal CNS signs 3
fever ]> 7 days 4
other ______      5
61. Normal at discharge
Yes 1 
No 0
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if no
62. Specify
63. Audiology Yes, once 1 
Yes, more than once 2 
Not done 3
64. If yes, where done Hospital 1
NAL 2
Private audiologist 3 
Other
Specify___________  4
65. Days after admission
f
66. Result
1
2
3
4
5
6 
7
NK
67. Follow up 3 months or longer Normal 1
Abnormal 2
Not known 3
Conductive 1 Unilat
Sens N Mild/mod 2
Bilat
Unilat
Sens N severe 3
Bilat
Unilat
Not known 4
Bilat
68. If abnormal, 
specify ____
69. Rifampicin prescribed for household Yes 1
No 0
70. Rifampicin
household
prescribed for contacts outside
Yes 1
No 0
If yes
71. Specify
playmates/relatives 1
child care centre 2
preschool 3
Other
specify _____________ 4
5
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APPENDIX FIVE
SHORT TERM COSTS OF Hib DISEASE
METHODS
Costing considered ward costs, divided into a number of components outlined below, medical salaries, transport, the 
costs of investigations (laboratory and imaging), drug treatment, the cost to families of after-hospital visits and time 
off work and long term costs associated with treatment of disability.
1. Ward Costs
a) Salaries and Wages (Nursing and Clerical)
b) Goods and Services
c) Meal Unit Cost
d) Housekeeping
e) Pharmacy (In-patient Pharmacy G&S)
f) Linen costs
Ward Activity was measured as patients treated and bed days.
Costing considered the following categories of ward :
a) ICU - Intensive Care ; requiring ventilation / intubation
b) HD - High Dependency; requiring a high degree of care
c) STANDARD - Standard care
The wards used for costing these categories of care were the Intensive Care Unit, B4b the High Dependency ward 
and B4a the medical standard dependency ward. Total costs were calculated for each ward category, summed and 
averaged to yield a bed-day cost for each level of care.
2. Medical Salaries
Medical salaries for the standard and high dependency wards included the categories of Visiting Medical Officer, 
Resident Medical Officer of various grades.
a) Visiting Medical Officer (VMO) - Paediatrics 
Medical VMOs only were included
b) 4 Residents 1st year trained 
4 Registrars 2nd year trained 
1 Registrar 4th year trained
3. Transport
4. Drug Costs
5. Laboratory Costs
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6. Imaging
7. Additional costs
a) Visits to Paediatrician,GP,Physio,NAL etc
b) Loss of work days for parents.
c) Rifampicin prophylaxis.
8. Long Term Costs
Long term cost of disability in various categories
COMPONENT COSTS 
1. Bed activity
Activity 1/7/89-30/6/90 source : Jill Howes
Management Information
Pts treated Separations Bed Days
B4a 2206 2199 5662
B4b 1014 982 2635
ICU 3815
Method for estimation of ward activity for B4a and B4b 
B4a = 20beds x 19 F.T.E (nursing) F.T.E / bed = .95 
B4b = 10 beds x 24 F.T.E (nursing) F.T.E / bed = 2.4 
B4a relative activity = .95 / 3.35 = 30 %
B4b relative activity =2.4 /3.35 = 70 %
Medical and V.M.O salaries allocated 30 I 70 ratio
2. Salaries and wages - Nursing
Salaries and Wages to 31/12/90 source : Margaret Tobome
Management Accounting
Budget Actual
B4a 576504 643638
B4b 756320 862328
ICU 3090517
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3. Goods and services - ward budgets
Goods and Services to 1/12/90
Budget Actual
B4a 40320 41352
B4b 59520 45578
ICU 633373
4. Pharmacy costs Source: Penny Thornton
Deputy Director of Pharmacy
Cost of one pharmacist = $31,000. Would spend approximately half their time in the childrens’ wards (B4a,b,c). 
Approximate cost to each ward = 5,000.
ICU would have one pharmacist allocated = 31,000
5. Housekeeping costs 
a) Paediatric wards
Source: Mustafa Aysen
Leading Hand Level 4
B4a & B4b
Mon - Fri 5 x Full-time assistants
Sat 4 x Full-time assistants (50% loading)
Sun 4 x Full-time assistants (75% loading) 
Average hourly wage = $10
Weekly housekeeping costs were calculated as follows:
Expenditure for one week
Mon -Fri 5 x 40 x 10 = 2000
Sat 4 x 8 x 15 = 480
Sun 4 x 8 x 17.5 = 560
Total 3040
Expenditure for one year 
3040 x 52 = 158080
Cost per bed day
Total bed days for B4a and B4b = 8027
Housekeeping cost cover B4a ,B4b and B4c 
Therefore B4a and B4b use approximately 2/3 of costs.
2/3 x 158080/ 8027 = $13
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b) Intensive care
ICU (staff composite 1988 cost study) 
Weekday Staff 3 x full time at 7.6 hours 
Weekend Staff 2 x full time at 7.6 hours
Hours per week
Total 114 week day hours at $10 =1140
Total 15.2 Saturday hours at $15 = 228
Total 15.2 Sunday hours at $17.5 = 266
Total wages for one week 1634
Total wages for one year = 1634 x 52 84968
Cost per bed day 84968/ 3815 $22
for housekeeping
6. Meal unit cost Source: Ms Walker
Head of Dietetics
$5 each meal. Figure comprises of 2/3 S+W 1/3 G+S
Three meals per day = $15
Formula feeds would be more expensive (Figure not available).
7. Medical salaries source : Jan Perrot 
Medical Administration
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a) Ward staffing - resident medical officers 
B4a and B4b
1st Year Resident ( 4 allocated between both wards)
$31,346 per year based on a 40 hour week
On Costs Including overtime,superannuation, 
workers compensation
Add 50% to salary = 47,109
2nd Year Registrar ( 4 allocated between both wards)
$42396 per year based on a 40 hour week 
On Costs Including overtime,superannuation, 
workers compensation
Add 50% to salary = 63,594
4th Year Registrar ( 1 allocated between both wards )
$48,970 per year based on a 40 hour week 
On Costs Including overtime,superannuation, 
workers compensation
Add 50% to salary = 73,455
Cost per year for Full Time Equivalents
1st year resident = 4 x $47,109 = 188436
2nd year registrar = 4 x $63.594 = 254376
4th year registrar = 1 x $73,455 - 73455
Total medical salaries for one year 516267
279
b) ICU staffing
4 x residents 1st year 
4 x registrars 2nd year 
2 x registrars 4th year
Full-Time Equivalent costs
4 x 47019 = 188076
4 x 63594 = 254736
2 x 73455 = 293820
Total 736632
c) Visiting Medical Officers (Paediatrics) Source: Jan Perrit
Two specialists, four senior specialists 
Visiting Medical Officers Hours worked 1990
98.55
Specialists
Total Hours = 266.80
Rate of Pay (includes S25 private practice fee) per hour = $127.50 
Cost per Year =266.8 x 127.50 = $28917
Senior Specialists 
Total Hours = 1133.29
Rate of Pay (includes private practice fee) per hour= $135.50 
Cost per Year = 1133.29 x 135.50 = $153560.75
B4a and B4b
2 specialists at $127.50 x 266.8 hrs = 28917
4 senior specialists at $135.50 x 1133.29 hrs = 153560.75 
total salaries per year 182477.75
Inpatient proportion of these salaries was estimated at 70% of total
Two
Total V.M.O salaries for B4a and B4b 127734
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d) I.C.U Specialists
Four full time staff specialists
One full time staff specialist = 100,000
Total salaries for four full time specialists = 400,000
8. Transport costs
Care flight Source: Blair Munford
Deputy Medical Director
400 patients per year
Operational costs 1.8 million
Sponsorship .9 million
Cost to Health Service .9 -1 million
Cost per patient = no. of patients / cost to health service
400/1800,000 = $5000
Ambulance Service Barry 7334
As from 26/6/90
Minimum call out charge of $126 for First 16 km.
$3.22 for every extra km.
Sending hospital pays
Average trip is 25km
Cost = 126 + (9 x 3.22) = $154.98
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9. Costs of Laboratory tests and imaging
Imaging Medicare Item No. Schedule Fee
Chest X-ray 
Other Plain X-rays
2625 32.50
Foot/leg 2524 30.00
Hand/wrist/elbow 2508 27.50
C/T scan(brain)
Without I/V contrast 2458 67.00
With 1/V contrast 2459 60.75
With and Without 2460 126.00
Ultrasound 110
Nuclear Scan
Brain Study with Blood
Barrier Agent 8820 120.00
Laboratory Tests
CSF me + s 2099 37.15
CSF antigen 2130 21.00
Blood c + s 2124 16.50
Urine me + s 2128 19.90
Urine antigen 2130 21.00
Throat swab 2088 18.75
Full blood count 1173 17.25
Biochemistry 1159 9.90
Faeces c + s 2118 45.00
Sputum me + s 2190 27.40
Swabs - nasal,ear
eye,throat 2088 18.75
Antibiotic assay 2236 23.65
Drug Assay 1713 19.90
Blood gases 1591 32.25
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10. Long term costs
a) Hearing Problems Source: Roger Lovegrove
N.AJL 4126853 Chatswood
Estimates the cost of a hearing aid and follow-up to be around SlOOO.See letter for more details. 
Audiogram-air and bone
conduction and speech code 870 $31.00
Audiogram-air,bone,speech
♦other cochlear tests code 874 $38.00
11. Visits to a General Practitioner, Paediatrician 
Paediatrician
First visit code 110 $95.00
Subsequent visits code 116 $47.50
General Practitioner code 23 $21.00
Other Specialist code 88 $54.00
Physiotherapy $28.00
Occupational Therapy $29.00
Speech Therapy $42.00
CALCULATION OF BED DAY COSTS
1. Standard bed costs
BED DAYS B4A N = 5662 
Salaries and Wages 643638 / 5662
Goods and Services 41352 / 5662
Medical Salaries 516267 x .3 / 5662 
VM.O Salaries 127734 x .3 / 5662 
Pharmacy 5000/ 5662
Housekeeping
Meal unit cost =
Linen Costs =
= 113.677
= 7.303
= 27.354
= 6.76
.88 
13.00 
15.00 
11.58
Total cost per STANDARD bed day 195.02
2. High dependency costs 
BED DAYS B4b N = 2635
Salaries and Wages 862328 / 2635 = 327.259
Goods and Services 45578 / 2635 = 17.297
Medical Salaries 516267 x .7 / 2635 = 137.148
V.M.O Salaries 127734 x .7 / 2635 = 33.93
Pharmacy 5000/ 2635 = 1.89
Housekeeping = 13.00
Meal unit cost = 15.00
Linen Cost = 11.58
Total cost per HIGH DEPENDENCY bed day 557.
3. Intensive care costs
BED DAY COSTS I.C.U N = 3815 (1987/88 figures)
Salaries and Wages 3090517.71 / 3815 = 810.09
Goods and Services 663373.71 / 3815 = 173.88
Medical Salaries 736632.00/3815 = 193.00
V.M.O Salaries 400,000 / 3815 = 104.84
Pharmacy 31,000 /  3815 = 8.15
Housekeeping 81952 / 3815 = 22.00
Meal unit cost = 15.00
Other costs (from R.A.H.C costing ) 
Linen costs = 11.58
Biomedical Engineering = 3.69
Inhalation Therapy = 2.63
Sterilising = 18.70
Total cost per INTENSIVE CARE bed day 1363
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CALCULATIONS OF COSTS FOR DISEASE CATEGORIES 
Five categories of disease type and category of care were used:
1. Meningitis I.C.U - those having spent part of their hospital stay in I.C.U.
2. Meningitis non I.C.U
3. Epiglotittis
4. Arthritis
5. Other
The last two categories were grouped together for some of the calculations.
Figures for imaging, drugs and laboratory tests were calculated using the sum of the particular item per category 
divided by the sum of the cases in that category.
Some of the calculations of bed day costs were based on data from both the prospective and the retrospective 
studies (where indicated). Otherwise calculations and data were derived from the prospective study only.
Deaths were excluded from the cost study.
Long term and follow up costs were calculated from the prospective study only. Data was collected from 
parents,doctors and hospital notes.
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1. MENINGITIS I.C.U N=13
Drug costs (ampicillin.chloramphenicol.cefotaxime) 
Total grams x cost (Westmead Pharmacy) / 13 187.8
Imaging
Total imaging x schedule fee (medicare) / 13 362.38
Laboratory Tests
Total tests x schedule fee (medicare) / 13 432.79
Total 982.97
Transport Costs
Ambulance and Helicopter (46% transported) / 13 1562
Bed Day Costs
Using cases from prospective and retrospective studies.
Days ICU = days ventilated
Days HD = days in ICU but not ventilated
Ratio days ICU to days HD = 6:4
Standard Days = Sum of total hospital days - sum of ICU days
Number of cases = 48
Days ICU (ventilated & non ventilated) = 169
Days ICU (ventilated) = .6 x 169 = 101
Days HD (non ventilated) = .4 x 169 = 68
Standard Days = 644
Bed Day Cost -Actual
Days ICU = 169 x 1362.42 = 
Standard = 644 x 197.06 =
230249
126906.6
Total
Mean
357155.60
7440.74
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Cost per hospital day in each category. 
costs: cost categories
LOW BASE HIGH ACTUAL
BED DAYS 6301.70 6301.72 6301.70 7440.74
IMAGING ETC 983 983 983 983
TRANSPORT 781(23%) 1562(46%) 2343(69%) 1562(46%)
TOTAL COST 8065 8846.72 9627.70 9985.74
2. MENINGITIS NON I.C.U N=71
Drug costs (ampicillin'Chloramphenicol.cefotaxirne)
Total grams x cost (Westmead Pharmacy) / 71 187
Imaging
Total imaging x schedule fee (medicare) / 71 118
Laboratory Tests
Total tests x schedule fee (medicare) / 71 
Total
Transport Costs 
Ambulance /  71 
Calculations of bed day costs
Actual bed days calculated using cases from Westmead Hospital (both retrospective and prospective cases)
1) mean bed days HD x cost per bed day / N plus 
mean bed days standard x cost per bed day / N
2) median bed days HD x cost per bed day / N plus 
bed days standard calculated as sum of total bed days -
(median bed days HD x number of cases) x cost per bed day/ N
Number of cases = 25
Sum days HD = 164 Mean days HD = 6.56 
Median = 5
Sum Hospital Days = 360 Mean Hosp Days = 14.4
All the below are calculated using prospective and retrospective cases and based on a mean for total hospital days of 
14. HD days estimated from Westmead data on days of monitoring/observations.
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525
26
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Cost per hospital day focusxost category
LOW BASE HIGH ACTUAL
BED DAY COST 3120 3481.54 4565.59 5207.64
IMAGING 525 525 525 525
TRANSPORT 13(9%) 26(17%) 39(26%) 26(17%)
TOTAL COST 3658 4032.54 5129.59 5758.64
3. EPIGLOTTITIS N=45
Drug costs (ampicillin.chloramphenicohcefotaxime)
Total grams x cost (Westmead Pharmacy) / 45 57.27
Imaging
Total imaging x schedule fee (medicare) / 45 65
Laboratory Tests
Total tests x schedule fee (medicare) / 45 89.33
Total 211.60
Transport Costs
Ambulance and Helicopter / 45 (75%) 854
Ambulance and Helicopter / 45 (50%) 569.33
Ambulance and Helicopter / 45 (100%) 1138.66
Calculations of bed day costs
Actual bed days calculated using both retrospective and prospective cases 
Number of cases = 136 Total ICU days = 390 Total Hospital Days = 683
1) sum of bed days ICU x cost per bed day / number of cases plus 
sum of bed days standard x cost per bed day / number of cases
Actual Cost
Bed Day Costs 4331.48 Drug costs .ImagingJLaboratory Tests
211
Transport Costs ( 60% transported) 846
Total 5396.48
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Cost per hospital day in each category, costs: cost categories
LOW BASE HIGH ACTUAL
BED DAYS 2117.89 3480.31 4842.73 4331.48
IMAGING ETC 211 211 211 211
TRANSPORT 564(40%) 846 (60%) 1128 (80%) 846 (74%)
TOTAL COST 2892.89 453731 6181.73 5388.48
4. OTHER & ARTHRITIS N=34
Drug costs (ampicillin,chloramphenicol,cefotaxime)
Total grams x cost (Westmead Pharmacy) / 34 82.19
Imaging
Total imaging x schedule fee (medicare) / 34 60.12
Laboratory Tests
Total tests x schedule fee (medicare) / 34 66.43
Total 208.7
Transport Costs
Ambulance / 34 13.64
Total cost per child 222.39
OTHER
Bed Days calculated from retrospective and prospective studies.
Bed days standard - sum of bed days x cost /  N 
Only actual costs calculated.
Cost for transport and imaging based on figures for focus = other + focus = arthritis.
Number of cases = 71 
Bed days = 447
Mean = 6
Actual
Bed day costs 447 x 197.06 / 71 
Imaging,drugs, tests =
Transport costs =
1240.65
208.1
13.64
Total 1462395
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ARTHRITIS
Bed Days calculated from retrospective and prospective studies.
Bed days standard - sum of bed days x cost / N 
Only actual costs calculated.
Cost for transport and imaging based on ’other’ figures (focus = other + focus = arthritis).
Number of cases = 19 
Hospital days = 224 
Mean = 11
Median = 11
Actual
Bed day costs 224 x 197.06 
Imaging,drugs,tests 
Transport costs
2323.23
208.1
13.64
Total 2544.94
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FOLLOW UP COSTS FOR EACH DISEASE CATEGORY 
1. Meningitis
Follow-up costs for meningitis were calculated in two categories - patients with meningitis who had abnormalities at 
the time of hospital discharge and were therefore likely to require more intense follow-up and patients who were 
normal at hospital discharge and likely to have one or two follow-up visits only
Meningitis who had abnormalities on discharge N = 22 :
Paediatrician 105 x 47.5 / 22 = 
General practitioner 19 x 21 / 22 = 
Audiometry 28 x 38 / 22 =
226.7
18.1
48.33
Total 293.11
Long Term Therapy :
6 needed at least weekly visits to one or more therapist 
3 needed physio + speech therapist 
1 needed speech therapy only 
1 needed physio + occupational therapist 
1 needed physio + O.T + S.T
Calculations based on a six month period :
Physio = $28 x 26(weeks) = 
O.T = $42 x 26 
S.T = $29 x 26
726
1092
754
Totals
5 need Physio = 5 x 726 = 
5 need S.T = 5 xl092 
2 need O.T = 2 x 754 =
3630
5460
1508
Total cost for six cases 10598
Short term therapy
3 x physio = 3 x 76 =
4 x ENT = 4 x 54 = 
Total
78
216
294
total cost of other therapists =10598 + 294 = 
Mean cost of other therapists =
10892
453
TOTAL COST OF FOLLOW UP = 453 + 293.11 = $746
(abnormal at discharge)
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Mengititis patients who were normal on discharge N = 62 :
Paediatrician 138 x 47.5 / 62 = 105.7
General practitioner 4 1 x 2 1 / 6 2  = 13.88
Audiometry 55 x 38 / 62 = 33.7
Other Therapists 4 X 54 / 62 = 3.354
TOTAL 156.33
Mean Follow Up cost for Meningitis was then calculated : 
N = 88
26% abnormal at discharge 74% normal at discharge 
of these |
/ \  1 
27% need weekly therapy 73% need some Fup
+ 1 
regular medical Fup 1 
at a cost of at a cost of regular F-up
$746 $293 $156
Cost per 100 cases
26 x .27 x 746 = 
26 x .73 x 293 = 
74 x 156 =
5236.92
5561.14
11544.14
Total 2234.06
Mean cost of = $223.4
meningitis follow-up
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2. Epiglottitis N = 45
Paediatrician 24 x 47.5 /  45 = 25.33
General practitioner 1 4 x 2 1 / 4 5  = 6.53
Total 31.86
3. Arthritis N = 6
Paediatrician 2 x 4 7 . 5 / 6  = 15.83
General practitioner 3 x 2 1 / 6  = 10.50
Other 2 x 54 /  6 = 18.00
Total 44.33
4. Oher cases N = 28
Paediatrician 21x 47.5 / 2 8  = 35.62
General practitioner 12 x 21 /  28 = 9.00
Total 44.62
SU M M A R Y  O F  F O L L O W  U P C O ST S
M eningitis __ 223.4
Epiglottitis = 31.86
Arthritis —
Other = 44.62
COSTS OF PARENTS LOST TIME FROM WORK
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The cost of lost employment time for parents was calculated from average weekly earnings and the average number 
of days taken off work by parents whose children had infection in each of the categories
Cost per working Day from ABS figures = $109.5
Calculated from mean number of days taken off work (per focus)
Mean multiplied by number who took time off work/ by total number in focus group.
Meningitis (ICU) = 12.4 x 10 x 109.5 / 13 = 1044.46
Meningitis (abnormal) = 8.6 x 15 x 109.5 / 22 = 642.1
Meningitis (normal) = 6.79 x 38 x 109.5 / 62 = 455.69
iglottitis = 5.6 x 25 x 109.5 / 45 = 340.66
thritis = 5.5 x 3 x 109.5 / 6 = 301.125
her = 7.7 x 13 x 109.5 / 28 = 392.46
e following table shows who in the family took time off work
ither father both Total
15 1 311 8 I 54 | 57.4% meningitis
8 1 10 7 25 | 26.6% epiglottitis
1 1 H 2 I 4 | 4.3% cellulitis
1 3 1 1 3 | 3.2% arthritis
3 2 I 5 5.3% pneumonia
2 1 2 2.1% bacteraemia
1 1 1 1 1 | 1.1% other
24 1 511 
1
19 | 94 | 100.0% Total
5.5% 54.3% 20.2% 100.0%
>ST OF RIFAMPICIN PROPHYLAXIS
>lic sector cost $ 6.64 / adult(dose) x 3 =$19.92 
$22.63 / syrup bottle
erage of 3 adults and one child in contact group = 19.92 + 22.63 = $42.55 
3f cases/contacts taking prophylaxis
ningitis 87% cost = .87 x 42.55 = $37 / case
glottitis 70% cost = .70 x 42.55 = $30 / case
ier 38% cost = .38 x 42.55 = $16 / case
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The following table sum m arises all the cost categories and sums them by disease category :
COSTS FOR H O SPITA L STAY. FOLLOW UP AND ASSOCIATED COSTS BY FOCUS
HOSPITAL COSTS FOLLOW UP DAYS OFF WORK RIFAMPICIN TOTAL
MEN ICU 9985 223 1044 37 11289
MEN NON ICU 5758 223 383 37 6401
EPIGLOTTITIS 5388 31 340 30 5789
ARTHRITIS 2544 44 301 16 2905
OTHER 1462 44 392 16 1914
THE RANGE O F HOSPITAL COST ESTIMATES BY FOCUS
LOW BASE HIGH ACTUAL
MEN ICU 7580.70 8361.7 9142.70 9500
MENINGITIS 3658 4032.54 5129.59 5758
EPIGLOTTITIS 2892.89 4537.31 6181.73 5388.4
ARTHRITIS 2544.94
OTHER 1462395
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APPENDIX SIX
QUESTIONNAIRE FOR CASE-CONTROL STUDY
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HAEMOPHILUS 
- RISK
INFECTION IN SYDNEY CHILDREN 
FACTOR QUESTIONNAIRE
Phone No: ......
Suburb: ........
Questionnaire No: 
Interviewer: ....
Good Moming/Aftemoon/Evening.
Is this .............  (repeat telephone number) ?
My name is ..............  from Westmead Hospital Childrens Department.
We are doing a survey to help find out why some young children 
get serious infections while others don’t. We need to talk 
to the parents of children under 5 years old. Do any 
children under 5 years old normally live in this household?
YES continue
NO thankyou for listening so far, I appreciate your cooperation.
Are you their parent or guardian?
YES continue
NO ask to speak to the mother or primary care giver of the child
and repeat the introduction. If the mother or primary care 
giver is not available, ask when you can ring back and record 
the time and date in the comment column.
Young children in America and some European countries are being 
immunised against meningitis and other serious infections.
This survey will help in deciding if this new type of immunisation 
should be started in Australia. It will take about 15 minutes and is 
completely confidential. Would you be able to help me?
First, I'd like to ask you some questions about the people in your 
household.
Q1. What are the names and ages in years and months of the child 
(children) under 5?
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1) Name................  years  months M F
2) Name................  years  months M F
3) Name................  years  months M F
4) Name................  years  months M F
Q2. Are there any older children who go to school?
YES...... 1
NO....... 2
IF YES,
Q3- What are their ages ?
1)   years
2 )   years
3 )    years
4)      years
04. How many adults including yourself are living in your 
house at present?
1 2 3 ^ 5 6 7 8 9  >=10
IF THERE IS A CHILD LESS THAN 2 YEARS GOTO Q5-, OTHERWISE GOTO 
Q7. , ASKING ABOUT THE YOUNGEST CHILD FIRST
Q5- Was (childs name)...........breast fed?
Yes 1 
No 0
IF YES GOTO Q.6 , OTHERWISE GOTO Q.7
06. How many months was ....... breast fed for?
mths.
1
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Q7 • Has ............ been looked after by anyone else
apart from you or his/her father in the past week?
Y e s ..1 
No.. .0
IF NO, GOTO Q8 . IF YES GOTO Q 9 .
Q8. Has ............. been looked after regularly by anyone
in the last six months?
Y e s . . 1 
N o ... 2
IF YES GOTO Q9. .OTHERWISE GOTO Q.l4
Q9. Is ........... normally looked after with other children?
Y e s ..1 
No.. .0
IF YES GOTO Q. 10, OTHERWISE GOTO Q.l4
Q10.Where i s ............... looked after?
YES NO
own home......... 1
another home.... 2
day care centre . . 3
preschool........ 4 ___
other..............  ...  ...
specify ______________________________ 5
_____________  6
Qll. How often does ............. attend (each centre mentioned)
type of centre ______________
at least once a week............1
at least once a fortnight......2
less than once a fortnight.....3
2
type of centre
at least once a week.......... 1
at least once a fortnight..... 2
less than once a fortnight....3
type of centre _____________
at least once a week.......... 1
at least once a fortnight..... 2
less than once a fortnight....
Q12. Which days does attend (each centre mentioned)
Centre Centre Centre
MON MON MON
TUE TUE TUE
WED WED WED
THU THU THU
FRI FRI FRI
SAT SAT SAT
SUN SUN SUN
ASK Q13. FOR EACH DAY GIVEN IN Q12.
Q13- How many hours does ....... attend (each centre mentioned in
Q.ll) on (day of the week)?
MON HRS MON HRS MON HRS TOTAL
TUE TUE TUE HOURS
WED WED WED PER
THU THU THU WEEK
FRI FRI FRI
SAT SAT SAT =
SUN SUN SUN
Ql4. We would like to contact (each centre mentioned)
to check details like the number of other children 
attending. Are you happy for us to do that?
YES___1
NO....2
IF YES,
Could you tell me the address and phone number of (each C)
Name............  Name..............  Name.............
Address.........  Address...........  Address..........
Phone Phone Phone
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Confirmed HRS. 
Number on roll
0- 1 yrs
1- 3 yrs 
3-5 yrs
Confirmed HRS. 
Number on roll
Confirmed HRS 
Number on roll
Now I would like to ask you some questions about which 
immunisations and illnesses .......... has had.
Q15. Has ....... ever been given any triple antigen injections ?
IF NO, GOTO Q16, IF YES GOTO Ql8.
Ql6.Has ........ ever been given any combined diptheria/tetanus
injections i.e. CDT
IF NO, GOTO Q17, IF YES GOTO Ql8
017-Has ........ ever had any injections against whooping cough
diptheria or tetanus?
YES NO DON'T KNOW
PERTUSSIS...... ....... 1 . . . ...2.......3.....
DIPTHERIA...... ....... 1 . . . ...2.......3.....
TETANUS........ ....... 1 . . . ...2.......3....
Ql8. Including boosters, how many of these injections has 
been given?
ONE.......... 1
TWO.......... 2
THREE........ 3
FOUR OR MORE..4
Q19- Has....... ever had measles?
YES........ 1
NO......... 2
IF CHILD IS LESS THAN 18 MONTHS OR YES, GO TO Q.21 
IF CHILD IS 18 MONTHS OR OLDER AND NO GO TO Q.20
020. Has ........ been given any injections against measles?
4
YES.......... 1
NO........... 0
DON’T KNOW___
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021. Where did ......go to recieve his/her immunisations?
LOCAL DOCTOR..... 1
COUNCIL CLINIC... 2
DOCTOR & CLINIC___3
HOSPITAL......... 4
OTHER
specify_________________________________________  5
022. Have you ever been given a card or booklet to list the
immunisations your child has had?
YES...............1
NO................0
Q23. If YES, Do you keep it up to date?
NO 0 
NO 0
YES...............1
NO................0
Q2^. Does ........ have any medical problem that he/she
has to see a doctor or hospital regularly for?
NO................0
YES
specify_____________________________________  1
Q25. How many visits to the doctor has 
had in the last six months?
NONE....... 0
ONE........ 1
TWO........ 2
THREE...... 3
MORE THAN 3 
specify_____
Q26. WOULD YOU BE HAPPY FOR US TO CONTACT YOUR D0CT0R/CLINIC TO 
CHECK THEIR RECORDS ABOUT .......... ?
YES......1
NO.......0
IF YES,
Could you give me the name and address of your doctor/clinic? 
Clinic/Doctor..........  Doctor...................
Address Address
Immunisations
DTP/CDT........1 2 3 4
MEASLES........YES NO
DATE CONTACTED
Visits last 12 mths _____
Antibiotics 3 mths _____
DTP/CDT...........1 2 3 i}
MEASLES...........YES NO
DATE CONTACTED
5
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Q27. How many other children usually sleep in the same room 
as ..........?
NONE................ 0
ONE................. 1
TWO................. 2
THREE............... 3
FOUR OR MORE........ 4
REPEAT QUESTIONS 5 TO 27 FOR ANY OTHER CHILD UNDER 2 YEARS AND 
QUESTIONS 6 TO 27 FOR ANY OTHER CHILD 2 TO 5 YEARS
Now I would like to ask you some questions about your family 
background and your household
Q28. Did your family live at this address one year ago?
Yes.............. 1
No............... 2
If No Within Sydney.... 1
In NSW,Town...... 2
In NSW,Rural..... 3
Interstate....... 4
Overseas......... 5
If 1-4, POSTCODE
Q29. Are you or .......'s father of Aboriginal or Torres Strait
origin ?
No............... 0
Yes, Aboriginal...1 
Yes, Torres St....2
Q30. Was born in Australia?
Yes.............. 1
No..............  0
Specify
Q31. Were you or ......... ’ s father born overseas?
No...............0
Yes......... . ....1
Country
Country
6
Q32. What language do you usually speak at home?
English................. 1
Other _______________ 2
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Q33• What country does your family come from originally?
Australia............... 1
Other 2
Q34. How many rooms are there in your family's house?
BEDROOMS........................ .......
COMBINED LOUNGE/DINING ......... .......
LOUNGE ROOM..................... .......  TOTAL
DINING ROOM..................... ....... ROOMS
KITCHEN......................... .......
BATHROOM........................ .......
FAMILY ROOM..................... .......
STUDY........................... .......
OTHER ROOMS................ ....
Q35* How many people usually sleep in the house?
Q36. What best describes the type of building 
you are living in?
READ OUT LIST
Separate house......................................1
Semidetached house..................................2
Row or Terrace house................................3
Town house..........................................4
Flat or Unit in a building over 3 stories............5
House or flat attatched to another dwelling..........6
Other specify.______________________________________ 7
Q37. What is your marital status?
READ OUT LIST
Single............1
Married...........2
Divorced..........3
Separated.........4
Defacto...........5
Widowed...........6
Q38. Do you have a fulltime or parttime paid job at present?
YES...............1
NO................0
7
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Q39- Does your partner (husband/wife) have a fulltime or parttime 
paid job at present?
YES............... 1
NO................ 0
Q40. Do you recieve any financial assistance from the government?
NO................ 0
YES
specify______________________________________________
Q4l. Does anyone in the household own a motor vehicle?
YES............... 1
NO................ 0
Q42. What is the highest level of education you have had? 
PROMPT ONLY WHEN NECESSARY
No schooling...................................... 0
Primary schooling only............................ 1
Intermediate/up to 3 years high school............ 2
School Certificate................................ 3
HSC/Leaving Certificate/Matriculation............. 4
Trade Certificate................................. 5
Technical College Diploma or equivalent............6
Graduate or Postgraduate Degree................... 7
Other (please specify)
_______________________ 8
Q42. What is the highest level of education your partner 
has had?
PROMPT ONLY WHEN NECESSARY
No schooling.......................................0
Primary schooling only.............................1
Intermediate/up to 3 years high school............ 2
School Certificate.................................3
HSC/Leaving Certificate/Matriculation............. 4
Trade Certificate..................................5
Technical College Diploma or equivalent_____....... 6
Graduate or Postgraduate Degree................... 7
Other (please specify)
8
8
Q43. What is the total family income before tax is taken out?
Per week Per year
<170 <9000..............0
170 - 290 9 - 15000.......... 1
290 - 420 15 -22000.......... 2
420 - 500 22 -26000 ......... 3
500 - 610 26 -32000.......... 4
610 - 760 32 -4 0 0 0 0.......... 5
760 - 950 40 -5 0 0 0 0.......... 6
960 plus 50000 plus......... 7
PENSIONER ........ 8
DON’T KNOW ....... 9
Q44. How many adults in the household smoke tobacco?
NONE.... 0
ONE..... 1
TWO..... 2
>=THREE..3
THANKYOU VERY MUCH FOR YOUR COOPERATION IN THIS SURVEY
9
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APPENDIX SEVEN
ADDITIONAL TABLES FROM CHAPTER RYE
307
Table A1 NON-ENGLISH SPEAKING PERSONS ACCORDING TO LANGUAGE
GROUPS IN SUBDIVISIONS OF THE SYDNEY STATISTICAL DIVISION 1986
STATISTICAL NON-ENGLISH ARABIC CHINESE/
SUBDIVISION SPEAKING VIETNAMESE
% % %
Northern 10.5 0.6 1.7
Central, Eastern 
and Southern 18.9 2.1 2.2
Western 19.1 3.3 1.7
Outer west 8.3 0.3 0.3
South west 29.2 4.7 4.3
Central coast 2.7 0.1 0.2
TOTAL 19.7 2.3 2.4
(N=3364858) (N=663506) (N=76503) (N=80354)
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TABLE A2
FOCUS OF 
INFECTION
MENINGITIS 
One child*
Two children 
Three or more
EPIGLOTTITIS 
One child*
Two children 
Three or more
OTHER FOCI 
One child*
Two children 
Three or more
ALL STRATA 
One child*
Two children 
Three or more
NUMBER OF CHILDREN UNDER FIVE YEARS IN THE HOUSEHOLD 
BY FOCUS OF INFECTION
CASES CONTROLS OR
30 163 1.0
36 52 3.76
9 11 4.45
15 75 1.0
15 17 4.41
2 2 5.00
12 52 1.0
22 11 2.17
3 1 13.0
57 290 1.0
62 91 3.47
14 14 5.27
(95% Cl) Heterogeneity test
referent
2.0 - 7.0 
1.5 - 12.9
referent 
1.7-11.8 
0.5 - 55.5
referent
0.8 - 6.3
1.0 - 356.7
referent
2.2 - 5.5 0.52
2.2 - 12.6 0.70
Test for trend significant (P<0.01)
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TABLE A3 TOTAL NUMBER OF CHILDREN IN THE HOUSEHOLD BY AGE GROUP
AGE GROUP CASES CONTROLS OR (95% Cl) Homogeneity
0 to 12 months* 
One child 6 41 1.0 referent
test (P)
Two children 18 28 4.39 1.4 - 14.3
Three or more 23 17 9.25 2.9 - 31.1
13 to 24 months
One child 10 39 1.0 referent
Two children 11 28 1.53 0.5 - 4.6
Three or more 12 20 2.34 0.8 - 7.2
25 to 36 months
One child 2 27 1.0 referent
Two children 15 30 6.75 1.3 - 47.2
Three or more 7 24 3.94 0.7 - 30.6
37 to 60 months
One child 4 24 1.0 referent
Two children 17 61 1.67 0.5 - 6.6
Three or more 8 56 0.86 0.2 - 3.8
All strata*
None 22 131 1.0 referent
One child 61 147 2.73 1.5 - 5.1 0.24
Two or more 50 117 3.18 1.8 - 6.6 0.03
Test for trend significant (P< 0.001)
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TABLE A4
AGE GROUP
0 to 24 months
Less than 0.8 
0.80 and higher
25 to 60 months
Less than 0.8 
0.80 and higher
Both strata
Less than 0.8 
0.80 and higher
HOUSEHOLD CROWDING (>0.8 PPROOM) BY AGE GROUP
CASES CONTROLS OR (95% Cl) Heterogeneity test
68 162 1.0 (referent)
11 12 2.60 1.0 - 6.7
51 200 1.0 (referent)
2 22 0.36 0.1 - 1.6
119 362 1.0 (referent)
14 33 1.30 0.6 - 2.6 P = 0.015
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TABLE A6 RELATIONSHIP BETWEEN HOUSEHOLD CROWDING AND THE
NUMBER OF PERSONS IN THE HOUSEHOLD (cases and controls N=528)
PERSONS PER ROOM
VARIABLE < 0.8 >0.8 OR (95% Cl)
Number of children 
less than 5 years
One child 326 22 1.0 referent
Two or more children 155 25 2.39 1.3 - 4.6
Number of school- 
aged children
None 264 9 1.0 referent
Any 217 38 5.14 2.3 - 11.7
No siblings 152 1 1.0 referent
One sibling 200 8 6.08 0.8 - 131
Two siblings 129 38 44.8 6.5 - 890
Number of adults
Two or less 451 35 1.0 referent
More than two 30 12 5.15 2.3 - 11.6
Number of persons
Four or less 342 2 1.0 referent
Five or six 128 28 37.4 8.5 - 231
11 17 264.3 49 - 1907Seven or more
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TABLE A7 NUMBER OF CHILDREN SLEEPING IN THE SAME ROOM
AS THE INDEX CHILD
AGE GROUP CASES CONTROLS OR (95% Cl) Homogeneity 
test (I
0 to 24 months
None 55 142 1.0 referent
One or more 25 31 2.08 1.1 - 4.0
25 to 60 months
None 34 142 1.0 referent
One or more 19 80 0.99 0.5 - 1.9
Both strata
None 89 284 1.0 referent
One child 44 111 1.43 0.9 - 2.3 0.10
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TABLE A8
CATEGORY
CHILD CARE BY AGE AND NUMBER OF SIBLINGS
CASES CONTROLS OR (95% Cl)
Age 0-24 months 
and no siblings
No child care 6 62 1.0 referent
Any child care 10 18 5.74 1.6 - 21.1
Age 0 - 24 months 
and has siblings 
No child care 38 78 1.0 referent
Any child care 26 15 3.56 1.6 - 8.0
Age 25 - 60 months 
and has no siblings 
No child care 0 17 1.0 referent
Any child care 6 34 infinity
Age 25 - 60 months 
and has siblings
No child care 15 75 1.0 referent
Any child care 32 96 1.67 0.8 - 3.5
All strata 
No child care 59 232 1.0
74 163 2.83
Homogeneity 
test (P)
Any child care 1.8 - 4.8 P= 0.15
TABLE A9 CHILD CARE BY AGE AND NUMBER OF SIBLINGS
LESS THAN FIVE YEARS OF AGE
AGE AND NUMBER 
OF SIBLINGS
0-24 months
CASES CONTROLS OR (95% Cl)
No young siblings :
No child care 14 90 1.0 referent
Any child care 18 24 4.82 2.0 - 12.1
Young siblings :
No child care 30 50 1.0 referent
Any child care 
25 - 60 months
18 9 3.33 1.2 - 9.3
No young siblings :
No child care 7 69 1.0 referent
Any child care 18 107 1.66 0.6 - 4.6
Young siblings :
No child care 8 23 1.0 referent
Any child care 20 23 2.50 0.8 - 7.7
All strata
No child care 59 232 1.0
Any child care 74 163 2.89 1.8 - 5.0
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TABLE A10 CHILD CARE BY AGE AND NUMBER OF SCHOOL-AGE SIBLINGS
AGE AND NUMBER CASES CONTROLS OR (95% Cl) Homogeneity
OF SIBLINGS test (P)
0-24 months
No school-age siblings :
No child care 22 98 1.0 referent
Any child care 24 25 4.28 2.0 - 9.5
School-age siblings :
No child care 22 42 1.0 referent
Any child care 12 8 2.86 0.9 - 9.2
25 - 60 months
No school-age siblings :
No child care 4 28 1.0 referent
Any child care 13 49 3.29 0.9 - 12.5
School-age siblings :
No child care 11 64 1.0 referent
Any child care 15 81 1.08 0.4 - 2.7
All strata 
No child care 59 232 1.0
74 163 2.55Any child care 1.6 - 4.3 P= 0.09
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TABLE A11 CURRENT VS NO AND PREVIOUS BREAST-FEEDING BY AGE GROUP
AGE GROUP AND 
BREAST-FEEDING 
STATUS
CASES CONTROLS OR (!
0 to 6 months
No breast-feeding 3 5 1.0 referent
Prior breast-feeding 4 10 0.62 0.1 - 5.9
Current breast-feeding 10 18 0.93 0.1 - 7.3
7 to 12 months
No breast-feeding 6 10 1.0 referent
Prior breast-feeding 13 22 0.99 0.3 - 4.1
Current breast-feeding 11 20 0.92 0.2 - 4.0
13 to 24 months*
No breast-feeding 8 7 1.0 referent
Prior breast-feeding 24 74 0.29 0.1 - 1.0
Current breast-feeding 1 6 0.16 0.0 - 1.8
All strata
No breast-feeding 17 22 1.0 referent
Prior breast-feeding 41 107 0.53 0.2 - 1.2
Current breast-feeding 22 44 0.65 0.3 - 1.7
Test for trend significant (P < 0.05)
